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Lay summary 
Influenza A virus (IAV) circulates in wild aquatic birds naturally, however, in some 
occasions, it can be spread to other hosts, such as chickens, ducks, horses, pigs, or humans. 
The infectious particle of IAV can display a range of shapes under the microscope, from small 
spherical particles to semi-long (designated bacilliform) or very long filamentous particles that 
are similar in appearance to a string of rope. In hosts such as humans or horses, it is common 
to find bacilliform or filamentous particles, which are lost when the virus is propagated repeatedly 
under laboratory conditions. Therefore, this suggests that the longer particles are necessary to 
ensure viral survival in those hosts. Furthermore, inside influenza particles lies the virus genetic 
material divided into 8 segments, which has previously been shown to contain a “signature” in 
segment 7 (M) that determines the shape of the infectious particle. Although these shapes of 
virus have been the focus of many studies since the late 1940s, to date there is still debate about 
their biological significance. Nonetheless, some studies have implied that filamentous particles 
play a role in host-to-host transmission. However, this is mainly known for mammalian hosts like 
humans or horses, yet IAV also infects birds, such as chickens, ducks or turkeys. Thus, knowing 
that IAV can spread from birds to animals and that the virus shape plays a role in host-to-host 
transmission, it is important to further explore the virus shape of avian-originated IAV.  Therefore, 
the main aim of this study was to investigate the shape of IAV particles that come from avian 
hosts, determine if their segment 7 also possess the “signature” found in human and equine 
strains of IAV and, lastly, if avian-origin IAV are also filamentous, then investigate the biological 
significance of this shape in a natural influenza infection.  
In this study we found that infectious particles of avian IAV display spherical and 
filamentous shapes, similar to what is observed in human and equine IAV. Furthermore, 
segment 7 was revealed to be very important in determining the virus shape, however the 
previous “signature” was not found in avian IAV. In fact, in avian viruses we identified a novel 
“signature” that set the shape of avian viruses available in the laboratory. Additionally, we also 
built pairs of otherwise identical viruses with spherical or filamentous shapes, and examined 
their replication in eggs, which revealed that those that produced spheres grew better than ones 
that produced filamentous particles. This explains why filamentous particles are lost upon growth 
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of viruses under laboratory conditions, as mentioned before. Lastly, to address the biological 
significance of the different shapes, we used an avian virus in which we could control particle 
shape to infect chickens and mimic a natural influenza infection. The filamentous virus was shed 
by the infected birds for longer periods of time, which also correlated with longer persistence 
within the host and in the environment. Therefore, this supports the hypothesis that filamentous 
particles are involved in host-to-host transmission. Overall, this study showed that filamentous 
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Abstract 
Pleomorphism is a characteristic of influenza A virus (IAV), which can produce spherical 
particles of ~100 nm in diameter and filaments up to 30 µm in length. Laboratory-adapted strains 
mainly produce spherical virions, whereas clinical isolates of human and equine strains of IAV 
are mostly filamentous, thus suggesting that this latter virion morphology may be involved in 
viral fitness in vivo. Furthermore, M1 is known to be the main morphology determinant of 
mammalian strains of IAV, and a “filamentous signature” within its amino acid sequence has 
been shown to switch virus budding between spherical and filamentous phenotypes. Even 
though filamentous virions have been consistently detected in clinical isolates of human and 
equine IAV, their biological significance still remains unclear, although recent studies have 
implied a role in transmission.  
In contrast, budding morphology of avian strains of IAV remains less well characterised 
with several unanswered questions, such as: (i) what is the predominant budding phenotype of 
avian IAV; (ii) is segment 7 also a major morphology determinant and, if so, is the mammalian 
“filamentous signature” present; and (iii) if avian IAVs do produce filamentous virions, what is 
their biological significance in this host? Therefore, the aim of this study was to answer these 
questions, starting with characterising the budding phenotype of 8 avian isolates by 
immunofluorescence assays (IF), which showed that avian isolates of IAV are as pleomorphic 
as mammalian isolates. Furthermore, using reverse genetics we identified avian segment 7 as 
the main determinant of budding morphology. Thus, in order to test a higher number of avian 
strains, complete nucleotide sequences of avian segment 7s available online were collected and 
organised into a phylogenetic tree, which was divided into clades (1 to 11) and fitted with 
segment 7s from avian strains available in the laboratory. For the clades with no representation, 
segment 7s were randomly selected, synthesised and cloned in a reverse genetics plasmid 
vector (pDUAL). Using this method, a total of 17 avian segment 7s were characterised as 7:1 
reassortant viruses in the background of the laboratory strain A/PR/8/34 (PR8). Similar to 
mammalian segment 7s, avian segment 7s showed a pleomorphic budding phenotype in the 
PR8 backbone and some were able to produce filaments up to 10 µm in length. However, when 
sequence alignment was performed with the avian M1 amino acid sequences, grouped 
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according to budding phenotype, this showed that avian strains do not contain the same 
mammalian virus “filamentous signature”. and, in fact, do not show a consistent pattern of amino 
acid alterations that would explain the different morphologies. However, by performing site-
directed mutagenesis on closely related avian strains with opposite budding phenotypes, we 
identified M1 positions 59, 169 and 234 as morphology determinants. Furthermore, it was 
observed that chicken viruses were mainly spherical while duck viruses were predominantly 
filamentous. Bioinformatics coupled with statistical analysis led to the hypothesised identification 
of position 234 of M1 as a novel avian host species-dependent morphology determinant of IAV 
budding, as we observed that spherical chicken viruses mainly possessed isoleucine at this 
position while filamentous duck viruses had leucine. To test this, a spherical chicken virus 
(A/chicken/Pakistan/UDL-01/2008 H9N2 [Ck/Pakistan]) with isoleucine at position 234 of M1 
was mutated to encode a leucine at this position. This resulted in conversion of a spherical 
chicken virus to a filamentous virus. Next, all the M1-mutant viruses and their WT counterparts 
were characterised in vitro and in ovo, showing that in vitro, spherical or filamentous 
morphologies were equally advantageous, whereas in ovo the spherical viruses showed a 
fitness advantage in some of the viruses characterised. Additionally, the ability to alternate the 
budding phenotype of Ck/Pakistan by a single amino acid change at position 234 of M1 provided 
the opportunity to determine the biological significance of filaments in vivo. Contact-infected 
birds with the filamentous mutant virus showed prolonged but similar higher-titre buccal 
shedding than the equivalent spherical virus. This observation correlated with the longer-lasting 
persistence of the filamentous virus in the environment and in vivo. Additionally, within the 
chicken host, spherical and filamentous morphologies replicated to comparable titre in the nasal 
tissues, but the filamentous virus showed a replication advantage in the tracheal tissues.  
Overall, this study showed that avian IAVs are as pleomorphic as human and equine 
IAVs. It also showed that avian IAVs budding morphology is determined by segment 7 but that 
these do not follow the genetic determinants identified in mammalian strains as defining budding 
morphology. Instead, this study identified a novel position within M1 that was able to determine 
budding phenotype in an avian host species-dependent manner. Lastly, the in vivo data 
corroborated the hypothesis that filaments are associated with viral transmission, perhaps due 
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Chapter 1: Introduction to influenza A virus 
1.1. Influenza A virus  
Influenza A virus (IAV) is an enveloped virus belonging to the Orthomyxoviridae family 
which also includes five other genera (influenza virus B, C and D, thogotovirus, quaranjavirus 
and isavirus) (ICTV, 2017). As typically seen within the Orthomyxoviridae family, IAV possesses 
a segmented single-stranded negative-sense RNA genome. The natural reservoir of IAV is wild 
aquatic birds (i.e. waterfowl, shorebirds); however, this zoonotic agent has a wide host range 
and can infect other avian species as well as mammalian hosts as described in more detail in 
section 1.5 (Webster, 1992). 
1.1.1. Virus structure  and composition 
Pleomorphism is a characteristic of IAV particles, which translates into the production 
of three main forms of virions: spherical particles of ~ 100 nm in diameter; an intermediate form 
termed “bacilliform” with a smaller diameter and up to 300 nm in length; and filamentous particles 
that like bacilliforms, are between 80 and 100 nm in diameter but can be up to 30 µm in length 
(Calder et al., 2010; Cox et al., 1980; Mosley & Wickoff, 1946; Roberts & Compans, 1998; 
Vijayakrishnan et al., 2013) (Figure 1.1 A). The laboratory-adapted viruses that have been 
serially passaged in eggs or cells, e.g. A/Puerto Rico/8/1934 (PR8) or A/WSN/1933 (WSN), 
produce predominantly spherical particles although filamentous structures were also detected 
(Mosley, 1946). Conversely, filamentous viruses that produce both filaments and spheres with 
generally a large overrepresentation of the first, have been mainly detected in human and 
veterinary clinical isolates, with several reports showing that these elongated structures are 
usually lost following serial passage in eggs or cells (Chu et al., 1949; Elton et al., 2013; Seladi-
Schulman et al., 2013). All forms of IAV are surrounded by a lipid bilayer originated from the 
host cell decorated with the viral glycoproteins haemagglutinin (HA) and neuraminidase (NA) 
(Palese & Shaw, 2007). HA is a homotrimeric protein that is produced as an HA0 precursor and 
cleaved by host proteases outside the cell into HA1 and HA2 subunits. 
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Figure 1.1 Structure of the influenza virus. (A) Schematic representations of spherical, 
bacilliform and filamentous influenza virions, respectively. Spherical virions are on average 100 
nm in diameter, while filamentous virions extend many micrometres in length. The viral envelope 
(lipid-bilayer) originates from the host plasma membrane and its surface is decorated with the 
viral glycoproteins (HA and NA) and the M2 proton channel protein. The viral matrix protein M1 
forms a protein layer underneath the virion that provides support and structure. The vRNA is 
encapsidated by viral proteins, forming the vRNPs, and packaged inside the virion by 
association with M1. NS2/NEP has also been found inside spherical virions. Cartoon drawn and 
kindly provided by Rute Pinto. (B) and (C) Scanning electron microscopy of MDCK cells infected 
with the spherical strain PR8 and the filamentous reassortant virus PR8 MUd. Scale bar 1 µm 
(Elton et al., 2013). (D) Immunofluorescent staining of surface HA of MDCK cells infected with 
the spherical strain WSN (top picture) or with the filamentous A/Udorn/1972 strain (bottom 
picture) (Elleman & Barclay, 2004). 
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This cleavage allows the exposure of the fusion peptide present in the HA2 subunit, which 
mediates the fusion of the viral and cellular membranes resulting in viral entry. On the other 
hand, NA is a tetrameric sialidase mainly involved in viral exit, facilitating clipping off the virus 
from the cell membrane (Palese & Ueda, 1974). IAV is further classified based on the 
antigenicity/sequence of the HA and NA glycoproteins. So far, there are 16 HA subtypes and 9 
NA subtypes identified that have been isolated in waterfowl and other a variety of other species 
(Palese & Shaw, 2007). Additionally, more divergent and probably evolutionarily isolated 
H17N10 and H18N11 subtypes have been solely identified in bat isolates (Tong et al., 2012; 
Tong et al., 2013).  
Anchored in the viral envelope is the proton ion channel protein M2, albeit to smaller 
amounts than the other structural proteins (Pinto et al., 1992). M2 is responsible for promoting 
the release of the vRNA into the host cell cytoplasm after membrane fusion but also plays a role 
in viral budding (Rossman & Lamb, 2011). Inside the IAV envelope, the viral matrix protein M1 
forms a lattice underneath the lipid bilayer that supports the virion and it is known to be the main 
determinant of virion morphology (Gomez-Puertas et al., 2000; Sha & Luo, 1997). Within the 
virion, there are eight genome segments where, on average, for every 24 nucleotides of the 
single-stranded vRNA, one molecule of the nucleoprotein (NP) binds the phosphate backbone 
of the genome with high affinity and little apparent sequence specificity (Baudin et al.,1994; 
Ortega et al., 2000). Furthermore, several reports have shown that the NP-bound vRNA is 
arranged in a loose double helix structure while the RNA-dependent-RNA polymerase (RdRp) 
complex binds the 5’ and 3’ ends of the genome, holding the ends together in a panhandle 
structure as shown in figure 1.2 A (Baudin et al., 1994; Hsu et al., 1987). These RNA-protein 
complexes make up the viral ribonucleoprotein (vRNP) to which M1 binds via interactions with 
NP and the vRNA in a sequence-independent manner (Sha & Luo, 1997; Ye et al., 1989). Also 
found within the virion in much lower quantities are the viral NEP/NS2 and the non-structural 
protein 1 (NS1) (Hutchinson et al., 2014; Yasuda et al., 1993). Although what has just been 
described is the main structure and composition of IAV virions, subtle differences have been 
detected between spherical, bacilliform and filamentous particles. 
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Figure 1.2 The viral ribonucleoprotein complex packaged inside the virion. (A) Schematic 
representation of a viral ribonucleoprotein (vRNP) complex. Each vRNP is composed of 
negative-sense single-stranded viral RNA coated by a NP monomer on average every 24 
nucleotides. The 5’ and 3’ end of the vRNA show partial complementarity, which causes the 
vRNA to fold its ends. The viral polymerase complex (composed of PB1, PB2 and PA subunits) 
sits on this partially double-stranded structure. Cartoon drawn and kindly provided by Rute Pinto. 
(B) The eight vRNPs are packed into virus particles arranged in a “7+1” conformation; i.e., one 
vRNP is typically found at the centre surrounded by the other seven. This is more readily 
observed in spherical virions but is supposed to be the same in filamentous particles. 
Filamentous virions group the vRNPs at one end of the virion (taken from (Dadonaite et al., 
2016)). (C) Tomogram section of a filamentous virion highlighting the vRNPs (red), the viral 
matrix layer formed by M1 (blue) and the viral glycoproteins HA (green) and NA (purple). Note 
the grouping of vRNPs at the opposite end to the NA clustering (taken from Calder et al., 2010). 
 
  5 
 
For instance, all three forms pack the genome similarly, where one vRNP is at the centre and 
the other seven surrounding it in a parallel array; however the longer virus particles have all 
vRNPs in this 7+1 arrangement at the distal end of the particle (figure 1.2 B and C) (Calder et 
al., 2010; Vijayakrishnan et al., 2013). Additionally, cryo-electron microscopy showed that longer 
filaments often lack vRNPs and instead possess a fibrillar material of unknown origin 
(Vijayakrishnan et al., 2013). On the other hand, spherical particles have been shown to 
incorporate host proteins into their virions, such as annexins, tetraspanins, or cytoskeletal 
proteins (Berri et al., 2014; Hutchinson et al., 2014; Shaw et al., 2008). Their role during viral 
infection is still unclear; however, the host cellular components that make up spherical virions 
are dependent on host species the virus originated from (Hutchinson et al., 2014).  
1.1.2. Genome organisation 
The IAV genome is composed of eight RNA segments which encode for the main 12 
viral proteins that are generally taken to be essential for viral replication outside of a laboratory 
setting. However, there are many more gene products encoded by the IAV genome which are 
summarised in table 1.1. The segment sizes vary between 0.89 Kb and 2.341 Kb, adding up to 
a total of 13.5 Kb (Palese & Shaw, 2007). All segments possess an antisense coding region 
flanked by short untranslated regions (UTRs), whose terminal regions are very conserved and 
show partial complementary.  
To date, the IAV genome is known or is predicted to encode for up to 22 proteins, 
however, the relatively small size of the genome forces the virus to use several mechanisms in 
order to produce all these proteins. The main 12 viral proteins are generally products of 
unspliced mRNA transcripts, with the exception of two proteins (M2 and NEP) that arise from 
spliced mRNA transcripts (Palese & Shaw, 2007). In addition to splicing, IAV also employs 
ribosomal frameshifting and translation initiation from alternative start codons to maximize the 
use of its genome. For instance, segments 1, 2 and 3 primarily encode PB2, PB1 and PA viral 
proteins, respectively, which together form the RdRp complex (Blaas et al., 1982; Braam et al., 
1983; Dias et al., 2009). These proteins are essential to viral replication; however, several 
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PB2 759 Subunit of the RdRp. Binds 5’ cap on host cell mRNA 
PB2-S1 508 mRNA spliced product shown to inhibit RIG-I-signalling 
2 
PB1 757 
Subunit of the trimeric RdRp. Catalyses nucleotide 
addition to produce viral RNA during transcription and 
replication  
PB1-F2 87 
Product from an alternative start codon with IFN-
antagonist and pro-apoptotic activity  
PB1-N40 718 




Subunit of the RdRp. Possesses endonuclease activity 
required for cap-snatching  during viral mRNA transcription 
PA-X 152 
Product of ribosomal frameshifting with host cell shut-off 
activity  
PA-N155 562 
Product from an alternative start codon with unknown 
function 
PA-N182 535 
Product from an alternative start codon with unknown 
function  
4 HA 565 
Viral glycoprotein involved in receptor binding, viral entry 
and budding 
5 NP 498 
Encapsidates vRNA, co-factor of RdRp activity and 
required for vRNP export from the nucleus 
6 NA 454 Sialidase activity for viral exit and mucous clearance 
7 
M1 252 
Structural protein that functions in vRNP nuclear export, 
virus budding, assembly and morphogenesis  
M2 97 
Ion channel protein involved in uncoating of vRNPs and 
virus assembly and budding 
M3* 9 Spliced mRNA product of unknown function  
M42 99 Splice variant of M2 function 
M4* 54 Spliced mRNA product of unknown function 
8 
NS1 230 Primary function as an IFN-antagonist  
NS2/NEP 121 
Spliced mRNA product involved in vRNP export from the 
nucleus 
NS3 187 Spliced mRNA product of unknown function 
tNS1 216 
Products from alternative start codons with IRF inhibition 
activity 
NSP* 150/152 Protein expression not detected. 
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studies have reported the expression of other viral proteins from these segments that are not 
essential but play complementary roles in viral infection. These latter products are therefore 
termed accessory proteins. Segment 1 has been shown to encode a shorter form of PB2, 
designated PB2-S1, derived from spliced mRNA (Yamayoshi et al., 2016). This protein was 
mainly expressed in pre-2009 human H1N1 strains and was identified as an inhibitor of RIG-I- 
signalling. By contrast, segment 2 has several start codons, including several flanked by a strong 
Kozak signal, which make these prime sites for alternative translation initiation events (Wise et 
al., 2011). So far two polypeptides have been identified: one from the fifth AUG codon, (in frame 
1, in frame with PB1) named PB1-N40 and another from the fourth AUG codon (in frame 2), 
designated PB1-F2 (Varga et al., 2012; Wise et al., 2009). Although the function of PB1-N40 is 
still uncertain, PB1-F2 has been shown to inhibit the interferon response in infected cells and 
induce apoptosis (Varga et al., 2012). Segment 3 not only encodes PA but due to ribosomal 
frameshifting it also produces the PA-X polypeptide, which has the endonuclease domain from 
PA and a C-terminus translated from the +1 reading frame of PA mRNA (Firth et al., 2012). PA-
X was shown to have host cell shut-off activity by destroying the cellular mRNA transcripts 
(Jagger et al., 2012). Similarly to segment 2, segment 3 mRNA also has other internal start 
codons that were recently shown to produce two N-terminally truncated forms of PA: PA-N155 
and PA-N182 (Muramoto et al., 2013). PA-N155 is expressed from the eleventh AUG codon, 
while PA-N182 is expressed from the thirteenth AUG codon, both in frame with PA. Although 
the function of these polypeptides is yet to be established, the authors suggested a role during 
the replication cycle of IAV, as mutants lacking these truncated forms of PA showed growth 
attenuation and lower pathogenicity in vivo. While segments 4 (HA), 5 (NP) and 6 (NA) only 
encode for one single protein each from an unspliced mRNA, the smaller segments of the IAV 
genome (segments 7 and 8) rely on splicing to produce essential and accessory proteins (Palese 
& Shaw, 2007). Segment 7 produces an unspliced mRNA 1 and three spliced transcripts named 
mRNA 2, 3 and 4 (Dubois et al., 2014). M1 is the product of mRNA 1, while M2 is translated from 
mRNA 2. The protein encoded by mRNA 3 has not yet been detected in the context of infection; 
however the product of this mRNA was shown to be preferred by the cellular splicing machinery, 
delaying the production of mRNA 2 (M2) until the viral RdRp complex is relatively abundant, as 
the binding of the viral polymerase complex blocks the splice donor site of mRNA 3 (Shih et al., 
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1995). Similarly to M3, the M4 protein (from mRNA 4) has yet to be detected, however, it was 
reported by Shih et al. that mRNA 4 is produced as abundantly as mRNA 2 by the A/WSN/33 
strain regardless of host species (Shih et al., 1998). More recently, the expression of the 
accessory protein M42, which can functionally replace M2, was also identified from mRNA4, but 
only in a small minority of IAV strains (Wise et al., 2012). Lastly, segment 8 encodes an unspliced 
mRNA that gives rise to NS1, which acts as an interferon antagonist, and a spliced mRNA that 
encodes for the other essential protein – NS2, now known as NEP – required for export of vRNPs 
from the nucleus (Hale et al., 2008; Lamb & Choppin & Tamm, 1979; O'Neill et al., 1998). Both 
NS2 and NEP are encoded from open reading frames (ORF) in the positive sense. However 
Zhirnov et al. reported the presence of an ORF in the negative sense genome that is predicted 
to encode for a transmembrane-like protein, which the authors called NSP (Zhirnov et al., 2007). 
The mechanism of expression and function of this protein has yet to defined, but peptides 
derived from it can be detected by the immune system of infected animals (Hickman et al., 2018). 
Another spliced mRNA transcript of segment 8 was identified following adaption of a human 
strain of IAV within a mouse host, which produced a polypeptide that the authors named NS3, 
with a currently unknown function (Selman et al., 2012). The latest and the last gene products 
identified from segment 8 are truncated products of NS1 expressed by alternative translation 
initiation from two downstream start codons, that give rise to N-terminally truncated forms of 
NS1 that have been shown to inhibit activation of the interferon regulatory factor 3 and interferon 
β in the PR8 strain of IAV (Kuo et al., 2016). 
1.2. Influenza epidemiology and clinical manifestations 
Influenza viruses are the causative agent of seasonal epidemics, which are estimated 
to cause severe illness in 3-5 million people and the death of 290,000 – 650,000 people every 
year (Iuliano et al., 2018). The term ‘seasonal’ derives from the fact that these epidemics mainly 
occur in the winter months, which can be explained from the findings of studies that have 
reported that virus transmission is greater at low temperatures and low humidity levels (Lowen 
et al., 2007; Schaffer et al., 1976). The mechanism by which zoonotic influenza viruses are 
transmitted to humans remains unclear; however there is evidence supporting airborne 
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transmission or direct contact with infected animals (Beigel et al., 2005; Brankston et al., 2007). 
The onset of influenza infection in humans is largely characterised by cough, headache, fever 
and malaise, which can last for several days. In children, elderly and immunocompromised 
individuals these symptoms can aggravate and cause severe illness (WHO, 2018b). Moreover, 
IAVs have also been responsible for sporadic pandemics over the last 100 years, which will be 
addressed later on in this chapter. 
Currently, H1N1, H2N2 and H3N2 are the only subtypes reported to have achieved 
consistent circulation in humans and are thus the types responsible for seasonal epidemics 
(Petrova & Russell, 2018). Although influenza viruses have been circulating in the human 
population since at least the early 1900s, they are still a major health concern for two main 
reasons: their fast-evolving RNA genome, and the segmented nature of it. The error-prone viral 
RNA polymerase shows deficient proofreading activity, resulting in mutations throughout the 
viral genome; importantly, mutations in the viral antigens (HA and NA) usually result in a virus 
that is no longer recognised by the host humoral immune response that protects them from re-
infection (Palese & Shaw, 2007). This is termed antigenic drift and is the main reason seasonal 
epidemics occur frequently and typically with mild symptoms. On the other hand, genome 
segmentation can result in antigenic shift. This occurs when two or more strains infect the same 
host cell, which promotes the exchange of genetic material or genome reassortment, thus 
resulting in a virus that is a mixture of the parental strains. This phenomenon is more alarming 
because the resulting virus possesses a new HA on its surface (but not always a new NA) that 
have not yet circulated in the human population, therefore has the potential to cause a pandemic 
(Webster et al., 1992). However, not all pandemics result from antigenic shift, in fact, the first 
recorded human pandemic is thought to have occurred due to adaptation of an avian strain of 
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1.3. Strategies to control influenza infection 
Currently, vaccination is the primary preventive measure to control seasonal influenza, 
but due to their long period of manufacturing (minimum of 6 months), pandemic preparedness 
is primarily dependent on antivirals (Petrova & Russell, 2018). Currently, there are three types 
of vaccines licensed for use in the human population: live-attenuated virus, recombinant viral 
HA or inactivated virus (Krammer et al., 2018). These vaccines contain the antigens from at 
least three circulating influenza strains: two IAV subtypes (2009 pandemic H1N1 and H3N2) and 
one IBV subtype (Victoria or Yamagata lineages). In recent years however, the circulation of 
another influenza B virus has given rise to a quadrivalent vaccine (Krammer et al., 2018). The 
most used vaccine is the inactivated influenza vaccine, which induces a neutralising antibody 
response against HA epitopes, therefore eliciting a protective humoral immune response 
(Osterholm et al., 2012). However, the main epitopes targeted by neutralising antibodies are 
present in the receptor binding domain of HA, which differ quite drastically between HA 
subtypes, thus reducing vaccine efficacy to one specific subtype (Wiley & Skehel, 1987). 
Although preventive vaccination has proved effective against seasonal influenza, the 
sudden emergence of a new HA subtype renders the vaccine useless; therefore antiviral drugs 
are used to provide a quick response to tackle influenza infection. There are two main classes 
of antivirals approved by the FDA and PHE for the treatment of influenza, which are 
neuraminidase inhibitors (NAIs) and M2 ion channel blockers. NAIs target the enzymatic activity 
of NA during viral exit, resulting in aggregation of progeny virions at the surface of the cell and, 
consequently, a reduction in the efficiency of viral spread (Colman, 1994; Palese & Ueda, 1974). 
Currently, there 3 main drugs approved within this class: oseltamivir (Tamiflu), zanamivir 
(Relenza) and peramivir (Rapivab) (Alame et al., 2016). The other class of antivirals, the 
adamantanes, target the ion channel activity of the M2 protein, which is responsible for acidifying 
the interior of the virion to promote dissociation of the genome from the viral envelope. Therefore 
these antivirals prevent the release of the RNA genome into the cytoplasm of the host cell, 
stopping the virus life cycle at the entry point (Cady et al., 2010; Pinto et al., 1992). However, 
this class of antivirals have been rendered largely ineffective towards influenza infection, with 
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almost half of available IAV protein sequences showing amino acid mutations in M2 known to 
confer resistance to adamantanes. Dong et al. showed that IAV subtypes currently circulating in 
human (H1 and H3) or poultry (H5, H7 and H9) populations were more prone to develop 
resistance (Dong et al., 2015). For instance, the seasonal H1N1 subtype before 2009 was 
reasonably resistant to adamantanes and even when the 2009 pandemic H1N1 replaced the 
seasonal H1N1, the latter proved to be resistant to M2 ion channel blockers as well. On the other 
hand, H3N2 subtypes showed varied frequency of resistant viruses over the last two decades 
(Dong et al., 2015). Resistant viruses were also observed within H5N1, H7 and H9N2 IAV 
subtypes, with an increase in frequency in more recent years. Therefore, the most widely used 
antivirals rely heavily on NAIs. However, resistant viruses have been already isolated, for 
example, the seasonal H1N1 viruses were completely resistant to NAIs by 2009 and the 2009 
pandemic H1N1 viruses were able to develop resistance rapidly after NAI treatment, in contrast 
to H3N2 subtypes which remained relatively sensitive to NAIs (McKimm-Breschkin, 2013). 
Furthermore, there are also compounds being developed and in clinical trials to target host 
factors that are required during influenza infection (Yen, 2016). Overall, continued research is 
needed to develop novel antivirals to tackle future influenza outbreaks. 
The current strategies to control avian influenza spread within domestic poultry are 
characterised by inclusion and exclusion biosecurity measures, although mass vaccination was 
recently reported as a success in China (Swayne, 2008). Inclusion biosecurity practices are a 
combination of measures employed to contain an infection within a certain area, which include 
quarantine, improved hygiene, disinfection of fomites and removal of infected animals within the 
flock. Conversely, exclusion biosecurity practices are used to protect naïve birds from infected 
birds with avian influenza, which include confinement of birds indoors during the bird migration 
season, therefore preventing the contact between domestic poultry and wild birds. Unlike in the 
case of human influenza, the use of vaccines in domestic poultry has stagnated over the years 
due to  a combination of overuse without updating the vaccine composition, resulting in the 
emergence of variants that were able to evade the immune response elicited by the vaccine 
(Capua & Marangon, 2006). The currently used vaccines are oil-emulsified inactivated whole 
IAV or live vectored (using fowl pox as a vector) with low pathogenic avian IAV (LPAI) field 
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outbreak strains. These are predominantly used in countries with endemic highly pathogenic 
avian influenza (HPAI), such as Pakistan, China or Mexico and also in developing countries, but 
require subcutaneous or intramuscular administration with re-administration every 2-3 years to 
account for virus evolution, making them labour intensive and costly (Capua & Marangon, 2006; 
Swayne et al., 2014). Another measure to control avian influenza is the surveillance of wild birds 
and domestic poultry, as this gives information on the diversity, evolution and spread of avian 
influenza strains, thus providing information on the pandemic potential of avian IAVs (Verhagen 
et al., 2015).  
1.4. Influenza A virus life cycle 
IAV primarily targets epithelial cells of the respiratory or intestinal epithelia, as described 
later on. Influenza viruses have the particularity of replicating their nucleic acid in the nucleus 
and their life cycle can be divided into the following stages: attachment, entry and uncoating of 
the viral genome; import of the vRNPs to nucleus; replication and transcription; export of the 
vRNPs from the nucleus into the cytoplasm and, lastly, assembly at the plasma membrane and 
budding. In tissue culture, this life cycle takes between 8 and 10 hours to complete and a 
diagrammatic representation is shown in figure 1.3 (Gaush & Smith, 1968). 
1.4.1. Attachment and entry into the host cell 
The first step of IAV infection is the binding of HA to the host cell surface. The main 
cellular receptor for IAV is N-acetylneuraminic acid or sialic acid (SA), which is commonly found 
in N- or O-linked oligosaccharides of glycoproteins and glycolipids, attached to the underlying 
galactose via α2,3 or α2,6 linkages (Johnson et al., 1964; Ohuchi et al., 1997). HA binding to 
the SA receptor is of low affinity, but the multiple HA molecules present in the virion provide a 
high-avidity attachment to the host cell surface (Sauter et al., 1989). HA exists as a trimeric 
protein with a globular head formed by the N-terminal domain of HA1 and a stalk region at the 
C-terminus mainly formed by the HA2 subunit, which anchors the protein to the surface of the 
virion (Palese & Shaw, 2007). HA is synthesised in the rough endoplasmic reticulum (ER) and 
glycosylated in the Golgi network to form the precursor, HA0, composed of the two subunits: 




































Figure 1.3 Schematic representation of the virus life cycle. (1) IAV attaches to the host cell via 
sialic acids on the cell surface and enters the cell by endocytosis. (2) The virus then follows the 
endocytic pathway inside the endosome, where acidification of the endosome triggers viral and 
endosome membrane fusion mediated by HA and release of the vRNPs into the cytoplasm of 
the host cell. (3) The vRNPs are then translocated to the nuclear pore complex (NPC) and enter 
the nucleus via the classical importin-α-importin-β1 pathway. (4) In the nucleus the vRNA is 
replicated into positive-sense cRNA that is amplified back to negative-sense vRNA for progeny 
virions. The RdRp also carries out vRNA transcription to produce viral mRNAs. During this 
process, it adds a cap at the 5’ end from cellular mRNAs by cap-snatching and poly(A) tails at 
the 3’ end. (5) Viral proteins are translated from their mRNAs and the internal proteins are 
translocated back into the nucleus while the viral transmembrane proteins migrate to the apical 
plasma membrane. (6) The newly formed vRNPs are exported out of the nucleus via the Crm1 
nuclear export machinery and are trafficked to the apical cell membrane in a microtubule-
dependent manner following the endocytic recycling pathway. (7) The viral proteins assemble 
at lipid raft domains and the progeny virions are released from the host cell. Cartoon drawn and 
kindly provided by Rute Pinto.  
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HA1 which contains the receptor-binding domain and HA2 which contains the transmembrane 
domain and the fusion peptide (Palese & Shaw, 2007). Regarding receptor binding, it was 
reported that HA of human and swine strains of IAV preferentially bind SA receptors with an α2,6 
linkage, while avian and equine strains recognise with high specificity receptors with α2,3-linked 
sialic acid (Connor et al., 1994).  
Following recognition of the receptor, the entry process begins with cleavage of the HA0 
precursor by proteases outside the host cell, exposing the receptor binding domain in the HA1 
subunit, which is held together with the HA2 via disulphide bonds (Skehel & Wiley, 2000). 
Spherical virions enter the cell mainly via clathrin-mediated endocytosis; however, IAV entry has 
also been reported in the absence of clathrin-coated pits (Matlin et al., 1981; Sieczkarski & 
Whittaker, 2002). In contrast, Rossman et al. recently showed that filamentous virions enter the 
host cell primarily via macropinocytosis when the cell engulfs large amounts of fluid, but this 
feature is not exclusive of filamentous virions and is rather induced by IAV infection (de Vries et 
al., 2011; Rossman et al., 2012). Once the virus enters the cell, it traffics along the endosomal 
trafficking pathway, thus being subject to more acidic pH in the maturing endosomes (Edinger 
et al., 2014). This low pH triggers a conformational change in HA, exposing the hydrophobic 
fusion peptide present in the N-terminus of the HA2 subunit, which inserts into the endosome 
membrane and brings into close proximity the viral and endosomal membranes, thus driving 
fusion of both membranes. Alongside the fusion event, the M2 ion channel protein allows for the 
entrance of protons into the virion, which results in acidification of the virus interior and 
dissociation of the M1 protein from the vRNPs, thus allowing the release of the vRNPs into the 
host cell cytoplasm via the pore formed by HA-mediated fusion (Bui et al., 1996; Pinto et al., 
1992).  
1.4.2. Import of vRNPs to the nucleus 
Once the vRNPs reach the cytoplasm of the host, these need to be translocated to the 
nucleus where the vRNA is transcribed and replicated. The nucleus is surrounded by a double 
membrane, termed the nuclear envelope, and inserted into this are protein complexes that form 
the nuclear pore complex (NPC). The nuclear envelope is a relatively permeable membrane that 
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allows the diffusion of molecules smaller than ~ 40 kDa through the NPC, though bigger 
molecules, such as proteins, mRNA and others, can only enter (or leave) the nucleus via the 
NPC in an energy-dependent process (Kabachinski & Schwartz, 2015). To cross the NPC and 
enter the nucleus via the classical importin-α/importin-β1 (IMPα-IMPβ1)-dependent pathway, 
the cargo must contain a nuclear localisation signal (NLS) (Stewart, 2007). In fact, NLSs have 
been identified in all four proteins of the vRNP complex and it has been demonstrated that PB2 
and NP enter the nucleus alone, while PB1 and PA enter the nucleus as a complex (Fodor & 
Smith, 2004; Mukaigawa & Nayak, 1991; Nath & Nayak, 1990; Nieto et al., 1992; O'Neill et al., 
1995). Therefore, the newly M1-dissociated vRNPs are recognised by the IMPα adaptor 
proteins, which in turn recognise the IMPβ transport receptor on the NPC and start the 
translocation of the IMPα-IMPβ-vRNP complex into the nucleus. The dissociation of IMPβ from 
the IMPα-vRNP complex is an energy-dependent process induced by binding of RanGTP to 
IMPβ, therefore releasing the cargo-carrier complex in the nucleus (Stewart, 2007). Lastly, 
dissociation of IMPα from the vRNP occurs by binding of the export carrier of IMPα, which sends 
IMPα back to the cytoplasm. Both IMPα and IMPβ are then individually recycled to undergo 
another cycle of nuclear translocation. 
1.4.3. Transcription and replication of the viral genome 
Once in the nucleus, the negative sense RNA genome of IAV is transcribed to mRNA to 
produce the viral proteins, and replicated via a full length cRNA intermediate which serves as a 
template for the synthesis of the full length negative sense RNA genome that will be incorporated 
into progeny virions (Eisfeld et al., 2015). The first step in transcription consists of the recognition 
of the viral promoter at the 5’ and 3’ ends of the vRNA by PB1, which activates the primer binding 
and endonuclease activities of the viral polymerase (Lee et al., 2003; Luytjes et al., 1989). 
Following this, the PB2 subunit binds to 5’ 7-methylguanosine (m7GpppXm) capped pre-mRNAs 
from the host cell and the endonuclease activity of the PA subunit cleave off the 5’ cap from the 
host pre-mRNA in a process called cap-snatching (Blaas et al., 1982; Dias et al., 2009; Plotch 
et al., 1981). This process leaves a hydroxyl group at the 3’ end of the mRNA fragment that is 
used by PB1, which has polymerase activity, as a primer to initiate transcription of the negative 
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sense vRNA into positive sense mRNA in the 3’ to 5’ direction using the 3’ end of the vRNA as 
a template (Braam et al., 1983). The elongation of the mRNA transcript continues until the active 
site of the polymerase finds a relatively long stretch of uracil nucleotides, positioned between 17 
and 22 nucleotides upstream of the 5’ end of the vRNA segments which acts as a 
polyadenylation signal (Robertson et al., 1981). The polymerase is forced to begin non-
processive transcription on this homopolymer due to spatial constraints, as the 5’ end of the 
vRNA remains associated with the viral polymerase during transcription, causing the viral 
polymerase to stutter on the poly(U) stretch resulting in the addition of a poly(A) tail to the newly 
synthesised viral mRNA (Zheng et al., 1999). The mRNAs are then exported to the cell 
cytoplasm, which are then translated in the host ribosome and spliced as required by the cell 
splicing machinery (see section 1.1.2: genome organisation). Equally important, the expression 
of the 8 viral genes does not occur simultaneously. Immediately following infection, PB2, PB1, 
PA, NP and NS1 proteins are detected, while the expression of HA, NA, M1 and M2 proteins is 
more strongly detected in a later stage of infection, even though the mRNA of early proteins is 
also detected at this stage of infection (Yamanaka et al., 1991). Following translation in the 
cytoplasm of the cell, the four vRNP protein components are transported back to the nucleus to 
carry out replication of the viral genome as well as amplified transcription. 
Regarding the first step of genome replication, synthesis of cRNA, a functional switch in 
the viral polymerase’s mode of transcription initiation and termination needs to occur.  Unlike 
transcription, genome replication produces a cRNA that is a full-length positive sense reverse-
complement copy of the vRNA, which includes the UTR at the 5’ and 3’ ends, the segment-
specific packaging signals and the ORF (Palese & Shaw, 2007). Genome replication is initiated 
de novo in a primer-independent manner as both cRNA and vRNA contain a 5’ triphosphate 
(Hay et al., 1982). The second stage of genome replication, synthesis of progeny vRNA from 
the cRNA replicative intermediates, occurs subsequently. To date it is still not clear if this is 
carried out by cis- or trans-acting viral polymerases and what the exact mechanism for this 
functional switch of the polymerase is (Fodor, 2013; Hay et al., 1977; Moeller et al., 2012). 
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1.4.4. Nuclear export of the vRNPs 
Following replication of the viral genome and formation of new vRNPs, these need to be 
exported out of the nucleus into the cytoplasm to be incorporated into progeny virions. This is 
performed in a CRM1-dependent manner via the NPC, as inhibition of this nuclear export 
receptor led to retention of vRNPs in the nucleus of infected cells (Elton et al., 2001; Watanabe 
et al., 2001). CRM1 recognises and binds cargo with a leucine-rich nuclear export signal (NES) 
and shuttles through the NPC in conjunction with RanGTP through interactions with 
nucleoporins at the NPC. After crossing the pore, RanGTP provides the energy necessary to 
dissociate CRM1 from its cargo in the cytoplasm of the cell (Hutten & Kehlenbach, 2007). The 
viral proteins shown to aid nuclear export of vRNPs are M1 and NEP (Martin & Helenius, 1991; 
O'Neill et al., 1998). In the nucleus, M1 binds to newly synthesised vRNPs through interactions 
with NP, while NEP binds to M1 and directs the vRNPs to the nuclear export machinery, by 
forming a bridge between vRNPs and CRM1 via its nuclear export signal (Huang et al., 2001; 
Neumann et al., 2000; O'Neill et al., 1998; Yasuda et al., 1993). Before nuclear export, vRNPs 
accumulate at the nuclear periphery by tethering to chromatin, enabling the access to CRM1, 
therefore hijacking the nuclear export machinery of the cell (Chase et al., 2011; O'Neill et al., 
1998). At the NPC, it is suggested that M1 bound to vRNPs forms a bridge to associate the 
vRNPs to NEP, which in turn interacts with CRM1 and facilitates shuttle of the complex through 
the NPC and release of the vRNPs into the cytoplasm of the cell (Akarsu et al., 2003; Yasuda et 
al., 1993). After nuclear export, the vRNPs need to traffic up to the apical plasma membrane to 
start virion assembly and budding (Misek et al., 1984; Rodriguez-Boulan et al., 1983). This starts 
with the accumulation of the vRNPs at the perinuclear microtubule organisation centre (MTOC) 
which are directed by the Y-box-binding protein 1 to the cellular microtubule network and 
trafficked to the apical plasma membrane (Amorim et al., 2011; Kawaguchi et al., 2012; Momose 
et al., 2011). This was shown to occur via the endocytic recycling pathway in Rab11-positive 
vesicles through interactions with the PB2 subunit (Bruce et al., 2010). Even though trafficking 
via the MTOC is the currently accepted model, it was recently reported that the vRNPs and 
Rab11(GTPase) can reach the apical cell membrane by IAV-induced extension of the ER 
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independently from the endosomal recycling pathway (de Castro Martin et al., 2017; Nturibi et 
al., 2017). 
1.4.5. Assembly and budding 
Once the vRNPs are exported out of the nucleus, the 8 vRNPs that comprise the IAV 
genome need to be packaged before budding to produce infectious particles. Both spherical and 
filamentous forms of influenza utilise cholesterol- and sphingolipid-rich raft domains in the apical 
cell membrane as the site of assembly and budding (Leser & Lamb, 2005; Scheiffele et al., 1999; 
Simpson-Holley et al., 2002; Takeda et al., 2003). This is initiated after the synthesis of the viral 
transmembrane (HA, NA and M2) proteins in the rough ER and their transport to the apical cell 
membrane via the Golgi network (Doms et al., 1993; Misek et al., 1984). HA and NA possess 
apical sorting signals in their transmembrane domains that facilitate their accumulation in lipid 
raft domains and insertion into the apical cell membrane, forming the assembly and budding site 
for IAV (Barman & Nayak, 2000; Lin et al., 1998; Takeda et al., 2003). In contrast, M2 is not raft-
associated and rather accumulates in areas of the membrane surrounding the lipid raft domains, 
probably due to its cholesterol binding domain (Leser & Lamb, 2005; Rossman et al., 2010). The 
accumulation of the internal viral proteins (including the vRNPs) at the sites of assembly and 
budding is also required. This has been variously described to occur in an MTOC- and/or actin 
cytoskeleton-dependent manner, yet more recent studies suggest that the ER can mediate viral 
protein trafficking all the way up to the cell membrane (Amorim et al., 2011; Avalos et al., 1997; 
Bruce et al., 2010; de Castro Martin et al., 2017; Digard et al., 1999; Nturibi et al., 2017). 
To assemble the vRNPs at the site of budding, it is currently accepted that the M1 protein 
forms a bridge between the vRNPs (bound to M1) and the viral transmembrane proteins. This 
interaction was suggested to occur between M1 and the cytoplasmic tails of HA and NA, as 
deletion of these latter domains resulted in viruses with altered morphology and a significant 
reduction in lipid-raft association and M1 and RNP incorporation, thus inhibiting viral assembly 
(Ali et al., 2000; Jin et al., 1997; Takeda et al., 2003; Zhang et al., 2000). Furthermore, M1 was 
shown to be recruited by either HA or NA, as viruses with tail-minus HA or tail-minus NA were 
both rescued, although replicating to much lower levels than the corresponding WT virus, 
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suggesting that only one envelope glycoprotein is necessary to ensure viral assembly and 
budding (Ali et al., 2000; Zhang et al., 2000). Although a direct interaction between M1 and HA 
has yet to be detected, co-evolution bioinformatics analysis suggested that there are residues 
in the boundary of the HA cytoplasmic tail domain that are likely to interact with residues within 
the C-terminus of M1 (Mintaev et al., 2014). Regarding M2, mutational analysis revealed that 
the cytoplasmic tail of M2 also interacts with M1 and promotes efficient virus assembly (Chen et 
al., 2008; Rossman et al., 2010). Therefore, M1 is thought to bridge the interaction between the 
vRNPs-HA/NA and M2-HA. However, recent studies showed that even though M2 possess a 
cholesterol-binding domain, it only accumulates adjacent to lipid rafts when raft-associated HA 
is present, even in the absence of M1 (Rossman et al., 2010; Thaa et al., 2010). Thus, the exact 
mechanism by which the viral bud zone is formed remains unclear, but it is predicted to be via a 
complex network of interactions between HA, NA, M1, M2 and NP (Leser & Lamb, 2017). Lastly 
but not least, another requirement for the formation of the viral assembly site is an intact actin 
cytoskeleton, as disruption of this was reported to affect filamentous virion assembly, but not 
assembly and budding of spherical particles (Simpson-Holley et al., 2002). In fact, Goswami et 
al. reported that the actin cytoskeleton is responsible for the formation of protein nanoclusters 
and/or maintenance of raft domains, which could explain the importance of actin in viral 
assembly and its presence in purified virions (Goswami et al., 2008; Shaw et al., 2008). 
The mechanism by which budding initiation occurs remains largely unknown. It is known 
that insertion of HA and NA into the plasma membrane induces membrane curvature, possibly 
initiating the budding event and once M1 is recruited via interactions with the cytoplasmic tails 
of the glycoproteins, it may suffer a conformational change that promotes M1 polymerization at 
the lipid raft domains (Gomez-Puertas et al.,, 2000; Rossman & Lamb, 2011). This 
polymerization of M1 underneath the plasma membrane was proposed to be the major driving 
force for VLP budding and may be involved in the formation of filamentous virions (Gomez-
Puertas et al., 2000). However individual expression of HA, NA or M2 in VLPs also suggested 
that these are capable of initiating virus budding, while only the presence of HA, NA, M1 and M2 
promoted efficient budding and release (Chen et al., 2007; Chlanda et al., 2015; Rossman et 
al., 2010). Once the bud is formed with M1 providing structural support underneath, the eight 
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vRNPs (bound to M1) are incorporated into the nascent virion. Electron microscopy and 
fluorescent in situ hybridization studies showed that majority of IAV particles contain all eight 
segments and these are present in one copy per virion (Chou et al., 2012; Noda, 2012; Noda et 
al., 2006). These and other studies have shown that genome packaging is segment-specific 
rather than random, as the probability of random packaging producing infectious particles is 
lower than that observed in laboratory infections (Hutchinson et al., 2010). Each segment of IAV 
contains a conserved stretch of nucleotides within the terminal coding and UTR regions, which 
were shown to act as packaging signals by deletion and mutational analysis or cloning of the 
UTRs onto a foreign gene, resulting in its incorporation in the virion (Gog et al., 2007; Liang et 
al., 2005; Luytjes et al., 1989; Marsh et al., 2007; Watanabe et al., 2003). The mechanism by 
which IAV is able to select only one copy of each segment is still unclear, however there is 
evidence showing that mutation of a packaging signal in one segment affects the packaging 
efficiency of the other segments, suggesting that RNA-RNA interactions can be important 
(Muramoto et al., 2006). Once the vRNPs are recruited via interactions with M1, these are 
packaged in a “seven around one” (7+1) conformation perpendicular to the budding site and, in 
the case of bacilliform and filamentous virions, the vRNPs are packaged at the distal end of the 
particle (Figure 1.2) (Calder et al., 2010; Vijayakrishnan et al., 2013). 
Following assembly and bud formation of the new virion with the eight vRNPs packaged, 
M2 catalyses membrane scission in an endosomal sorting complex required for transport 
(ESCRT)-independent manner (Rossman et al., 2010). The ion channel protein is recruited to 
lipid raft domains most likely by M1, where it inserts its amphipathic helix (present in the 
cytoplasmic tail) into the cell membrane, inducing membrane curvature, followed by constriction, 
destabilization (forming a budding neck) and scission of the membrane (Martyna et al., 2017; 
Roberts et al., 2013). Figure 1.4 illustrates a proposed mechanism for budding of progeny virus 
highlighting the role of HA, NA, M1 and M2. Once the virion is formed and in order to be released, 
the sialidase activity of NA is required to cleave off cell-surface sialic acid moieties to prevent 
aggregation of the newly formed virions (Palese & Ueda, 1974). This might explain the clustering 
of NA at one end of the progeny virions, predominantly seen with bacilliform and filamentous 
forms of influenza A virus (Calder et al., 2010). Furthermore, it was hypothesised that the 
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Figure 1.4 Schematic representation of the proposed mechanism for assembly and budding of 
IAV. (A) HA and NA initiate budding by clustering in lipid raft domains and the vRNPs are 
assembled in this region via association with M1, which is in turn recruited via interactions with 
the cytoplasmic tails of HA and/or NA. (B) This interaction triggers a conformational change in 
M1 which initiates oligomerization underneath the plasma membrane and, consequently, 
promotes elongation of the virion with the vRNPs at the opposite end of budding. (C) Once the 
membrane has elongated enough, M2, which accumulates in regions adjacent to the lipid rafts 
domains, is recruited by M1 and inserts its C-terminal amphipathic helix into the plasma 
membrane, causing membrane constriction and scission of the newly formed virion at the 
budding site. An overview of the viral transmembrane protein distribution during virus budding 
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clustering of NA at one end might result in the formation of filamentous virions with high amounts 
of sialic acid moieties which in turn can be recognised and bound by HA of filaments in the 
vicinity, thus promoting the formation of cord-like bundles of filamentous virions, as often seen 
by confocal or other forms of microscopy on the surface of infected cells (Dadonaite et al., 2016). 
However, it remains unclear whether filaments exit the cell as an individual particle or as a 
bundle of filamentous virions.  
1.5. Host range 
Wild aquatic birds, such as waterfowl and shorebirds, are the natural reservoir of IAV, which 
explains (or is suggested by) the high number of HA and NA subtypes isolated from these hosts 
(Webster et al., 1992). However, a subset of IAV subtypes have been isolated in chickens, 
turkeys, pigs, horses, dogs, seals and human hosts, thus showing that avian IAV is a epizootic 
and zoonotic pathogen with a wide host range, as illustrated in figure 1.5. Although avian IAV 
can infect a broad range of hosts, these are usually sporadic infections that result from direct 
(with the infected animal) or indirect (aerosols, infected material) contact and typically are poorly 
transmitted by the new host (Cauldwell et al., 2014). On the other hand, the mammalian strains 
of IAV largely infect only one single species, with the exception of a few subtypes, such as H3N8 
equine IAV that can infect both dogs and horses or various H3N2 and H1N1 strains, which have 
been reported to infect pigs and humans (Crawford et al., 2005; Olsen et al., 2006). 
1.5.1. Avian influenza 
Influenza virus in wild aquatic birds predominantly replicates in the intestinal mucosa 
and is therefore transmitted faecal-orally through water (Webster et al., 1992). By contrast, avian 
IAVs isolated from domestic poultry have acquired the ability to preferentially replicate in the 
respiratory tract, which can facilitate transmission in densely-populated poultry 
houses(Vandegrift et al., 2010). Bird populations are affected by two types of avian IAV: LPAI 
and HPAI. The difference in virulence between these two types is largely associated with 
disease severity, namely in the order Galliformes (domestic poultry) (Yoon et al., 2014). As 
explained before, HA is cleaved by host cellular proteases, which in the case of LPAI 
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Figure 1.5 IAV host range. All HA and NA subtypes of IAV (excepting two bat-specific HA and 
NA subtypes), in almost all possible combinations have been isolated from their natural reservoir 
(wild aquatic birds). A large amount of these subtypes can be transmitted to other avian species, 
such as poultry, or mammalian species. Crossing of the species barrier occurs predominantly 
from wild birds to other mammalian species, but the fact that only a minority of HA subtypes are 
found in mammalian species suggest that these transmission events are usually dead-ends for 
the virus, as it is not adapted to the new host. For instance, the main subtypes maintained in 
humans are H1, H2 and H3. Currently, the origin of H17 and H18 isolated in bats is of unknown 
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HA subtypes, is mainly by extracellular trypsin-like enzymes, which limits the spread of the virus 
within the host to the respiratory or intestinal epithelia (Boycott et al., 1994). However, some 
strains evolve into HPAI HA subtypes by insertional mutations, resulting in a polybasic cleavage 
site that is recognised by ubiquitous intracellular proteases found within the host, therefore 
leading to a systemic infection and increased pathogenicity (Horimoto & Kawaoka, 2005; Wright 
et al., 2007). Thus, while LPAI infection of poultry causes mild infections that result in trouble 
breathing, reductions in egg production and depression, HPAI infection causes severe morbidity 
(respiratory distress, diarrhoea, thrombosis) and/or sudden death (Horimoto & Kawaoka, 2005). 
H5, H6, H7 and H9 IAV subtypes currently circulate in domestic poultry and are predominantly 
LPAI, with the exception of H5 and H7 that have evolved to HPAI phenotypes and can now 
cause high morbidity and mortality in the order Galliforme. However, in more recent years, the 
HPAI strains have also been detected in wild birds of the orders Anseriformes (waterfowl) and 
Charadriiformes (shorebirds) (Yoon et al., 2014). 
1.5.2. Host adaptation 
It was noted that when avian IAV spreads and adapts to other hosts, the virus goes 
through rapid evolution with the emergence of new strains that evolve into individual clades 
(Worobey et al., 2014). Regarding avian IAV transmission to mammalian hosts, the first barrier 
encountered by the virus is the different binding affinity of the HA receptor. As described 
previously, the cellular receptor recognised by HA is the sialic acid moiety present on 
glycoproteins or glycolipids on the cell surface. However, avian strains of IAV have a preference 
for sialic acids with α2,3 linkages, which are abundant in the intestine of avian species but mainly 
found in the lower respiratory tract of humans. In contrast, mammalian-adapted HAs have a 
preference for α2,6-linked sialic acids, which are commonly found in the upper respiratory tract 
of humans, including trachea, nasal mucosa, pharynx and bronchi (Connor et al., 1994; 
Matrosovich et al., 2004). This barrier, however, can be lifted by amino acid substitutions in the 
receptor binding domain of HA, as reported for H1, H2 and H3 avian IAVs following transmission 
to mammalian hosts (Matrosovich et al., 2000). Another barrier associated with HA is its stability 
in an acidic environment, as it is important that pH-mediated exposure of the fusion peptide 
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occurs inside the endosome so the virus can fuse with the endosomal membrane. It has been 
reported that avian HAs fuse at higher pH values, while mammalian strains of IAV fuse at more 
acidic pH (fusion reported to occur below pH 5.3); therefore avian strains of IAV are limited in 
their transmissibility to and between mammalian hosts until the rise of adaptive mutations that 
stabilise HA in the human nasal mucosa, which show pHs as low as 5.3 (England et al., 1999; 
Galloway et al., 2013).  
Further evidence suggests that the balance between the activities of HA and NA is 
another determinant of host range, as changes in either of the viral glycoproteins that affect HA 
affinity for sialic acid or NA sialidase activity can affect viral replication (Mitnaul et al., 2000). 
However, NA alone can also modulate host range, as de Wit et al. reported that mutations in NA 
of an avian H7N7 virus, following infection in humans, increased NA activity even when this 
particular NA was inserted in the backbone of another avian H7N7 isolate (de Wit et al., 2010). 
Other studies have also shown that the length of the NA stalk affects viral replication and 
transmission. For instance, Sorrell et al. reported that adaptation of an H2N2 avian virus from 
wild aquatic birds to domestic poultry resulted in a 27 amino acid deletion in the NA stalk, which 
changed virus tropism in the respiratory tract, promoting transmission to naïve birds via indirect 
respiratory contact (Sorrell et al., 2010). On the other hand, Blumenkrantz et al. reported that 
the short stalk of HPAI H5N1 subtypes in the 2009 pandemic H1N1 backbone limits virus 
transmission via respiratory contact between ferrets, showing by insertional mutation that a 
longer NA stalk is needed for efficient transmission in a mammalian host (Blumenkrantz et al., 
2013). 
Other viral proteins that have been associated with host adaptation are the components 
of the viral polymerase and the ‘non-structural’ proteins. Regarding the virus polymerase, it is 
known that an avian IAV polymerase is not always as efficient in a mammalian host. 
Compensatory mutations are therefore required to ensure viral fitness in these hosts, which can 
be achieved by co-evolution of the components of the RNP complex (Naffakh et al., 2008). For 
instance, a single amino acid substitution at position 627 of the PB2 subunit of avian influenza 
strains can result in a polymerase with enhanced activity in mammalian hosts (Subbarao et al., 
1993). Equally important, a study carried out a screen of the chicken genome and identified the 
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host protein ANP32A as a host factor that the PB2 627 E/K variant depends on to increase avian 
polymerase activity in chickens and mammalian hosts, thus adding another layer to the 
understanding of host barriers (Long et al., 2016). More recently, Bussey et al. reported that the 
avian-origin human PA from a 2009 pandemic H1N1 strain showed three amino acid 
substitutions at residues 85, 186 and 338 when compared with the PA of an avian H3N2 strain. 
Following replacement of the avian PA with the human PA in the backbone of the avian viral 
polymerase, the authors reported that the chimeric avian polymerase was actively transcribing 
the reporter gene at 37°C (upper respiratory tract of humans) and at 39°C (avian gut), suggesting 
that adaptive mutations in PA also contribute to host adaptation of avian strains of IAV (Bussey 
et al., 2011). As a last example of specific changes in viral polypeptides that mediate host 
adaptation, several studies have reported that amino acid substitutions in the NS1 protein 
increased avian H5N1 pathogenicity in mammalian hosts, while mutations in NEP of human 
H5N1 isolates were shown to increase virus replication (Mänz et al., 2012; Seo et al., 2002). 
Another possible and less well addressed determinant of host adaptation is virion 
morphology. As described in section 1.1.1, influenza viruses are able to produce spherical or 
filamentous virions and the latter can reach several µm in length. There are many studies 
addressing the viral and cellular determinants that govern production of the two morphologies 
(discussed in more detail in section 1.6), however, to date, their biological significance remains 
unclear. Nonetheless, the generally accepted assumption is that these morphologies can also 
be a modulator of host adaptation. This possibility rises from the fact that following adaptation 
into domestic poultry or mammalian hosts, avian IAVs that usually replicate in the bird gut gain 
the ability to replicate in the respiratory tract. Consequently a potential route of transmission to 
other hosts will be airborne in addition to faecal-oral (Tellier, 2009; Webster et al., 1992). 
1.5.3. Influenza epidemics and pandemics 
As discussed in the previous section, it is clear that for avian IAV to cross the species 
barrier and establish itself in mammalian hosts, the virus requires a number of adaptive 
mutations to ensure fitness in the new species. In majority of the cases, avian IAVs are unable 
to establish a sustained infection chain in mammalian species, explaining the relatively low 
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number of HA subtypes isolated from these hosts. However, when avian strains of IAV are able 
to infect and successfully adapt to transmit within (for instance), humans, seasonal epidemics 
or pandemics are likely to occur.  
In humans, influenza pandemics are sometimes the direct result of IAV genome 
reassortment or antigenic shift. This gives rise to a new virus with novel HA and NA combinations 
that render the host population generally susceptible, as there is little or no cross-protection 
between different IAV subtypes (Krammer et al., 2018). To date, there are definitive records of 
five pandemics in the human population that span the last 100 years. The most famous IAV 
pandemic for which the virus strain is known was in 1918 (Spanish flu), which is estimated to 
have caused a death toll in the order of 50 million and temporarily reduced overall life expectancy 
figures by approximately 10 years (Taubenberger & Morens, 2006). This pandemic was caused 
by an H1N1 influenza virus of unknown source, but phylogenetic studies point to it having 
originated from direct transmission and adaptation of avian influenza to a human host, as there 
are many avian virus-like sequence features of the viral polymerase and other internal genes 
(Taubenberger et al., 2005; Worobey et al., 2014). This pandemic was of particular importance 
because it was the ancestor of subsequent seasonal lineages that persisted for the remainder 
of the 20th century (Taubenberger & Morens, 2006). The other three pandemics of the 20th 
century were in 1957 (Asian flu), 1968 (Hong Kong flu) and 1977 (Russian flu), which were 
caused by H2N2, H3N2 and H1N1 viruses, respectively (Kilbourne, 2006). The 1957 pandemic 
originated in China after reassortment of an avian H2N2 virus with the existing H1N1 strain, 
however this novel virus caused much lower mortality than seen in the previous human 
pandemic (Scholtissek et al., 1978). Approximately 10 years later, an avian H3 virus entered the 
human population, as a result of genome reassortment between the avian virus and the 
circulating human H2N2 virus, giving rise to an H3N2 pandemic human virus that still circulates 
in humans as seasonal H3N2 influenza (Kilbourne, 2006; Scholtissek et al., 1978). These first 
three pandemics of the 20th century each drove the previous virus into extinction in the human 
population. The last pandemic of the 20th century, in 1977, has a controversial origin, as it 
showed high RNA sequence similarity with the 1950s descendants of the 1918 H1N1 viruses, 
suggesting that the reported outbreak was a re-emergence of this strain (Nakajima et al., 1978). 
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Therefore the seasonal H1N1 viruses had somehow gone latent rather than extinct between 
1957 and 1977. True latency within the host is not a known feature of IAV so the most likely 
hypothesis is that the 1977 pandemic viruses reappeared due to failed laboratory containment 
during live virus vaccine trials with the H1N1 pandemic strain (Kilbourne, 2006). Unlike previous 
pandemics, the re-emergence of H1N1 IAV did not replace the previous H3N2 virus in the 
human population, resulting in two seasonal strains of IAV that persist until the present day. 
The first pandemic of the 21st century was reported in 2009 in Mexico, caused by a 
swine-derived H1N1 virus that entered the human population and spread worldwide in a short 
period of time, making it the most highly transmissible influenza virus of the 21st century (Fraser 
et al., 2009). Even though the WHO only reported around 18,000 laboratory-confirmed deaths, 
it is estimated that the 2009 pandemic caused between 123,000 to 203,000 fatalities in 2009 
alone. However this pandemic was not considered deadlier than the previous seasonal strains 
of IAV (Simonsen et al., 2013). Sequence and phylogenetic analyses revealed that the 2009 
pandemic H1N1 virus had a mixed origin that included viruses from avian, swine and human 
hosts, representing the result of reassortment events between swine viruses of mixed origins. 
Firstly, the viral polymerase components (PB2, PB1 and PA) were derived from a swine IAV 
lineage that is a triple reassortment of avian, swine and human origin viruses (Garten et al., 
2009). The HA, NS and NP genes came from a swine H1N1 strain circulating in North America, 
while the remaining genes (NA and M) were originally derived from an avian virus that adapted 
to and established an endemic infection in pigs in Europe and Asia (Campitelli et al., 1997; 
Taubenberger & Morens, 2006). This H1N1 subtype has now replaced the previous seasonal 
H1N1 IAV and now circulates alongside H3N2 and strains of IBV in the human population. 
The most notable avian IAV outbreak occurred in 1996, when a HPAI H5N1 virus spread 
within the poultry population in Hong Kong (Lewis, 2006). This outbreak got special attention 
due to the zoonotic risk of the HPAI H5N1 virus, which caused 6 fatal cases out of 18 recorded 
in poultry workers (Lewis, 2006). Furthermore, this resulted in the culling of over 1.5 million 
chickens by the end of 1997 to contain the outbreak, which contributed to the extinction of this 
HPAI H5N1 virus (Chan, 2002). However, reassortment of the parental H5N1 viruses with LPAI 
strains circulating in domestic poultry and wild birds resulted in the re-emergence of HPAI H5N1 
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viruses in 2003/2004, which were reported to cause the death of 52 people in south east Asia 
(Lewis, 2006). Since then, infections with avian HPAI H5 subtypes have been reported 
worldwide in humans, with mortality ratios of up to 80% (WHO, 2018a). Thankfully, transmission 
of HPAI H5 subtypes in humans is unlikely at best, but there is evidence for limited person to 
person spread, thus raising the concern of H5 subtypes as the source of a human pandemic 
(Ungchusak et al., 2005). 
More recently, from 2013 onwards, the exposure of domestic birds to wild birds and the 
reassortment between wild and domestic strains of IAV resulted in the emergence of H7N9 and 
H7N7 viruses (Liu et al., 2013). These viruses possess a LPAI phenotype and have caused 
several waves of infection in live bird markets, causing only mild symptoms in domestic poultry 
(Su et al., 2017). However, these subtypes of avian IAV have drawn attention due to their 
zoonotic risk, as up until now these have caused over 600 deaths in humans (FAO, 2018). 
Although these viruses possess an increased binding affinity to human receptors and airborne 
transmission in ferrets, human-to-human transmission remained limited and most cases of 
infection resulted from direct exposure to infected poultry (Herfst et al., 2012; Imai et al., 2012). 
Even though these subtypes were mild to the poultry population, in September 2017 the Chinese 
government set up a mass vaccination campaign using an inactivated bivalent vaccine 
containing H5 and H7 viruses (Zeng et al., 2018). Surveillance up until June 2018 revealed that 
only a few birds were positive for H7N9 and only three human cases were reported, suggesting 
that the vaccination campaign was successful although continued surveillance is under way 
(Zeng et al., 2018). 
1.6. Virion morphology of IAV 
Spherical and filamentous forms of influenza virus have been detected in influenza A, B 
and C genera (Morgan et al., 1956; (Nishimura et al., 1990) however the majority of the studies 
performed to date have focused on strains of IAV and these will be summarised in this section. 
The first report that described the presence of spherical and filamentous particles was by Mosley 
and Wickoff, who showed by electron microscopy that purified preparations of A/Puerto 
Rico/8/1934 (PR8) and A/WSN/1933 (WSN) strains of influenza A viruses were composed of 
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both filaments and spheres (Mosley & Wickoff, 1946). Later, in 1949, Chu et al. compared the 
morphology of freshly isolated human viruses with low egg passage and PR8 strain (which by 
then had undergone extensive egg passage). The authors reported that the human viruses 
showed a greater number of long filamentous particles than PR8, thus suggesting that 
filamentous virions are lost upon egg passage (Chu et al., 1949). This hypothesis was later 
corroborated by several laboratories, as the authors showed that serial passage (over 12 times) 
of a filamentous virus in the allantoic cavity of chicken eggs resulted in the loss of the filamentous 
morphology, which was associated with suboptimal growth in this system (Burnet & Lind, 1957; 
Choppin & Tamm, 1960; Kilbourne & Murphy, 1960). More recently, Seladi-Schulman et al. also 
showed that a human filamentous strain loss its filamentous morphology upon serial passage in 
embryonated eggs, while the spherical strain PR8 (re-)acquired the ability to produce 
filamentous particles upon passage in guinea pigs, thus providing evidence of the benefit of the 
filamentous morphology in vivo  (Seladi-Schulman et al., 2013). Equally importantly, Burnet and 
Lind showed that filaments were a genetically-encoded trait of IAV, as filtration of the virus 
population to remove filaments still resulted in a virus able to produce the characteristic 
elongated forms upon infection (Burnet & Lind, 1957). This was corroborated by Kilbourne and 
Murphy, as they showed that genetic reassortment of a filamentous human IAV strain with PR8 
resulted in a predominantly spherical reassortant with the replication phenotype of PR8 
(Kilbourne & Murphy, 1960). Even though both morphologies of virion were detected in virus 
preparations, the initial hypothesis was that spherical particles were a result of the fragmentation 
of the longer filamentous particles. However, this was proved not to be the case when Morgan 
et al. showed by electron microscopy that spherical and filamentous particles extruded from the 
surface of infected cells concomitantly at 6-8 hours p.i., therefore demonstrating that both 
morphologies were produced independently (Morgan et al., 1956). 
1.6.1. Viral determinants of virion morphology 
1.6.1.1. M1 and M2 
Filamentous morphology was shown to be a genetic trait of influenza virus in the late 
1950s, but it was not until the late 1990s that the first report appeared demonstrating the clear 
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importance of the segment 7-encoded M1 and M2 proteins for the phenotype. M1 is a 252-amino 
acid protein that forms a helix underneath the viral envelope, providing support and structure to 
the virion. Biochemical and structural studies with M1 showed that this protein has three largely 
α-helical domains; N-terminal and middle domains that have been crystallised, attached by a 
flexible linker sequence to a C-terminal domain that remains unknown structure-wise due to its 
inability to crystallise, but it is suggested to be more disordered than the N-terminus. The 
domains of M1 and their respective functions are illustrated in figure 1.6 A. Conversely, M2 is a 
97-amino acid protein that plays roles in viral uncoating inside the endosome and viral budding. 
This protein is composed of an ectodomain, tetramers of single-pass transmembrane helices 
and an amphipathic helix within the cytoplasmic tail as illustrated in figure 1.6 B. In a study led 
by Roberts et al, the authors used a now well-known filamentous strain, A/Udorn/1972 (Udorn), 
to show that treatment of infected cells with an antibody against M2 (14C2) prevented the 
formation of filamentous particles (Roberts et al., 1998). Furthermore, they found that antibody-
resistant variants of Udorn presented mutations in M2 (at residues 71 and 78) but retained their 
filamentous morphology, while another variant that presented a single mutation in M1 (at 
position 41) showed a predominantly spherical morphology, thus demonstrating the importance 
of M1 as a major determinant of budding morphology. Later, Bourmakina & Garcia-Sastre built 
a reassortant virus with the M segment of Udorn in the backbone of WSN and showed that this 
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Figure 1.6 Schematic representation of domains within IAV M1 and M2 proteins. (A) The N-
terminal and middle domains of M1 have been associated with virion incorporation of M1 and 
the vRNPs via interactions with NP and non-sequence specific interactions with the vRNA, 
respectively (Noton et al., 2007; Sha & Luo, 1997; Ye et al., 1989). Once translated, M1 enters 
the nucleus via its NLS to aid in the nuclear export of vRNPs, which requires a bridge between 
M1 and CRM1 at the NPC that has been reported to occur via NEP (Ye et al., 1995). M1 
associates with NEP via its middle and C-terminal domains and in turn NEP associates with 
CRM1 via its NES (Ward et al., 1995). However, a NES in M1 was recently reported and shown 
to impair M1 and NEP export, suggesting that M1 might interact directly with CRM1 (Cao et al., 
2012). The C-terminus domain of M1 was recently reported to regulate the ability of M1 to 
associate or dissociate at different pH, suggesting a role in M1 dimerization (Shtykova et al., 
2017). (B) The ectodomain (or extracellular domain) of M2 is a highly conserved sequence that 
has been used as part of a “universal” vaccine for IAV, but this domain is also thought to be 
involved in incorporation of M2 into the virion (Park et al., 1998; Pica & Palese, 2013). The 
transmembrane domain of M2 is embedded in the virion lipid bilayer and it forms a proton 
channel that promotes virion acidification and release of the vRNPs into the cytoplasm (Pinto et 
al., 1992). The cytoplasmic tail of M2 was shown to be composed of: (i) an amphipathic helix 
that promotes membrane scission between newly formed virions and the host cell; (ii) a M1 
binding motif that most likely helps recruit M2 to the lipid raft domains to initiate membrane 
scission; and (iii) a LC3-binding motif that allows M2 to recruit this protein to hijack the autophagy 
cell machinery to source budding virions with cellular membrane (Beale et al., 2014; Chen et al., 
2008; Roberts et al., 2013; Rossman et al., 2010). 
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shown by individual expression of Udorn M1 in the WSN backbone (Bourmakina & Garcia-
Sastre, 2003). Moreover, the authors also showed by mutational analysis that the amino acid 
identity at positions 95 and 204 of M1 were important genetic signatures for virion morphology 
determination. A similar study by Elleman and Barclay also showed that virion morphology was 
a transferable trait encoded on segment 7 regardless of subtype and, by constructing the Udorn 
strain expressing its own M1 but M2 from the spherical WSN strain the authors showed that M1 
was the sole determinant of virion morphology in the M segment (Elleman & Barclay, 2004). 
Similarly to the previous study, the authors also showed that amino acid identity at positions41, 
95 and 218 were sufficient determinants to transfer the filamentous morphology of Udorn to the 
WSN strain. More recently, by comparing M1 amino acid sequences between classical swine 
H1N1 strains and human H1N1 strains from the 2009 pandemic, Bialas et al. showed that 
substituting amino acid position 207 of the human M1 gene to swine virus-like conferred a 
filamentous morphology to the human pandemic strain (Bialas et al., 2012). Campbell et al. 
identified a natural occurring polymorphism at the highly conserved position 41 of M1 between 
human and swine influenza. The authors showed that amino acid substitution at this position of 
human M1 to swine-like M1 resulted in a human virus with a filamentous morphology (Campbell 
et al., 2014; Furuse et al., 2009). Although the majority of these studies were performed in 
human strains of IAV, Elton et al. also showed that segment 7 was the main morphology 
determinant of H3N8 equine strains of IAV and by mutational analysis identified positions 85 
and 231 within M1 as capable of transferring budding morphology between strains (Elton et al., 
2013).  
 Other studies that were not directly focussed on identifying the genetic determinants of 
IAV budding morphology have inadvertently found other M1 residues that affect particle shape. 
For instance, Burleigh et al. reported a study that set out to identify functional properties of the 
helix 6 domain of M1, which included acting as an NLS, binding to vRNPs, viral assembly and 
others. However, the authors found by alanine substitution mutation that amino acid 
substitutions at positions 95, 98, 101 and 102 resulted in WSN virions with a range of 
morphologies. Mutant 102 was the most notable for the production of filamentous virions in the 
WSN background (Burleigh et al., 2005). Another study looking at the mechanism of M1 
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oligomerization also showed that residues in the C-terminus are important determinants of virion 
morphology. Also using scanning alanine mutagenesis, the authors reported that substitutions 
at residues 183 and 185 altered the oligomerization pattern of M1 and conferred a filamentous 
morphology to WSN strain (Zhang et al., 2015). Although the residues identified in these studies 
do not constitute a natural “filamentous signature”, they nonetheless provide information on 
filament formation itself, which appears to be highly dependent on the folding of M1 into an 
ordered helix capable of forming a rigid filamentous structure as reported by Calder et al. 
following cryo-electron microscopy of purified Udorn virus (Calder et al., 2010). 
In addition to M1, M2 is also known to affect virion morphology. For instance, Roberts 
et al. showed that mutations in the highly conserved residues of the amphipathic helix of M2, 
namely residues 47, 48, 51, 52 and 55 (within the cytoplasmic tail), largely abrogated the 
formation of filaments by Udorn, suggesting that this domain, thought to be involved in 
membrane scission during budding, also plays a role in virion morphology (Roberts et al., 2013). 
More recently, Beale et al. reported that PR8-MUd viruses (segment 7 of Udorn in a PR8 
backbone) with amino acid substitutions at positions 91 and 94 of M2 produced fewer 
filamentous bundles on the surface of infected cells (Beale et al., 2014). The authors identified 
these positions as lying within an LC3-interacting motif with which M2 interacts to hijack the 
autophagy cell machinery, suggesting that M2 contributes to filament formation by using the 
autophagy machinery as a source of cell membrane. 
1.6.1.2. Other viral proteins 
Several studies have focused on the importance of other proteins on viral 
morphogenesis. For instance, Jin et al. reported that WSN virions lacking the cytoplasmic tail of 
HA (known to interact with M1) retained their spherical morphology, however, when the 
cytoplasmic tails of both glycoproteins were absent the spherical shape was largely replaced by 
long irregularly shaped virions, suggesting that the interaction between the cytoplasmic tail of 
NA and M1 mediates budding morphology of spherical particles (Jin et al., 1997). This was 
corroborated by Gomez-Puertas et al., who showed by electron microscopy that expression of 
M1 by itself or in combination with the viral glycoproteins in a VLP system induced the formation 
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of elongated structures compatible with IAV virions; however, when NA was not present, the 
VLPs were predominantly spherical and formed aggregates (Gomez-Puertas et al., 2000). More 
recent studies have suggested that NA itself can also induce filamentous particle formation. For 
example, Campbell et al. showed that inserting the NA gene of a filamentous human strain into 
an otherwise spherical PR8 virus resulted in a few filamentous virions on the surface of infected 
cells. However, only the combination of the M segment and the viral glycoprotein NA of the 
filamentous human strain increased filament formation by the spherical PR8 virus (Campbell et 
al., 2014). Similarly, Chlanda et al. showed that expression of NA alone in transfected cells 
resulted in the formation of irregularly shaped long filamentous structures on the surface of the 
cells, yet only when the M protein was expressed alongside the glycoprotein did the authors 
observed regularly shaped filamentous influenza particles characteristic of a filamentous virus 
(Chlanda et al., 2015). 
Another viral protein that has not received as much emphasis as the viral membrane-
associated polypeptides but has also been reported to influence virion morphology is NP. For 
example, Liu et al. reported that the association of PR8 M1 and NP (spherical) was stronger 
than the association of M1 and NP of a human filamentous strain, suggesting that the strength 
of the interactions between the M1 and vRNP is associated with viral morphology but it remains 
unclear which drives which (Liu et al., 2002). A more recent study showed that the M segment 
of a 2009 H1N1 pandemic human strain containing a typical “filamentous signature” at the M1 
amino acid level did not induce filament formation in its natural background, but it did when the 
M segment was placed in a PR8 backbone (Bialas et al., 2014). By genetic reassortment, the 
authors showed that this inhibition was caused by NP and identified residues 214 and 217 in NP 
as the main determinants of filament abrogation in the WT human strain. 
1.6.2. Cellular determinants of morphology 
It is well established that serial passage of influenza strains in embryonated eggs results 
in the loss of the filamentous phenotype, therefore it has been suggested that host factors could 
play a role in viral morphogenesis. For example, Roberts and Compans showed that polarised 
epithelial cells from different host species infected with Udorn strain displayed the characteristic 
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filamentous structures on their surface, while cells of fibroblast origin did not, suggesting that 
polarisation is an important factor in filament formation even though both morphologies of virion 
bud at the apical plasma membrane (Roberts & Compans, 1998). However, other studies using 
fibroblasts or other non-polarised cell types found that filaments were still detected on the 
surface of these cells, thus cell polarisation could be a more complex trait in determining filament 
formation than first thought (Al-Mubarak et al., 2015; Bruce et al., 2009). A potentially significant 
observation made by Al-Mubarak et al. revealed that fibroblast cells of chicken origin prevented 
filament formation upon infection with a duck filamentous strain, while duck-origin fibroblast cells 
displayed filamentous structures on their surface. However, filamentous structures were 
detected on both cell types upon infection with a filamentous equine strain of IAV, indicating that 
filament formation could also be host species-dependent (Al-Mubarak et al., 2015). Furthermore, 
filament formation is dependent on an intact actin cytoskeleton, whose disruption was shown to 
severely inhibit the formation of long filamentous structures on the cell surface upon infection 
with a filamentous strain (human or avian), yet it had little to no effect on the assembly and 
budding of spherical particles (Al-Mubarak et al., 2015; Roberts & Compans, 1998). Other 
cellular factors identified as capable of modulating virion morphology were Rab11 and Rab11-
family interacting protein 3 (FIP3) (Bruce et al., 2010). As described previously, Rab11 is a 
component of the endosomal recycling pathway involved in the apical transport of the viral 
vRNPs, while FIP3 mediates the transport of the viral components-Rab11 complex up the 
microtubules via interactions with a kinesin motor complex (Bouchet et al., 2018). As reported 
by Bruce et al, depletion of Rab11 affected budding of both spherical and filamentous particles, 
while depletion of FIP3 particularly inhibited filament formation, thus suggesting that FIP3 plays 
a role in filament formation that remains to be elucidated (Bruce et al., 2010). 
1.7. Functions associated with virion morphology of IAV 
1.7.1. Escaping host barriers 
It is well established that human and avian IAVs adapted to domestic poultry 
preferentially replicate in the epithelial cells of the respiratory mucosa. In fact, budding of 
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spherical and filamentous influenza particles has been documented in vitro from the microvilli of 
differentiated human airway epithelial cells, providing further evidence of the importance of 
epithelial cells within the respiratory mucosa (Kolesnikova et al., 2013). Therefore, one of the 
first functions suggested for filament formation was the more efficient clearance of the mucous 
layer that coats the respiratory epithelium, facilitating virus entry to the epithelial cells 
underneath (Roberts & Compans, 1998). The respiratory mucosa is composed of a rigid gel-like 
mucous layer that sits on top of a more fluid periciliary layer, which is composed of basement 
membrane with connective tissue underneath (lamina propria) where the mucous secretory 
gland is embedded, as represented in figure 1.7 (Fahy & Dickey, 2010). Both ciliated epithelial 
cells with microvilli on their surface and goblet cells sit underneath  the mucous layer that is 
composed of mucins, which are heavy glycosylated sialic acid-rich proteins that provide the 
viscoelastic properties associated with mucous membranes. Influenza A virus is known to 
interact with these mucins and block of neuraminidase activity by NAI drugs showed that NA is 
important in the clearance of the mucous layer to allow virus penetration of the barrier (Cohen 
et al., 2013). Studies using NAI inhibitors and/or exogenous NA support a role of viral NA in the 
diffusion and penetration of the mucous layer by the virus (Yang et al., 2014). Consequently, it 
is possible that the sialidase function of NA is involved in two processes: facilitating viral 
penetration of the mucous barrier downwards to allow virus entry into the mucosal epithelial cells 
or clearance of the surrounding viscoelastic barrier to enable viral release into the upper mucous 
layer, promoting viral transmission from host-to-host. Therefore, since filamentous virions have 
an increased neuraminidase activity compared with their spherical counterparts and can reach 
up to 30 µm in length, it has been suggested that these viral particles can cross through the 
periciliary fluid layer (7 µm in depth), invade the upper mucous layer and likely transmit more 
efficiently than spherical particles (Cox et al., 1980; Dadonaite et al., 2016; Seladi-Schulman et 
al., 2014) . Furthermore, it was recently reported that HA and NA viral glycoproteins act as motile 
machinery in IAV and influenza C virus (ICV) that allow the virus to travel along a sugar-coated 
surface until several HA attach and start viral entry (Sakai et al., 2017; Sakai et al., 2018). 
Spherical PR8 IAV particles were shown to move randomly in any direction except backwards, 
as the NA cleaves off the sialic acid. However, a filamentous strain of ICV displayed a more 
regulated movement in one direction on the surface, thus suggesting that filamentous influenza 





































Figure 1.7 Respiratory mucosal membrane. (A) Schematic representation of the respiratory 
mucosal surface of the lumen-side of the trachea. The mucous blanket is composed of a gel 
layer that contains mucous (produced by the goblet cells) and mucins which contribute to the 
high viscoelasticity of the gel layer. This layer also contains immune cells, chemicals and 
antibodies, providing the first barrier against respiratory pathogens. The sol layer underneath 
(also termed the periciliary layer) is a more fluid layer that involves the cilia on the surface of the 
epithelial cells. This layer also contains mucins, though to a lesser extent. The cilia move in a 
rhythmic beating motion, facilitating movement of the secretions upwards to the central airways 
(throat) where these are disposed of. These layers make up the respiratory epithelium, which is 
anchored by a basal membrane on top of the lamina propria that contains the mucus gland. 
Figure provided by Dr Xiaoyun Yang. (B) Cross section and Haematoxylin and Eosin staining of 
the tracheal tissue indicating the main areas of the respiratory mucosal membrane. Adapted 
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virus have an advantage when travelling along the respiratory mucosa when compared with 
spherical particles.  
Another barrier IAV needs to evade when entering a new host is the innate and adaptive 
immune responses. Upon entry, the virus first encounters physical barriers, such as the mucus 
barrier. Additionally, an innate immune response is elicited upon recognition of pathogen-
associated molecular patterns (PAMPs) by host pathogen recognition receptors, leading to the 
activation of transcription factors that will turn on interferon (IFN)-stimulated genes (ISGs) 
(Iwasaki & Pillai, 2014). This response produces IFN and cytokines that compose the first line 
of the immune response in combination with neutralising antibodies (e.g. IgA or IgM), making 
this a rapid but unspecific response. The adaptive immune response then starts when antigen 
presenting cells (APCs) such as dendritic cells present viral antigens to naïve CD8+ T cells and 
activates these to cytotoxic T lymphocytes (CTLs), which in turn are capable of kill virus-infected 
cells. Regarding this, two main functions have been hypothesised for filaments: (i) lure the host 
immune response away from infectious spherical particles or (ii) evade the innate immune 
response by cell-to-cell transmission (Roberts & Compans, 1998). The first hypothesis was 
proposed following observations that filamentous particles often lack a complete set of vRNPs, 
suggesting that these non-infectious particles could act as a “decoy” for neutralising antibodies, 
allowing the establishment of infection by infectious particles, yet this remains to be confirmed 
(Vijayakrishnan et al., 2013). On the other hand, filamentous particles were hypothesised to 
evade the innate immune response (e.g. neutralising antibodies) by cell-to-cell transmission 
without the need to be released due to their elongated form (Roberts & Compans, 1998). This 
has yet to be observed; however Roberts et al. showed that filamentous IAV vRNPs can travel 
to neighbouring naïve cells via intercellular junctions without by manipulating the actin 
cytoskeleton of the host cell (Roberts et al., 2015).  
1.7.2. Viral transmission 
In the 1940s, Andrewes and Glover reported that airborne transmission of IAV was 
possible, as transmission was detected between ferrets in close proximity, at great distances or 
even in animals placed several centimetres upwards (Andrewes & Glover, 1941). Thereafter, 
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several studies have reported the ability of mammalian and avian strains of IAV to transmit via 
respiratory droplets from the respiratory tract of infected animals (Campbell et al., 2014; Herfst 
et al., 2012; Imai et al., 2012; Lakdawala et al., 2011). However, it still remains unclear the role 
of the filamentous morphology in this transmission. Of note, clinical isolates of human and 
veterinary (equine and porcine) origin have revealed the predominant presence of filamentous 
forms mixed with a smaller amount of spherical particles (Choppin & Tamm, 1960; Chu et al., 
1949; Elton et al., 2013; Kilbourne & Murphy, 1960; Nakajima et al., 2010; Seladi-Schulman et 
al., 2013). Even though true evidence from in vivo IAV budding morphology is difficult to obtain, 
a couple of studies have shown filamentous forms budding out from lung slices ex vivo, thus is 
reasonable to suggest that filamentous forms are produced in vivo (Nakajima et al., 2010; 
Weinheimer et al., 2012). Regarding the morphology of avian influenza isolates, there is only a 
few reports showing that avian isolates of IAV are composed of filamentous virions, however it 
remains unclear if that is the predominant phenotype as in the case of mammalian isolates (Al-
Mubarak et al., 2015; Pu et al., 2017; Smirnov et al., 1991).  
Lakdawala et al. reported that viruses with the NA and M segments of the pandemic 
H1N1 2009 human strain showed higher neuraminidase activity and a filamentous morphology 
(Lakdawala et al., 2011). Later, another study showed that insertion of the HA, NA and M 
segments of a pandemic H1N1 2009 human strain enhanced contact transmissibility of the 
poorly transmissible PR8 strain in guinea pigs (Campbell et al., 2014). The resultant reassortant 
virus also showed a filamentous morphology and, in fact, the authors suggested that the M 
segment and changes in virion morphology are able to modulate NA activity and, therefore, 
enhance transmissibility. Overall, the studies described here suggest that virion morphology is 
a complex trait of influenza viruses that deserves more attention. 
1.8. Aims of the study 
To date, majority of the studies that address virion morphology have focused on 
mammalian (human, swine or equine) strains of IAV, which we now know display a range of 
morphologies as described above. However, up to my knowledge, only three reports exist that 
explicitly address the virion morphology of avian strains of IAV (Al-Mubarak et al., 2015; Pu et 
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al., 2017; Smirnov et al., 1991). Singly and collectively, these studies fail to elucidate the 
biological significance of particle shape in avian IAV. For mammalian strains of IAV, it is well 
established that the M segment is a major determinant of budding morphology and specific 
amino acid residues within M1 have been proposed to compose a “filamentous signature” that, 
as the name suggests, can modulate virion morphology and be used as a tool to predict virus 
behaviour from nucleotide sequence. However, regarding avian strains, it remains unclear 
whether the M segment is also a determinant of morphology and, if so, whether avian strains 
also present this or another “filamentous signature” in their M1 gene. Finally, reverse genetics 
coupled with microscopy studies with the pandemic 2009 strains revealed that the M segment 
conferred a filamentous morphology to these viruses. This is particularly important because the 
M segment is derived from an avian strain of IAV that adapted to and circulates in pigs in Europe 
and Asia (Campitelli et al., 1997). Knowing this and that M1 is the most conserved protein in 
both avian and human strains of IAV, it is plausible to ask whether avian IAVs could also be 
filamentous (Furuse et al., 2009). 
Therefore, the main aim of this study was to assess the budding morphology of avian 
strains of IAV and, if filaments are present, determine their biological significance in vivo. 
Chapter 2 addresses the budding phenotype seen with avian IAVs and tests the importance of 
the M segment in determining virion morphology. The definition of a novel “filamentous 
signature” is described in chapter 3 and the behaviour of mutant and WT viruses with opposing 
budding morphologies are characterised in vitro and in ovo in chapter 4. Lastly, in chapter 5, the 
biological significance of filaments produced by an avian IAV in vivo is addressed. Concluding 
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Chapter 2: Characterisation of avian IAV budding morphology in vitro 
2.1. Introduction and aims 
As discussed in chapter 1, influenza A viruses are able to produce spherical particles of 
~ 100 nm in diameter (Chu et al., 1949) and long filamentous virions, with an average diameter 
of 80 nm that can be up to 30 µm in length (Choppin & Tamm, 1960; Chu et al., 1949; Cox et al., 
1980; Morgan & Murphy, 1956; Roberts et al., 1998; Valentine & Isaacs, 1957; Vijayakrishnan 
et al., 2013). Spherical particles are commonly seen with laboratory-adapted strains that have 
been serially passaged in cells and/or eggs, such as A/Puerto Rico/8/1934 (PR8) and A/WSN/33 
(WSN) (Burnet & Lind, 1957; Kilbourne & Murphy, 1960). Conversely, filamentous virions are 
predominantly selected in vivo and can be found in clinical isolates and/or early egg or cell 
passage viruses (Choppin & Tamm, 1960; Chu et al., 1949; Nakajima et al., 2010; Seladi-
Schulman et al., 2013). These strain-dependent variations in IAV budding morphology are 
mainly due to sequence polymorphisms in the viral matrix protein M1, encoded by segment 7 
(Bialas et al., 2012; Bourmakina & Garcia-Sastre, 2003; Elleman & Barclay, 2004; Elton et al., 
2013; Roberts et al., 1998). The M1 protein forms a lattice that underlies the viral envelope and 
determines particle shape (Noda, 2012). The majority of the IAV virion morphology studies have 
focused on mammalian strains of the virus, which have identified single amino acid mutations in 
M1 that can alter particle shape. Within the M1s of human H1N1 and H3N2 strains, the amino 
acid identity at positions 41, 95, 204, 207 and 218 (Bialas et al., 2012; Bourmakina & Garcia-
Sastre, 2003; Elleman & Barclay, 2004; Roberts et al., 1998) have been termed as the 
“signature” that define filamentous morphology (Elton et al., 2013), with a later addition of 
position 85 identified in equine H3N8 strains (Elton et al., 2013). However, it remains unclear to 
what extent this M1-determined filamentous versus spherical pleomorphism applies to avian 
IAVs. 
Therefore, the aim of this part of the study was to characterise the budding morphology 
of avian isolates of IAV with (if variability was found), the next step correlating M1 sequence 
polymorphisms with morphology, in order to identify single amino acid substitutions that 
determined virus particle shape.  
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2.2. Results 
2.2.1. Validation of plant lectin staining as a substitute for antibody stain in fully 
avian viruses 
The most commonly used approach to test whether a given IAV produces filamentous 
particles is to infect cells and then examine the cell surface by microscopy after the onset of 
budding (> 6-8 h p.i) for the characteristic filamentous structures (Cox et al., 1980). Typically this 
is done by confocal microscopy after staining for the viral HA (Roberts & Compans, 1998; 
Simpson-Holley et al., 2002). The first aim of this part of the study was to test the budding 
morphology of avian strains of IAV in MDCK cells and characterise their budding phenotype by 
immunofluorescence assays (IF). However, specific antibodies against the surface proteins for 
each strain where not available. In order to overcome this, plant lectins were tested as 
alternatives for staining the surface of infected cells. Plant lectins are carbohydrate-binding 
proteins that bind both mono- and oligo-saccharides present on glycolipids and glycoproteins 
(Lagarda-Diaz et al., 2017). These can be found inside or outside the cells, either as soluble or 
membrane-associated proteins. Although the function of plant lectins remains uncertain, it has 
been shown that these confer protection against pathogens (Lagarda-Diaz et al., 2017). Lectins 
are able to bind glycans in proteins. Glycosylation of N-linked proteins starts in the endoplasmic 
reticulum, continuing in the Golgi complex (Schwarz & Aebi, 2011). The addition of the glycan 
to newly formed proteins is initiated in the endoplasmic reticulum, where the glycan is transferred 
to an asparagine residue, designated N-linked or asparagine-linked glycosylation. Further 
processing of the N-glycan occurs in the Golgi complex, where the glycan is trimmed to its core 
structure (figure 2.1 A) for posterior addition of carbohydrates. The most common glycan 
structures found within N-linked glycans are represented in figure 2.1 A (Stanley et al., 2009). 
The final structure of the glycan determines if the protein will be membrane-bound (i.e. 
glycoprotein) or secreted (Schwarz & Aebi, 2011; Xu & Ng, 2015). 
Upon budding, IAV incorporates the cell membrane and associated proteins into newly 
produced particles (Berri et al., 2014). Given that cell membranes are rich in carbohydrates 
(typically as N-linked glycans); plant lectins present a good alternative to replace antibody 
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Figure 2.1 Validation of plant lectin staining as an alternative to antibody staining. (A) Schematic 
representation of N-linked glycans. (B) Candidate plant lectins with the recognition sites 
identified (grey boxes): concanavalin A (Con A), wheat germ agglutinin (WGA) and L. 
esculentum agglutinin (LEA). MDCK cells were infected (or mock-infected) with PR8 MUd virus 
at a MOI of 3 and fixed 16 h p.i. Cell surface was stained with plant lectins Con A (Alexa 488-
conjugated), WGA or LEA (both biotin-conjugated) in green, rabbit anti-PR8-Alexa 594 antibody 
for viral surface proteins (red staining) and DAPI (blue staining). Biotin-conjugated lectins were 
detected with a secondary streptavidin-FITC conjugate. Images were collected using the 
widefield LEICA DLMB microscope with the 40x objective and are representative of two 
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staining. The main consideration for a successful choice of lectin was based on the fact that its 
recognition site could not contain sialic acids, as these are cleaved off by the viral NA protein 
during budding (Els et al., 1989). Therefore, based on this criterion three plant lectins were 
selected to determine their ability to detect virions on the surface of infected cells. These were 
from: Canavalia ensiformis (Concanavalin A, abbreviation Con A), Triticum vulgaris (Wheat 
germ agglutinin: WGA) and Lycopersicon esculentum (Lycopersicon esculentum agglutinin: 
LEA). Their recognition sites within N-linked glycans are represented in figure 2.1 B (Dorscheid 
et al., 1999; Yi et al., 2001).  Con A and WGA lectins are able to recognise the core structure of 
the glycan, whereas LEA is only able to recognise carbohydrate structures on more complex N-
linked glycans. 
In order to test the selected lectins, MDCK cells were infected (or mock-infected) with a 
well-characterised (Beale et al., 2014; Bruce et al., 2010; Bruce et al., 2009; Elton et al., 2013; 
Noton et al., 2007) filamentous strain previously generated by the Digard laboratory containing 
segment 7 from A/Udorn/301/72 in the background of A/PR/8/34 (PR8 MUd) at a MOI of 3 and 
fixed 16 h post infection (p.i.). Prior to imaging, the cells were stained with Con A (Alexa 488-
conjugated), WGA (biotin conjugated-streptavidin complex) or LEA (biotin conjugated-
streptavidin complex) lectins all in green, rabbit-anti PR8 antibody for PR8 surface proteins 
(mainly HA) in red and DAPI to delineate the nuclei. As expected, mock-infected cells showed 
no red staining, while the green lectin staining was dotted and showed a diffused pattern (figure 
2.1 B, bottom half), also as expected (Yi et al., 2001). On infected cells, it was possible to 
observe the characteristic long bundles of filamentous particles produced by the virus, 
prominently stained with the anti-PR8 antibody in red (figure 2.1 B, white arrows). Obvious 
colocalization of antibody and lectin (green) happened with Con A and WGA lectins, but not with 
LEA. This lack of recognition of virions with LEA lectin was unexpected as in theory removal of 
sialic acid should not have affected the carbohydrate structure it recognises. Nevertheless, 
these data identified two lectins that could substitute for HA antibody staining as a means of 
staining viral filaments. Therefore, Con A lectin (488-conjugated) was used throughout the study 
whenever the viral glycoproteins present on the virus were not of PR8 origin. 
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 Next, the budding phenotype of 7 avian IAV isolates available in the laboratory (Table 
2.1, bold strains) was examined. First, MDCK cells were infected with these strains to determine 
if the cells were permissive to infection with avian IAV isolates. MDCK cells were infected with 
these isolates at a MOI of 3 for 16 h. Cells were fixed, permeabilised and stained with antibody 
against viral NP and DAPI to delineate nuclei prior to imaging by confocal microscopy. Z-stacks 
were taken maximum intensity projections were collected. Expression of viral NP was detected 
in almost 100% of infected cells, indicating that these avian isolates were able to infect MDCK 
cells upon high MOI infection (figure 2.2). To determine the budding phenotype of the avian 
isolates, MDCK cells were infected and the surface stained using Con A staining. In addition, 
WT PR8 and PR8 MUd were used as controls for viruses with well-defined spherical and 
filamentous budding morphologies, respectively.  MDCK cells were infected with these strains 
at a MOI of 3 and fixed 16 h p.i.. Cells were stained with Con A lectin and DAPI to indicate nuclei 
prior to imaging by confocal microscopy. As seen above, mock-infected cells presented punctate 
foci of Con A staining across the plasma membrane along with apparently more continuous 
staining of the lateral membranes (Figure 2.3). PR8-infected cells showed a more diffuse pattern 
of lectin staining with fewer bright puncta but still with staining of the lateral membranes, while 
PR8 MUd infected cells showed a dramatic reorganisation of Con A staining into long 
filamentous structures on their surface (Figure 2.3, white arrows). When cells infected with the 
panel of avian strains of IAV were examined, cells inoculated with the Dk/Singapore, Ck/Israel, 
Ck/Saudi Arabia and Ck/Italy strains of virus showed a reorganised pattern of surface Con A 
staining comparable to that seen with WT PR8, suggesting the cells had been successfully 
infected but were not producing filamentous structures visible by light microscopy. Conversely, 
infection with Dk/England, Dk/Netherlands and Tk/Canada promoted the formation of long 
filamentous bundles on the surface of infected cells, similar to what was isolates, both 
filamentous and non-filamentous budding could be observed. Overall, these data allowed the 
detection and classification of viral morphology for a number of avian isolates and suggested 
that these can be as pleomorphic as mammalian IAVs. 
 
 




















Figure 2.2 Detection of infectivity of avian strains in MDCK cells. Cells were infected with the 
viral strains indicated at a MOI of 3, fixed 16 h p.i and permeabilised. Cells were stained with 
mouse anti-NP antibody (green staining) and DAPI (blue staining) prior to imaging. Images were 
collected using the Zeiss 710 confocal with a 63x objective and are representative of three 

































Figure 2.3 Determination of the budding phenotype of avian IAV strains by IF. MDCK cells were 
infected (or mock-infected) with the indicated viruses at a MOI of 3 for 16 h before fixation. Plant 
lectin Con A was used to stain surface carbohydrates (green) and DAPI used to stain nuclei 
(blue). PR8 WT and PR8 MUd viruses were used as positive controls for spherical and 
filamentous budding, respectively. Images were collected on the Zeiss 710 confocal microscope 
with a 63x objective and are representative of three independent experiments. Images represent 
maximum intensity projections from Z-stacks. Filamentous bundles present on the surface of 
infected cells are indicated by white arrows. Scale bar (20 µm) indicated. 
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2.2.2. Segment 7 is the major determinant of budding morphology 
A small panel of avian IAVs showed a mix of budding phenotypes that did not obviously 
correlate with passage history (Table 2.1, bold strains), suggesting that filamentous budding 
might be a less common trait for avian viruses. However, it was desirable to test a larger and 
wider range of viruses before making further conclusions. The variety of HA and NA subtypes 
and the biosafety rules required to work with highly pathogenic avian IAVs, as well as strain 
availability presented as limiting steps to characterisation of a panel that would be representative 
of avian strains. To overcome this, using 7:1 reassortant viruses with segment 7 of avian strains 
in a PR8 backbone was considered. As discussed in more detail in chapter 1, budding 
morphology studies on mammalian IAVs have often focused on 7:1 reassortant viruses, typically 
with segment 7 of a filamentous strain in a spherical strain backbone (Bourmakina & Garcia-
Sastre, 2003; Elleman & Barclay, 2004; Elton et al., 2013). From these studies, it became clear 
that the viral matrix protein M1 encoded by segment 7 is a strong determinant of budding 
phenotype. However, in addition to segment 7, other studies have identified segments 4 (HA), 5 
(NP) and 6 (NA) as capable of modulating morphology of IAVs (Bialas et al., 2014; Chlanda et 
al., 2015; Jin et al., 1997; Liu et al., 2002). Segment 5 was shown to inhibit filament formation in 
the context of an avian isolate (Bialas et al., 2014). In contrast, segments 4 and 6 were shown 
to modulate filament size and formation (Chlanda et al., 2015; Gomez-Puertas et al., 2000). 
Chlanda et al suggested that NA in particular plays an important role in filamentous particle 
assembly and release, shown by electron microscopy of membranes of transfected 293T cells 
(Chlanda et al., 2015). Thus, to test this in our system, we took advantage of the fact that the 
filamentous Dk/Netherlands virus tested above was made by reverse genetics from a complete 
set of cloned segments (kindly provided by Dr Laurence Tiley), which were also available in the 
laboratory. Accordingly, reassortant viruses with segments 4, 5, 6 and 7 individually or in 
combination in a PR8 backbone were built to determine the importance of these segments on 
the morphology of avian IAVs. 
Firstly, 293T cells were transfected with reverse genetics plasmids (pDUAL) of 
segments 4, 5, 6 and 7 of Dk/Netherlands strain (Bourret et al., 2013) individually or in 
combination in the backbone of PR8 to generate P0 stocks (section 7.2.3.1). The fully avian 
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Dk/Netherlands virus was also similarly rescued. A positive control rescue with PR8 WT and a 
negative control lacking a PB1 plasmid and thus unable to generate infectious particles, were 
also included. Generation of P1 stocks consisted of infecting MDCK cells with the P0 stocks for 
48 h. Throughout the courses of infection, CPE was monitored using microscopy and compared 
to cells inoculated with the supernatant from the negative control (lacking PB1) cells to 
determine if the rescues were successful or not. The P1 viruses were titrated by plaque assay. 
All viruses were rescued twice independently, with titres ranging 105-108 PFU/ml (figure 2.4 A). 
Reassortant viruses with (HA NP M), (HA M NP), (HA NA) and (M HA NA) were associated with 
more difficult rescues and lower titres. Thus, as a further measure of viral fitness, plaque 
phenotype was done in monolayers of MDCK cells under avicel. Cells were fixed, permeabilised 
and plaques visualised by immunostaining for viral NP (Figure 2.4 B). The viruses that showed 
the smallest plaques were the ones described before as difficult to rescue, which suggest that 
these viruses do not spread well on a monolayer of cells. 
To determine the importance of segments 4, 5, 6 and 7 in the budding morphology of 
avian IAVs, the reassortants and parental WT viruses rescued were used to infect MDCK cells 
at a MOI of 3 for 16 h. Cells were fixed and stained for surface carbohydrates as described 
previously (Figure 2.5). Since all reassortants were made with the non-filamentous PR8 strain 
backbone, PR8 WT-infected cells were used as a morphology control. As before, mock-infected 
cells showed a dotted and diffused pattern of Con A staining, while cells infected with PR8 WT 
showed the more irregular distribution of lectin staining associated with infection by a virus with 
a spherical phenotype. Next, the budding morphologies of the 7:1 reassortant virus with segment 
7 of Dk/Netherlands in a PR8 backbone (PR8:Dk/Netherlands M) and Dk/Netherlands WT were 
determined. Both viruses showed a filamentous phenotype with many elongated bundles of 
particles present on the surface of the cells (Figure 2.5, white arrows). However, although 
obviously filamentous, PR8:Dk/Netherlands M reassortant virus produced fewer bundles of 
filamentous virions when compared with Dk/Netherlands WT. Thus, it appeared that other viral 
proteins along with M1/M2 promoted a stronger filamentous budding phenotype. Individual PR8 
7:1 reassortant viruses with Dk/Netherlands segments 4, 5 or 6 showed a Con A staining pattern 
comparable to WT PR8, as well as 6:2 reassortant with both HA and NA from the avian virus, 

























Figure 2.4 Replication phenotypes of reassortant viruses between Dk/Netherlands and PR8.  (A) 
MDCK cells were infected with 1:10 dilutions of P0 stocks and left for 48 h before supernatants 
were collected and plaque titred on MDCK cells. Data represent mean +/- SEM (n = 2) from two 
independently rescued stocks of viruses. Blue bars indicate viruses with a spherical budding 
phenotype while orange bars represent filamentous viruses (see later). (B) Plaque phenotypes 
were assessed in monolayers of MDCK cells under Avicel. Cells were permeablised, stained 
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Figure 2.5 Budding phenotypes of reassortant viruses between Dk/Netherlands and PR8. WT 
or reassortant viruses with the indicated segments of Dk/Netherlands (blue lines) in a PR8 
backbone (green lines) were used to infect MDCK cells at a MOI of 3 and fixed 16 h p.i.. Cells 
were stained with Con A (green) for surface carbohydrates and DAPI (blue) prior to imaging on 
a Zeiss LSM710 confocal microscope with a 63x objective. Images were collected as maximum 
intensity projections and are representative of three independent experiments. Arrows indicate 
bundles of filaments. Scale bar (20 µm) indicated. 
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suggesting a spherical budding phenotype had been maintained. On the other hand, when the 
Dk/Netherlands segment 7 was added to these reassortants to produce 6:2 viruses or a 5:3 with 
HA, NA and M, filamentous bundles were observed on the surface of the cells, but the 
reassortant with Dk/Netherlands M HA and NA was the virus that showed the phenotype closest 
to Dk/Netherlands WT.  
In order to provide a more quantitative measure of the IAV filamentous budding 
phenotype, the confocal images were used to determine the percentage of filament- producing 
cells and the filament bundle size. For the first metric, a minimum of 80 infected cells were scored 
per virus over three independent experiments with 2 separate rescues for the presence or not 
of at least one bundle of filaments and the % of filament- producing cells determined. For the 
filament length, 20 filament bundles (when visible) produced by the cells were measured from 
each of three independent experiments (see chapter 7, section 7.2.7, figure 7.3). WT 
Dk/Netherlands showed approximately 100% of infected cells producing filaments (Figure 2.6), 
whereas all the reassortant viruses without Dk/Netherlands segment 7 (M) showed 
predominantly a spherical phenotype, with only a few cells displaying filamentous structures 
(blue bars). The addition of the avian virus segment 7 to the PR8 backbone resulted in about 
50% of infected cells producing filaments. This percentage was significantly increased by the 
addition of NP (segment 5) and the glycoproteins HA and NA (segments 4 and 6, respectively); 
however, only the 5:3 reassortant PR8:Dk/Netherlands M HA NA virus induced a filamentous 
budding in a comparable percentage of infected cells to Dk/Netherlands WT. When the sizes of 
the viral filaments were considered, it was observed that all reassortants with M segment of 
Dk/Netherlands strain induced the formation of filamentous bundles that ranged between 7-10 
µm (Figure 2.6 B). WT Dk/Netherlands and PR8 reassortant viruses with Dk/Netherlands M and 
NA and M, HA and NA showed equivalent lengths, while reassortant viruses with M, M and HA 
and M and NP all formed significantly smaller filamentous bundles on the surface of the cells, 
suggesting that NA played a role in determining filament length. 
Taken together, these data suggested that segment 7 could be a major morphology 
determinant for avian strains of IAV, as the 7:1 reassortant with segment 7 of Dk/Netherlands in 
a PR8 backbone showed a prominent filamentous phenotype. Furthermore, the addition of



















Figure 2.6 Quantification of the budding phenotypes of reassortant viruses between 
Dk/Netherlands and PR8. WT or reassortant viruses with the indicated segments of 
Dk/Netherlands in a PR8 backbone were used to infect MDCK cells at a MOI of 3 for 16 h. (A) 
A minimum of 80 infected cells were counted per virus and the percentage of filament-
producing cells was determined. (B) 60 filaments were measured per virus (when visible). Data 
are the mean +/- SEM (n = 3). ANOVA statistical analysis was used to compare all viruses 
against Dk/Netherlands WT (green asterisks) and compare all reassortants with M (pink 
asterisks) individually or in combination with HA, NP and/or NA. * p<0.05; ** p<0.01; *** 
p<0.001; **** p<0.0001. Limits for viruses to be classified as possessing a filamentous budding 
morphology are indicated (> 15% of infected cells producing at least one bundle of filaments 
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segments 4 (HA), 5 (NP) and 6 (NA) resulted in modulation of the filamentous phenotype, by 
increasing the number of cells producing visible filamentous bundles on their surface. 
Additionally, the presence of segments 4 (HA) and 6 (NA) promoted the formation of longer 
filamentous particles, as previously reported by Chlanda et al. with human strains of IAV 
(Chlanda et al., 2015). However, although the addition of other avian virus segments to the 
PR8 reassortant with the foreign segment 7 modulated the budding phenotype closer to 
Dk/Netherlands WT, segment 7 by itself determined filament production, confirming the value 
of 7:1 reassortant viruses to virion morphology studies. This allowed characterisation of avian 
IAV morphology to proceed based on testing 7:1 reassortant viruses, therefore eliminating 
constrains on the selection of avian IAVs. 
 
2.2.3. Determination of the budding phenotype of IAVs through 
characterisation of PR8-based 7:1 reassortant viruses with segment 7s from avian 
strains 
To further characterise the budding morphology of avian IAVs, several segment 7s 
were selected and used to rescue 7:1 reassortant viruses in a PR8 backbone. Several avian 
virus segment 7s were already available within the laboratory from other projects. However, to 
more systematically choose candidate viruses to donate their M genes, complete nucleotide 
sequences of segment 7 were collected from the online Influenza Research Database in May 
of 2016. From a sample of 8,000+ sequences, a subsample of 2000+ was selected based on 
HA sequence diversity, the nucleotide sequences aligned using MEGA6 and grouped into a 
phylogenetic tree using the neighbour-joining algorithm with 100 bootstraps (Hillis & Bull, 
1993). The scripts necessary to this analysis were built using R by Dr Samantha Lycett. 
Grouping M1 sequences by phylogeny resulted in a tree that showed two main branches: one 
composed mainly of samples from Eurasia and the other branch formed of samples collected 
in the American continent (Figure 2.7). For clear visualisation, countries that represented 
Europe (blue), Asia (blue) and American (red) continents were colour coded. The next step 
  57 
 
was to divide this tree further into clades, where Eurasia contained clades 1 to 6 and America 
contained clades 7 to 11. The avian strains already tested (Figure 2.2) and the segment 7s 
already available were fitted into these clades. Then, for the clades with no representation at 
least one segment 7 was randomly selected for gene synthesis. Exclusively, A/Zhejiang/DTID-
ZJU01/2013 (H7N9) was of human-origin isolated during the 2013 epidemic in China (Chen et 
al., 2013), but the sequence of the M gene in this virus is identical to that of a contemporary 
virus isolated from a live bird market in the same area, A/chicken/Zhejiang/DTID-ZJU01/2013 
(Li et al., 2014), so for the purpose of this study the segment was considered as Ck/Zhejiang. 
The final sample of segment 7s included a variety of HA and NA subtypes from across the 
world collected over the last 50 years (Table 2.1).  
Following selection, the segment 7s were commercially synthesised or kindly provided 
by colleagues in the laboratory. For brevity, segments/viruses were named after the host 
species and the country/city where the avian strain was collected (Table 2.1). The synthesised 
segments were then subcloned into the pDUAL vector plasmid to proceed with reverse 
genetics. As described before, generation of P0 stocks of 7:1 reassortant viruses with segment 
7 of avian strains in a PR8 backbone was performed in 293T viruses with segment 7 of avian 
strains in a PR8 backbone was performed in 293T cells. These P0 stocks were then 
propagated once on MDCK cells (P1) and titrated by plaque assay to use thereafter. WT PR8 
and PR8 MUd were also rescued in parallel because these viruses were important morphology 
controls for this study. All viruses rescued readily twice, with the exception of the 
PR8:Ck/Penn/1. This reassortant rescued once and it was not possible to rescue it again. More 
than 10 rescues were attempted in either mammalian (293T) or avian cells (QT-35 and DF-1). 
Ck/Penn/1 HA with an altered polybasic cleavage site (due to the high pathogenic nature of 
Ck/Penn/1) along with NA were used to rescue 6:2 and 5:3 reassortants but with no success. 
Moreover, from clade 3, the first avian strain selected – A/duck/Zhejiang/925169/2014 (H5N8) 
– was not possible to rescue the PR8-based 7:1 reassortant virus with the segment 7 of the 
avian virus. Further attempts were performed as 6:2 reassortants with Dk/Netherlands HA or 
NA and 5:3 with Dk/Netherlands HA and NA and the internal genes of PR8, but with no 
success. Accordingly, further viruses were chosen from clade 3, synthesised, cloned and 



















 Figure 2.7 Phylogeny of viral matrix protein M1 from avian strains. More than 8,000 segment 
7 sequences were retrieved from Influenza Research Database and a subsample of 
approximately 2000 sequences were aligned and organised into a phylogenetic tree based on 
the nucleotide sequence of M1. The tree showed two main branches: Eurasia and America 
continents with the countries that represent each branch colour coded as red for countries of 
the American continent and blue and green for countries of Eurasia, while black represent 
other countries. The phylogenetic tree was done with the help of Dr Sam Lycett. 
Eurasia 
America 
USA, Canada, Brazil and 
Chile 
Germany, France, Sweden, 
Russia and China 
Other countries 
Japan 
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 Table 2.1 IAV strains used in this study. One or more segment 7s were selected from each of the clades of the phylogenetic tree from the avian viruses 
indicated. Fully avian viruses are represented in bold and are referred as isolate. Origin of the virus and passage history is indicated. RG indicate 
viruses from reverse genetics. Top two mammalian strains were used as controls throughout this study. Avian strains at the bottom of this table (below 
the second bold line) were added to strengthen the bioinformatics analysis performed in section 3.2. 
 
Full name Abbreviation Subtype1 Clade Distribution Origin Passage history 
Reference or 
accession number 
A/Puerto Rico/8/1934 (mammalian) PR8 H1N1 - - RG High (various) Francis, 1934 
A/Udorn/1972 (mammalian) PR8 MUd H3N2 - - 7:1 RG - Noton et al., 2007 
A/duck/England/1962 Dk/England H4N6 1 Eurasia Isolate Low GQ404577 
A/duck/Korea/GJ54/2004 Dk/Korea H5N2 1 Eurasia 7:1 RG Isolate GU351861 
A/duck/India/02CA10/2011 Dk/India H5N1 (HP) 2 Eurasia 7:1 RG Isolate Kumar et al., 2017 
A/duck/Tripura/103597/2008 Dk/Tripura H5N1 (HP) 2 Eurasia 7:1 RG Isolate Kumar et al., 2017 
A/duck/Shandong/Q1/2013 Dk/Shandong H5N6 3 Eurasia 7:1 RG Isolate KM504104 
A/duck/Dongguan/2685/2013 Dk/Dongguan H5N8 3 Eurasia 7:1 RG Low KP285008 
A/Duck/Shantou/1588/2000 Dk/Shantou H9N1 4 Eurasia 7:1 RG Isolate AF523499 
A/chicken/Pakistan/UDL-01/2008 Ck/Pakistan H9N2 5 Eurasia WT/7:1 RG Isolate Iqbal et al., 2013 
A/duck/Singapore/5/1997 Dk/Singapore H5N3 5 Eurasia Isolate Low GU052803 
A/chicken/Israel/215/2007 Ck/Israel H9N2 5 Eurasia Isolate Low Wang et al., 2016 
A/Zhejiang/DTID-ZJU01/2013  Ck/Zhejiang H7N9 5 Eurasia 7:1 RG Human isolate2 KC885959 
A/chicken/Saudi Arabia/SP02525/3AAV/2000 Ck/Saudi Arabia H9N2 5 Eurasia Isolate Low de Geus et al., 2011 
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A/chicken/Italy/1067/1999 Ck/Italy H7N1 (HP) 6 Eurasia Isolate/7:1 RG Low Molesti et al., 2013 
A/duck/Mongolia/200/2015 Dk/Mongolia H3N8 6 Eurasia 7:1 RG Low LC339876 
A/mallard/Netherlands/10-Cam/1999 Dk/Netherlands H1N1 6 Eurasia WT/7:1 RG 
Moderate 
(various) 
Bourret et al., 2013 
A/mallard/Wisconsin/1719/1983 Dk/Wisconsin H4N2 7 America 7:1 RG Isolate  CY179300 
A/mallard/New York/170/1982 Dk/New York H1N2 8 America 7:1 RG Isolate CY014902 
A/chicken/Pennsylvania/1/1983 Ck/Penn/1 H5N2 9 America 7:1 RG Isolate 
Kawaoka & 
Webster, 1985 
A/chicken/Pennsylvania/1370/1983 Ck/Penn/1370 H5N2 (HP) 9 America 7:1 RG Low Swayne, 2006 
A/turkey/Canada/1965 Tk/Canada H3N2 9 America Isolate Low GU052877 
A/gull/Maryland/1824/1978 Gull/Maryland H13N9 10 America 7:1 RG Low JX982948 
A/turkey/South Dakota/7034/1986 Tk/South Dakota H1N1 11 America 7:1 RG Low EU743168 
A/chicken/Shandong/lx1023/2007 Ck/Shandong H9N2 5 Eurasia Isolate Low Pu et al., 2017 
A/chicken/Jiangsu/TS/2010 Ck/Jiangsu H9N2 5 Eurasia Isolate Low Pu et al., 2017 
A/mallard duck/England/7277/2006 3 Dk/England/06 H2N3 1 Eurasia Isolate Low 
Al-Mubarak et al., 
2015 
 
1HP indicates the parental virus has a HPAI phenotype. 
2Human isolate collected during the 2013 epidemic in China (Chen et al., 2013). 
3Kindly provided by Dr Janet Daly (University of Nottingham). 
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rescued as before. Of the viruses which would rescue, average titres were approximately 108 
PFU/ml, with no significant differences between the reassortants (Figure 2.8 A). However, 
clear differences in plaque size were noticeable between some of the strains (Figure 2.8 B); 
PR8 produced large plaques, as did some of the reassortants (e.g. Ck/Zhejiang and 
Ck/Pakistan), while others produced smaller ones (e.g. PR8 MUd and Gull/Maryland), 
indicating subtle differences in replication fitness in vitro.  
To determine the budding morphology of these 7:1 reassortant viruses, MDCK cells 
were infected at a MOI of 3 and fixed 16 h p.i. Cells were stained with antibody against whole 
PR8 virions (green), which mainly detects HA, and DAPI for nuclei (blue). As expected, mock-
infected cells showed no signs of infection, only giving background staining associated with 
the in-house made nature of the polyclonal anti-PR8 antibody. WT PR8 and PR8 MUd 
reassortant viruses were used as spherical and filamentous positive controls. PR8 WT-infected 
cells showed an evenly distributed green staining, while cells infected with PR8 MUd showed 
the characteristic filamentous bundles on the surface of the cells (Figure 2.9). The PR8-based 
7:1 reassortants with segment 7 of Dk/Korea, Dk/Tripura, Dk/Dongguan, Dk/Shantou 
Dk/Netherlands, Dk/Mongolia, Dk/Wisconsin, Dk/New York, Ck/Penn/1370, Gull/Maryland and 
Tk/South Dakota induced the formation of long filamentous bundles on the surface of the cells, 
comparable to PR8 MUd but rather shorter filaments. Cells infected with the 7:1 reassortants 
with the segment 7s from Dk/India, Dk/Shandong, Ck/Pakistan, Ck/Zhejiang, Ck/Italy and 
Ck/Penn/1 did not alter the evenly distributed staining characteristic of spherical budding 
phenotype as seen with the PR8 WT. 
In order to better define the budding phenotype of the virus strains tested, cell counts 
and filament measures were performed. MDCK cells were infected three times with two 
independent rescues, stained as described before (Figure 2.9) and two maximum intensity 
projections were collected per experiment for subsequent counting. The threshold previously 
defined (Figure 2.6) where a virus was considered filamentous if more than 15% of infected 
cells produced filaments of at least 2 µm in length was applied. As observed previously, PR8 
WT fell below the threshold to be considered a filamentous strain, whereas PR8 Mud virus was 






















Figure 2.8 Replication phenotypes of PR8 7:1 reassortants with the selected avian M 
segments. (A) MDCK cells were infected with 1:10 dilutions of P0 stocks and left for 48 h before 
supernatants were collected and plaque titred on MDCK cells. Data represent mean +/- SEM 
(n= 2) from two independent rescues, with the exception of Ck/Penn/1 which was only possible 
to rescue once. Numerous attempts were performed in avian and mammalian cells and/or with 
HA and NA of Ck/Penn/1 but with no success. Colour coding divides the viruses in spherical 
(blue) and filamentous (orange) budding phenotypes (see later). (B) Plaque phenotypes were 
visualised in infected monolayers of MDCK cells under Avicel which were fixed and stained 
with toluidine blue.  
A 
B 




PR8 WT PR8 MUd Mock Dk/Korea 
Dk/India Dk/Tripura Dk/Shandong Dk/Dongguan 
Dk/Shantou Ck/Pakistan Ck/Zhejiang Ck/Italy 
Dk/Netherlands Dk/Mongolia Dk/Wisconsin Dk/New York 
Ck/Penn/1 Ck/Penn/1370 Gull/Maryland Tk/South Dakota 
MDCK 
  64 
 
Figure 2.9 Budding phenotype of PR8 7:1 reassortant viruses in MDCK cells. Reassortant 
viruses were constructed with the segment 7s from table 2.1 in a PR8 backbone and used to 
infect MDCK cells at a MOI of 3 for 16 h. Cells were fixed and the surface stained with anti 
PR8 antibody for viral proteins (green) and DAPI for DNA (blue). Images were collected as 
maximum intensity projections on the Zeiss 710 confocal microscope with a 63x objective and 
are representative of three independent experiments. PR8 WT and PR8 MUd viruses were 
used as spherical and filamentous positive controls, respectively. Mock-infected cells were 
used as an experimental control. Arrows indicate bundles of filaments. Scale bar (20 µm) 
indicated. 
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well above it, inducing filaments in approximately 60% infected cells (Figure 2.10 A). By this 
threshold, 11 out of the 17 avian reassortant strains showed a prominent filamentous 
phenotype, which differed significantly from PR8 WT. The filamentous 7:1 reassortant viruses 
all presented more than 30% of infected cells with filamentous bundles on their surface (orange 
bars), whereas the spherical strains (blue bars) were all well below the defined threshold 
(15%). Regarding filament length, all strains considered filamentous according to the 
percentage of cells they induced filaments in, promoted formation of filamentous bundles 
ranging from 6 - 10 µm, whereas strains that failed to produce obvious filament bundles in a 
substantial proportion of infected cells showed lengths below the threshold (2 µm) in the rare 
instances seen, comparable with the WT PR8 virus control (Figure 2.10 B). Thus similarly to 
the results obtained with a panel of authentic avian IAV isolates, a broader set of avian virus 
segment 7s that represented all major clades of the M1 gene conferred a mixture of 
filamentous and non-filamentous budding phenotypes. The classification of the 7:1 
reassortants according to their budding phenotypes allowed correlations to be drawn with virus 
replication in tissue culture. Looking back at Figure 2.8, there was no obvious link between 
end-point titres of virus replication in MDCK cells and budding morphology. However, plaque 
size can be a more sensitive measure of virus spread in tissue culture (Medvedeva et al., 
1968). Therefore, to test this, the 7:1 reassortant viruses were used to infect monolayers of 
MDCK cells under Avicel and the plaque size examined after staining with toluidine blue (figure 
2.8 B). To provide quantitative data, a minimum of 72 plaques were measured per virus. These 
data showed that filamentous reassortant viruses presented significantly smaller plaques 
when compared with PR8 WT, while spherical strains showed plaques equivalent to PR8 WT 
(Figure 2.11 A). Furthermore, the filamentous budding phenotype as assessed by the % of 
cells displaying filaments was plotted against plaque size (Figure 2.11 B). The data was fitted 
by linear regression and showed an inverse linear relationship between plaque measure and 
percentage of filamentous phenotype. Additionally, the t-test showed that the spherical and 
filamentous virus populations significantly differed in terms of plaque size, with spherical 
viruses having larger plaques while filamentous viruses formed smaller plaques (Figure 2.11 
C). Given the good fit of the data (R2 = 0.659), this will be used as a linearized model throughout 
the study. 
























Figure 2.10 Quantification of the budding phenotypes of PR8 7:1 reassortant viruses. MDCK 
cells were infected at an MOI of 3 for 16 h before fixing. (A) A minimum of 100 infected cells 
were counted per virus and the percentage of filament-producing cells was determined. (B) 90 
filaments were measured per virus (when visible). Data are the mean +/- SEM (n = 3). ANOVA 
statistical analysis was performed to compare all 7:1 reassortant viruses to PR8 WT. ** p<0.01; 
**** p<0.0001. Limits for viruses to be classified as possessing a filamentous budding 
morphology are indicated (> 15% of infected cells producing at least one bundle of filaments 
of 2 µm or longer). Bars are accordingly colour coded for spherical (blue) and filamentous 



























Figure 2.11 Plaque phenotype of PR8 7:1 reassortant viruses and  its association with budding 
morphology. (A) Plaques represented in figure 2.8 B were measured and the dimensions were 
scaled to PR8 WT (considered 100%). A minimum of 72 plaques were measured. Data 
represent mean +/- SEM (n = 3). One-way ANOVA was performed to compare all 7:1 
reassortant viruses to PR8 WT. ** p<0.01 *** p<0.001 **** p<0.0001. Spherical viruses are 
represented in blue while filamentous in orange. PR8 WT and PR8 MUd were used as 
spherical and filamentous positive controls, respectively. (B) Data points represent individual 
(circle outline) or average (circle coloured in) of plaque measure plotted against % filament-
producing cells. The data was fitted to a linear regression and the trendlines for the individual 
and average data points are represented. Spherical viruses are represented in blue while 
filamentous in orange. Graph drawn by Dr Sam Lycet (C) t-test was performed to compare 
spherical and filamentous virus populations regarding percentage of filamentous phenotype 
and plaque size. ** p<0.01 * p<0.05. Spherical viruses are represented in blue while 
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Thus as previously noted, filamentous budding is not advantageous for virus spread in tissue 
culture monolayers (Bourmakina & Garcia-Sastre, 2003; Roberts et al., 1998) 
Given that the viruses tested were of avian-origin but only tested in mammalian cells, 
the next step was to test these PR8-based 7:1 reassortants in avian cells: chicken embryo 
fibroblasts (CEF) and duck embryo fibroblasts (DEF). CEF cells infected with PR8 WT 
presented a uniformly distributed staining characteristic of a spherical phenotype. PR8 MUd-
infected cells showed long filamentous bundles characteristic of this virus, arising mainly from 
the centre of the cells (Figure 2.12 A). The 7:1 reassortant viruses that maintained the spherical 
phenotype of PR8 WT in MDCK, also kept that budding phenotype in CEF cells (Dk/India, 
Dk/Shandong, Ck/Pakistan, Ck/Zhejiang, Ck/Italy and Ck/Penn/1). The 7:1 reassortant viruses 
with Dk/Korea, Dk/Tripura, Dk/Dongguan, Dk/Shantou Dk/Netherlands, Dk/Mongolia, 
Dk/Wisconsin, Dk/New York, Ck/Penn/1370, Gull/Maryland and Tk/South Dakota promoted 
the formation of filamentous bundles in infected CEF cells, comparable to PR8 MUd but 
consistent with a spherical phenotype. PR8 MUd-infected DEF cells showed the characteristic 
filamentous bundles as previously observed in MDCK and CEF cells. DEF cells showed a 
pattern similar to CEF cells, but with a less accentuated filamentous phenotype when 
compared to MDCK cells. With DEF cells, it was observed that some 7:1 reassortant viruses 
lost their ability to promote filament formation (e.g. Ck/Penn/1370 and Tk/South Dakota), but 
generally the budding phenotypes observed with DEF cells were similar to those observed with 
MDCK and CEF cells. Thus, these data suggest that avian strains maintain their spherical or 
filamentous budding phenotypes regardless of cell origin. 
The finding that avian IAV strains exhibited a mixture of filamentous and non-
filamentous budding phenotypes allowed the correlation of M1 sequence polymorphism with 
virion morphology. The M1 amino acid sequences from all the virus strains tested, grouped 
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Figure 2.12 Budding phenotype of PR8 7:1 reassortant viruses in chicken embryo fibroblast 
(CEF) and duck embryo fibroblast (DEF) cells. Reassortant viruses were constructed with the 
segment 7s from table 2.1 in a PR8 backbone and used to infect CEF (A) and DEF (B) cells at 
a MOI of 3 for 16 h. Cells were fixed and the surface stained with anti-PR8 antibody for viral 
proteins (green) and DAPI for DNA (blue). Images were collected as maximum intensity 
projections on the Zeiss 710 confocal microscope with a 63x objective and are representative 
of three independent experiments. PR8 WT and PR8 MUd viruses were used as spherical and 
filamentous positive controls, respectively. Mock-infected cells were used as an experimental 
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figure 2.13. 
As described in chapter 1, it has been shown in human and equine strains of IAV M1 
that the amino acid identity of residues 41, 85, 95, 204, 207 and 218 are major morphology 
determinants (figure 2.13, grey rectangles). However, a closer look at these positions in the 
aligned avian M1 sequences revealed no consistent differences between spherical and 
filamentous avian strains (above and below the line of figure 2.13, respectively). In fact, at the 
aforementioned positions, the amino acid composition was very similar within all avian M1 
sequences. Residues 85, 204 and 218 did not vary in all avian M1 sequences, while residues 
41, 95 and 207 varied but this variation did not correlate with the different budding 
morphologies seen with avian IAVs. This suggested that residues identified in M1s of human 
and equine strains of IAV as determining filamentous budding are not the same in avian IAV 
M1s. Therefore, if there are “rules” for determining avian IAV budding morphology, these will 
be different from those previously identified for mammalian strains. 
 
 2.3. Discussion 
Characterisation of the budding morphology of mammalian strains of IAV (equine and 
human) revealed that these strains are able to produce both spherical and filamentous 
particles (Bourmakina & Garcia-Sastre, 2003; Chu et al., 1949; Elleman & Barclay, 2004; Elton 
et al., 2013; Roberts et al., 1998). In fact, filamentous viruses are commonly found in clinical 
isolates and selected in vivo (Chu et al., 1949; Nakajima et al., 2010; Seladi-Schulman et al., 
2013) while spherical strains are selected in vitro, normally following serial passage in cells 
and/or eggs (Burnet & Lind, 1957; Kilbourne & Murphy, 1960; Seladi-Schulman et al., 2013). 
Several studies have reported the viral matrix protein M1 as the main determinant of budding 
morphology (Bourmakina & Garcia-Sastre, 2003; Chlanda et al., 2015; Elleman & Barclay, 
2004; Gomez-Puertas et al., 2000; Roberts et al., 1998), where the amino acid identity at 
positions 41, 85, 95, 204, 207 and 218 play a role in determining the resulting budding 
phenotype (Bialas et al., 2012; Bourmakina & Garcia-Sastre, 2003;  Elleman & Barclay, 2004; 
Elton et al., 2013; Roberts et al., 1998).
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Figure 2.13 Sequence alignment of the avian M1 proteins from viruses and/or segment 7s tested for budding morphology in this study. All avian M1 
sequences tested in this study were aligned using MEGA6. Strains are organized from the top from spherical to filamentous budding phenotypes (the 
black line divides between the two morphologies). Positions highlighted with grey rectangles correspond to amino acids previously identified in 
mammalian strains of IAV as morphology determinants (41, 85, 95, 204, 207 and 218). 
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These residues are known as the filamentous ‘signature’ of mammalian strains of IAV (Elton 
et al., 2013). However, regarding avian strains of IAV it still remains largely unknown what is 
their predominant budding phenotype. Therefore, the aim of this section of the study was to 
characterise the budding morphology of avian IAVs and, if these produce filaments, then 
determine if there are specific residues within M1 that can regulate budding morphology and 
compare these with the ones previously identified in mammalian IAVs.  
The avian isolates tested for budding morphology in this study indicated that avian 
strains of IAV are as pleomorphic as mammalian strains, with 3 of the 5 isolates showing the 
characteristic filamentous structures on the surface of infected cells (Figure 3.3). However, a 
sample of 5 avian isolates could not be used as a representative sample of avian strains of 
IAV. The only way to test more strains would be to get more isolates, but there were a few 
limiting steps, such as isolate availability, biosafety measures to handle HPAI strains and 
antibodies for all the different HA and NA subtypes of avian viruses. Therefore, in order to 
overcome this, PR8-based 7:1 reassortant viruses were considered as alternatives. To test the 
viability of using 7:1 reassortant viruses with an avian segment 7 in a PR8 backbone. 
Therefore, reassortant viruses with segments 4, 5, 6 and/or 7 of Dk/Netherlands strain were 
built, since all these segments were previously shown to affect budding morphology of 
mammalian and avian strains (Bialas et al., 2014; Chlanda et al., 2015; Gomez-Puertas et al., 
2000; Jin et al., 1997; Liu et al., 2002; Roberts et al, 1998). PR8- based 7:1 reassortant viruses 
with segments 4, 5 and 6 of Dk/Netherlands individually did not altered the spherical phenotype 
characteristic of PR8 WT (Figure 2.5). This is in agreement with reports by Gomez-Puertas et 
al. and Chlanda et al., which showed that segments 4, 5 and 6 of human strains did not alter 
the budding morphology of the virus (Chlanda et al., 2015; Gomez-Puertas et al., 2000). 
Combination of segments 4 and 6 of Dk/Netherlands in a PR8 backbone also resulted in a 
spherical budding phenotype, as previously shown for human strains (Chlanda et al., 2015). 
When segment 7 of Dk/Netherlands was added to PR8, it induced filament formation on the 
surface of budding morphology of the virus like mammalian segment 7s (Bourmakina & Garcia-
Sastre, 2003; Elleman & Barclay, 2004; Roberts et al., 1998). M and NP of Dk/Netherlands in 
PR8 promoted the formation of filaments, unlike previously published for another avian strain 
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(Bialas et al., 2014). In fact, the authors showed that the avian segment 5 prevented filaments 
even with an avian segment 7 that was able to induce filament formation in the backbone of a 
human spherical strain. Lastly, addition of segments 4, 6 and 7 of Dk/Netherlands to PR8 
resulted in a virus with a budding phenotype that mimicked Dk/Netherlands WT budding 
morphology (Figure 2.6 A and Figure 2.6 B), in agreement to previous reports in human strains 
(Chlanda et al., 2015). This comes as no surprise, since HA (4) and NA (6) proteins were 
shown to modulate filamentous budding morphology (Jin et al., 1997) due to their interaction 
(via the cytoplasmic tails) with the M1 protein (Ali et al., 2000; Jin et al., 1997). Nonetheless, 
these data showed the importance of 7:1 reassortant viruses and their viability in budding 
morphology studies instead of the avian isolates. 
 The segment 7s selected for characterisation of the budding phenotype of avian IAVs 
was based on availability in the Digard laboratory and random selection based on M1 
phylogeny. M1 sequences grouped into a phylogenetic tree showed two main branches 
(America and Eurasia), which were divided into clades from where at least one segment 7 was 
collected in order to have avian strains representative of each clade (Figure 2.7). This allowed 
for a great range of HA and NA subtypes to be tested, as well as HPAI strains, resulting in a 
reasonable representation of avian strains of IAV (Table 2.1). The PR8-based 7:1 reassortant 
viruses with avian segment 7 were built and the budding morphology characterised 
qualitatively (Figure 2.9) and quantitatively (Figure 2.10) in MDCK cells. This characterisation 
revealed that majority of the avian strains tested showed a filamentous budding phenotype 
with 30% - 80% of infected cells producing filaments ranging 6 – 10 µm in length. Significantly, 
as previously reported for human H3N2 strains (Roberts et al., 1998), avian strains with a 
filamentous phenotype showed a strong negative correlation with plaque size, i.e., these 
produced smaller plaques in monolayers of infected MDCK cells. 
Characterisation of the PR8-based 7:1 reassortant viruses with segment 7 of avian 
strains was mainly done in mammalian cells, therefore, to test whether the budding 
phenotypes observed were transferable to their original host, CEF and DEF cells were infected 
with the reassortant viruses. Overall, CEF and DEF cells infected with these viruses showed 
that the 7:1 reassortants kept their original budding phenotype as seen in MDCK cells 
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(compare figure 2.9 with figure 2.12 A and figure 2.12 B). However, in these cells, the 
filamentous phenotype was much less accentuated, more remarkably so in DEF cells as 7:1 
reassortants that were producing long filamentous structures in MDCK cells hardly produced 
visible filaments in DEF cells (e.g. Dk/Netherlands, Dk/Mongolia). However, to determine if 
these data was cell-type dependent, CK cells were also infected with the PR8-based 7:1 
reassortant viruses, showing that the filamentous phenotype was as prominent in these cells 
as in MDCK cells, indicating that the budding phenotype is maintained regardless of cell origin. 
This contradicts the study performed by Al-Mubarak et al, which showed that the budding 
morphology on an avian isolate differed between CEF and DEF cells (Al-Mubarak et al., 2015).
  
Lastly, since it is now known that avian strains can be as pleomorphic as mammalian 
strains, the next step was to identify sequence polymorphisms in avian M1s based on the 
previously characterised filamentous “signature” of mammalian strains. As mentioned before, 
amino acid identity at positions 41, 85, 95, 204, 207 and 218 is an important regulator of 
budding morphology (Elton et al., 2013). To determine if these positions would be morphology 
determinants for avian strains, all the avian M1s used in this study (for which budding 
morphology was known) were aligned and separated by budding phenotypes (Figure 2.13). At 
residues 85, 204 and 218, all the avian M1s possessed asparagine, glutamic acid and 
threonine, respectively, thus these positions were disregarded. By contrast, at position 41 
there were strains with alanine or valine, at position 95 amino acids lysine or arginine were 
represented and at position 207 there were strains with asparagine, serine or glycine. In human 
H1N1 and H3N2 strains, it is known that V41A, K95R and N207S substitutions successfully 
promote the formation of filaments (Bialas et al., 2012; Elleman & Barclay, 2004; Roberts et 
al., 1998). However, these substitutions on avian M1s did not form a consistent pattern that 
would explain the different budding morphologies observed. For instance, at position 41 
majority of the avian strains possessed an A, while two strains with opposite budding 
morphologies possessed a V. At position 95, only three spherical strains presented a K, while 
the remaining spherical and the entirety of the filamentous strains possessed a R. At residue 
207 a similar trend was observed, where majority of strains possessed an S and a combination 
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of spherical and filamentous strains presented a N. The mixed budding phenotypes observed 
with avian strains that contain the filamentous “signature” on their M1 amino acid sequence 
has also been reported by Louisirirotchanakul et al, however this study fails to indicate which 
residues can then modulate avian IAV budding morphology (Lourisirirotchanakul et al., 2013). 
Therefore, one can conclude that avian strains clearly do not follow the mammalian 
filamentous “signature”. 
Overall, this section of the study revealed that avian strains are as pleomorphic as 
mammalian strains of IAV and, considering that almost all avian strains were isolates or with 
a low passage number in the laboratory (see table 2.1), it is tempting to suggest that, like 
mammalian strains, avian IAVs could be predominantly filamentous on their original host. Just 
like in the case of mammalian strains, avian segment 7s are able to govern the budding 
morphology of avian IAVs and avian HA and NA proteins can also modulate the filamentous 
budding phenotype. Equally important, the budding phenotype observed with the PR8-based 
7:1 reassortant viruses in MDCK cells was maintained in CEF, DEF and CK cells, indicating 
that this is truly a genetic aspect of the virus not dependent on cell origin. Significantly, this 
section of the study also pointed out that the previous identified “signature” for M1 sequence 
polymorphisms that determine the filamentous phenotype in human and equine strains of virus 
were not confirmed for avian IAVs, suggesting that avian strains may possess a different 
“signature”. This brings on the challenge of finding a filamentous “signature” for avian strains 







Chapter 3: Identification of sequence polymorphisms in avian IAV 
M1 polypeptides correlating with different budding morphologies 
3.1. Introduction and aims 
As previously discussed in chapter 1, various human and equine IAV strains have 
been shown to produce either spherical or mixtures of filamentous and spherical virus 
particles, defined by sequence polymorphisms within M1. In particular, the identities of amino 
acids at positions 41, 85, 95, 204, 207 and 218 were reported to be important filamentous 
“signatures” for human and equine strains of IAV. Within human H1N1 and H3N2 strains, it 
was reported that substitutions A41V (Roberts et al., 1998), R95K (Bourmakina & Garcia-
Sastre, 2003), E204D (Bourmakina & Garcia-Sastre, 2003) abrogated the production of 
filaments, whereas substitutions V41A, K95R, N207S (Bialas et al., 2012)  and T218A 
(Elleman & Barclay, 2004) successfully promoted the formation of filaments by a previously 
spherical strain. The importance of position 85 was demonstrated with equine H3N8 strains, 
where Elton et al switched serine (predominantly represented in filamentous H3N8 equine 
strains) to asparagine in the M1 sequence, abolishing the filamentous budding phenotype 
(Elton et al., 2013). 
 In the previous chapter, avian isolates of IAV as well as 7:1 reassortant viruses with 
segment 7 from avian strains in a PR8 backbone were characterised for budding phenotype. 
Confocal microscopy and quantification of budding phenotype showed that avian IAVs differed 
in budding phenotype, with some but not all strains producing filamentous particles of 6 - 10 
µm in length. However, sequence alignment of the avian M1 polypeptides showed no 
consistent differences at positions 41, 85, 95, 204, 208, 214 and 218 that could explain the 
different budding morphologies seen. Therefore, it was concluded that avian IAVs deviate from 
the M1 filamentous “signatures” identified in human and equine strains.  
Thus, the aim of this part of the work was to (1) investigate the sequence 
polymorphisms seen within the avian M1s and to correlate these with virus particle shape; and 
(2) if sequence polymorphisms were identified as morphology determinants, test whether 
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3.2.1. Identification of sequence polymorphisms in avian M1s 
Simply aligning all M1 amino acid sequences of the avian strains tested had not 
revealed a consistent pattern between spherical and filamentous avian strains (Figure 2.13, 
strains above and below the line). However, a closer look at the sequences showed pairs of 
closely related avian strains with opposite budding phenotypes that nevertheless shared very 
similar M1 sequences. These were: (1) Dk/India and Dk/Tripura; (2) Ck/Penn/1 and 
Ck/Penn/1370; and (3) Ck/Italy and Dk/Netherlands. Pairwise alignment of these strains 
showed three amino acid substitutions between Dk/India and Dk/Tripura strains and only one 
single amino acid substitution between the other two pairs (Ck/Penn/1 and Ck/Penn/1370; 
Ck/Italy and Dk/Netherlands) (Figure 3.1, grey boxes). Since these were the only differences 
on M1 amino acid sequence between the pairs identified, these positions represented good 
candidates to justify the different budding morphologies observed. Amino acid sequence 
similarity between the M2 of these pairs was also assessed to determine whether there were 
differences in regions of this protein known to affect budding morphology. These are: (1) a 
region of interaction with M1 (residues 70 to 77) (McCown & Pekosz, 2006) and (2) the 
amphipathic helix domain of M2 (residues 50 to 61), which was reported to modulate budding 
morphology (Roberts et al., 2013). The M2 polypeptides of Dk/India and Dk/Tripura pair 
showed two amino acid differences at positions 10 and 82, while those of Ck/Penn/1 and 
Ck/Penn/1370 varied at positions 43 and 44. By contrast, Ck/Italy and Dk/Netherlands shared 
a 100% identical M2 amino acid sequence (data not shown). Given that the variable positions 




3.2.2. Correlating sequence polymorphisms in M1 with budding morphology 
of Dk/India and Dk/Tripura avian strains 
The M1 proteins of Dk/India and Dk/Tripura varied at three positions: T37A, I59M and 
I205V, where the first amino acid listed was present in Dk/India M1 and the second in M1 
Dk/Tripura (figure 3.1, top pair). Therefore, the first step was to build Dk/India and Dk/Tripura 
7:1 reassortant viruses with these residues reciprocally mutated. WT segment 7 of both 
Dk/India and Dk/Tripura strains was mutated individually or in combination at positions 37, 59 
and 205 by site-directed mutagenesis. Monolayers of 293T cells were then transfected with 
the reverse genetics plasmids of the PR8 backbone and the segment 7s (WT or mutated M1) 
of Dk/India and Dk/Tripura strains to generate P0 stocks. These P0 stocks were propagated 
in MDCK cells for 48 h and titred by plaque assay. All viruses rescued readily twice, and 
replicated to average titres of approximately 108 PFU/ml with no significant differences 
between them (Figure 3.2 A). Plaque phenotype was assessed in monolayers of infected 
MDCK cells stained with toluidine blue. Mock-infected cells showed no detectable levels of 
infectious particles. As seen in the previous chapter (figure 2.8 B) the plaque phenotype of 
Dk/India and Dk/Tripura 7:1 reassortant viruses was distinguishable, with the former producing 
noticeably larger plaques than the latter. Mutation of position 37 and/or 205 had little obvious 
effect on plaque size in either virus background. However, mutation of position 59, either singly 
or in combination with the other sites decreased the plaque size of Dk/India or conversely, 
increased the plaque size of Dk/Tripura, suggesting subtle differences in replication fitness in 
vitro (Figure 3.2 B). 
The next step was to determine the budding phenotype of the WT and M1-mutant 7:1 
reassortant viruses of Dk/India and Dk/Tripura with single, double and triple mutations at 
positions 37, 59 and 205. MDCK cells were infected at a MOI of 3 for 16 h. Cells were fixed 
and the surface stained with anti-PR8 antibody for viral surface proteins (green) and DAPI to 
indicate nuclei (blue) prior to imaging. Mock-infected cells showed no signs of infection and 
the spherical (PR8 WT) and filamentous (PR8 MUd) positive controls showed their expected 
phenotypes (data not shown). As expected, WT Dk/India showed the evenly distributed pattern 
of punctate plasma membrane staining associated with a spherical budding 
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Figure 3.1 M1 sequence alignments of closely related avian strains with opposite budding morphologies. Pairwise alignments of the indicated avian 
M1 amino acid sequences were performed using BioEdit 7.0.0 ed. Spherical viruses are represented on the top of all 3 alignments. The residues 




































































































Figure 3.2 Replication fitness of WT and M1-mutant Dk/India and Dk/Tripura 7:1 reassortant 
viruses. (A) MDCK cells were infected with 1:10 dilutions of P0 stocks of the indicated viruses 
and left for 48 h, supernatants collected and titred by plaque assay in MDCK cells. Data 
represent mean +/- SEM (n = 3) from two independent rescues. Bars are coloured to indicate 
spherical (blue) or filamentous (orange) budding phenotypes. (B) Plaque phenotype in 




phenotype, whereas Dk/Tripura showed on obviously filamentous budding phenotype, 
producing (Figure 3.3, top panel; filamentous bundles indicated with white arrows). Reciprocal 
changes of amino acids at positions 37 or 205 did not alter the budding morphologies of 
Dk/India and Dk/Tripura strains. In contrast, alteration of amino acid 59 reciprocally altered 
Dk/India and Dk/Tripura budding morphologies; Dk/India became filamentous while a spherical 
budding phenotype was transferred to Dk/Tripura. For mutant viruses that already had position 
59 altered, the further change of amino acids at positions 37 and/or 205 did not substantially 
affect the outcome; i.e., the budding morphologies remained reciprocally altered (Figure 3.3, 
lower panels). Additionally, mutant viruses with double reciprocal changes at positions 37 and 
205 showed no major alteration compared to the corresponding WT budding morphologies of 
Dk/India and Dk/Tripura. Thus, M1 position 59 was the major virion morphology determinant 
between Dk/India and Dk/Tripura strains.  
In order to quantify the budding phenotype of these mutants, cell counts and filament 
measures were performed as described before. MDCK cells were infected at a MOI of 3 for 16 
h with two independently rescued virus stocks and cell surface HA stained and imaged. Two 
maximum intensity projection confocal images were collected per repeat for scoring (Chapter 
2, section 2.2.2). As before, a threshold was defined whereby a virus was considered 
filamentous if more than 15% of infected cells produced filaments and these were longer than 
2 µm. By these criteria, WT Dk/India and Dk/Tripura viruses showed a spherical and 
filamentous budding phenotype, respectively (Figure 3.4 A, B). However, reciprocal change of 
amino acids at position 59 caused an alteration in the budding morphologies of both viruses, 
where Dk/India showed a great increase (over 50%) in the number of cells producing 
filamentous particles (Figure 3.4 A). Conversely, the Dk/Tripura budding phenotype was 
converted to a spherical phenotype, although the magnitude of the decrease in the percentage 
of cells displaying filaments was somewhat lower (only circa 25%). Changes in the length of 
filamentous particles (when present) for both strains were also not perfectly reciprocal when 
amino acids at position 59 were altered, as while mutation of Dk/India produced bundles of 
filaments around 5 µm long, the remaining filaments produced by Dk/Tripura were still 
reasonably (over 2 µm) long (figure 3.4 B). 
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Figure 3.3 Budding phenotype of Dk/India and Dk/Tripura strains with WT or mutated M1 
proteins. M1 genes of Dk/India and Dk/Tripura were mutated either individually or in 
combination at the positions indicated and the viruses were rescued as 7:1 reassortants in a 
PR8 backbone. WT and mutant viruses were used to infect MDCK cells at a MOI of 3 for 16 h. 
Cells were fixed and the surface stained with anti PR8 antibody (green) and DAPI (blue) prior 
to imaging. Images were collected as maximum intensity projections from Z-stacks on the 
Zeiss 710 confocal microscope with a 63x objective and are representative of three 
independent experiments. Filamentous bundles on the surface of the cells are indicated (white 

































Figure 3.4 Quantification of the budding phenotype of the PR8-based Dk/India and Dk/Tripura 
WT and M1-mutant viruses. MDCK cells were infected at a MOI of 3 for 16 h and stained as in 
figure 3.3. (A) A minimum of 100 infected cells were counted and the percentage of filament-
producing cells was determined from 3 independent experiments. (B) A total of 90 filaments 
were measured per virus (when visible). One-way ANOVA was performed to compare WT and 
M1-mutant viruses of Dk/India and Dk/Tripura avian strains. *** p<0.001; **** p<0.0001; ns not 
significant. Limits for viruses to be classified as possessing a filamentous budding morphology 
are indicated (> 15% of infected cells producing at least one bundle of filaments of 2 µm or 







On the other hand, reciprocal change at positions 37 and/or 205 did not significantly alter the 
budding phenotype of the mutant viruses in comparison with the WT counterpart of Dk/India 
or Dk/Tripura. However, the cumulative effect when all differing positions were swapped 
resulted in a triple mutant Dk/India virus that was considerably different from its WT counterpart 
in both % of filament-producing cells and average filament length (Figure 3.4). For Dk/Tripura, 
reciprocal changes at positions 37, 59 and 205 considerably reduced the % of filament-
producing cells. The average filament length of Dk/Tripura was significantly reduced with the 
alteration of position 59, however, only the addition of positions 37 and/or 205 reduced the 
average filament length of Dk/Tripura to below the defined threshold. In fact, the triple mutant 
of Dk/Tripura was significantly different from its WT counterpart regarding filamentous 
phenotype, yet similar to Dk/India WT and conversely was observed for Dk/India. Therefore, 
this indicated that although position 59 was the strongest determinant of virion morphology for 
Dk/India and Dk/Tripura strains, positions 37 and 205 also played a role. 
Having established the budding phenotype of the mutated Dk/India and Dk/Tripura 
viruses, the previous observation that switching the amino acids at position 59 individually or 
in combination with positions 37 and 205 affected their plaque phenotype was revisited. To 
obtain quantitative data, a minimum of 70 plaques (as seen in figure 3.2 B) were measured 
per virus. Dk/India WT and mutants mutated at positions 37 and/or 205 showed significantly 
larger plaques than Dk/India M1 59 mutant virus, either individually or in combination with 
positions 37 and 205 (Figure 3.5 A). Conversely, Dk/Tripura mutant viruses with position 59 
mutated individually or in combination with positions 37 and 205 showed generally larger 
plaques than their WT counterpart or the mutants at positions 37 and/or 205 (Figure 3.5 B). In 
both virus backgrounds, plaque size correlated well with budding phenotype. As a further test 
of this correlation, the % of filament-producing cells was plotted against plaque size; this 
grouped Dk/India and Dk/Tripura WT and M1-mutant viruses into two clusters: one composed 
of viruses where position 59 was altered, thus budding morphology was affected, and the other 
formed of viruses without alteration at position 59, maintaining their WT budding phenotype 







Figure 3.5 Plaque size of Dk/India and Dk/Tripura WT and M1-mutant 7:1 reassortant viruses 
and its association with the % of filament-producing cells. (A, B) Plaques represented on figure 
3.2 B were measured and the dimensions were scaled to Dk/India WT (A) or Dk/Tripura WT 
(B). A minimum of 70 plaques were measured per virus over 3 independent experiments. 
Spherical viruses are represented in blue while filamentous ones are depicted in orange. Data 
represent mean +/- SEM (n = 3). One-way ANOVA was performed to compare the M1-mutant 
viruses to the corresponding WT (considered as the 100% value), within Dk/India or Dk/Tripura 
groups. * p<0.05; ** p<0.01; *** p<0.001. (C, D) Data points represent individual (circle outline) 
and average (circle coloured in) plaque measure plotted against % filament-producing cells for 
(C) Dk/India and (D) Dk/Tripura viruses. The data was linearized and fitted against the model 
data from figure 2.11 B. WT viruses are represented in red and mutant viruses in orange. 































These analyses showed an inverse linear relationship between filamentous phenotype and 
plaque size. The data was linearized and plotted against the linearly fitted data from figure 2.11 
B (linearized model). The good fit of Dk/India and Dk/Tripura viruses to the model data 
indicated that there was a trend for spherical viruses to produce bigger plaques whereas 
filamentous viruses formed smaller plaques. This further supported the generalisation 
discussed in Chapter 2 that viruses with filamentous phenotype tend to have smaller plaques 
than spherical strains, suggesting differences in viral replication in vitro (Roberts et al., 1998). 
Overall, reciprocal changes of amino acids at M1 positions 37, 59 and 205 of the 
spherical Dk/India and filamentous Dk/Tripura viruses revealed the importance of the I59M 
polymorphism as a major morphology determinant between these two strains. However, 
further reciprocal changes of amino acids at positions 37 and 205 were required to completely 
swap the budding morphologies of the two strains of IAV.  
 
 3.2.3. Importance of position 169 in M1 of Ck/Pennsylvania strains 
Ck/Penn/1 and Ck/Penn/1730 showed one sequence polymorphism in M1: I169T, as 
well as two amino acid polymorphisms in M2 at positions 43 and 44, which were disregarded 
as previously mentioned in section 3.2.1. Thus, the aim was to test whether the change at 
position 169 in M1 was the sole determinant that explained the opposite budding morphologies 
observed with the Ck/Pennsylvania strains.  
Firstly, codon 169 of the M1 genes of Ck/Penn/1 (isoleucine) and Ck/Penn/1370 
(threonine) were reciprocally changed by site-directed mutagenesis. PR8 7:1 reassortant 
viruses with WT or mutated avian virus segment 7s were rescued and titred by plaque assay 
as before. All viruses were rescued twice, with the exception of Ck/Penn/1 WT (which could 
only be rescued once as explained in chapter 2.2.3) and the M1-mutant (M 169) virus, for 
which all (> 10) rescue attempts were unsuccessful (more details in figure 7.1). The viruses 
that were rescued gave an average titre of 108 PFU/ml, with no significant differences between 





























Figure 3.6 Replication fitness of Ck/Penn/1 and Ck/Penn/1370 strains with WT or mutated M1 
at position 169. (A) P0 stocks were used to infect MDCK cells at a 1:10 dilution for 48 h. 
Supernatants were collected and titred by plaque assay in MDCK cells. Data represent mean 
+/- SEM (n = 3) of two independent rescues, with the exception of Ck/Penn/1 (one stock) and 
Ck/Penn/1 M 169 (N.R – not rescued). Coloured bars indicate spherical (blue) or filamentous 
(orange) budding phenotypes. (B) Plaque assays were performed in a monolayer of MDCK 







showed that plaques for Ck/Penn/1370 M WT were smaller than those generated by 
Ck/Penn/1370 M 169; the latter showed larger plaques more comparable to the ones produced 
by Ck/Penn/1 (Figure 3.6 B). Thus the T169I change in Ck/Penn/1370 likely had a subtle effect 
on virus fitness in vitro. The M1 T169I change resulted in different plaque sizes between WT 
and M1-mutant Ck/Penn/1370 viruses, which also drastically reduced filament production by 
Ck/Penn/1370 strain. Therefore, as previously seen, a filamentous phenotype was 
disadvantageous for plaque formation in vitro. 
To test the importance of position 169 for the budding phenotype of Ck/Penn/1 and 
Ck/Penn/1370, MDCK cells were infected with the rescued viruses at a MOI of 3 for 16 h. Cells 
were fixed and stained for surface viral glycoproteins as before prior to imaging. The standard 
controls of mock-infected, PR8 WT and PR8 MUd infected cells gave the expected outcomes 
of no substantial staining; spherical and filamentous patterns of plasma membrane HA (data 
not shown). Ck/Penn/1 showed a predominantly spherical budding phenotype with an evenly 
distributed pattern of viral antigen staining, whereas Ck/Penn/1370 presented prominent 
filaments on the surface of infected cells (Figure 3.7). The single change of a threonine to an 
isoleucine at position 169 in the M1 of Ck/Penn/1370 abolished the formation of filaments by 
this virus. Although the reciprocal effect on Ck/Penn/1 could not be tested as the virus did not 
rescue, this suggested that the amino acid side chains at position 169 had a significant role in 
determining the budding phenotype of the Ck/Penn/1370 strain.  
To strengthen these observations, MDCK cells were infected with the viruses over 
three independent occasions using (where possible) two separately rescued stocks. Per 
repeat, two maximum intensity projection images were collected for scoring of the budding 
phenotype. As described before, for a virus to be considered filamentous, it had to promote 
filament assembly in over 15% of infected cells and these filaments had to be longer than 2 
µm. By these measures, it was clear that Ck/Penn/1 showed a predominantly spherical 
budding phenotype in contrast to Ck/Penn/1370, which was strongly filamentous (Figures 3.8 
A, B). Significantly, when position 169 in M1 of Ck/Penn/1370 was mutated to an isoleucine, 
the filamentous budding phenotype was drastically reduced. In fact, comparison of 
Ck/Penn/1370 M 169 with Ck/Penn/1 M WT revealed no significant differences in both the %  
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Figure 3.7 Budding phenotype of 7:1 Ck/Pennsylvania reassortant strains with WT or mutated 
M1 at position 169.  WT and M1-mutant viruses were used to infect MDCK cells at a MOI of 3 
for 16 h. Cells were fixed and the surface stained with anti-PR8 antibody (green) and DAPI 
(blue) prior to imaging. Images were collected as maximum intensity projections from Z-stacks 
on the Zeiss 710 confocal microscope with a 63x objective and are representative of three 

















Figure 3.8 Quantification of the budding phenotype of the Ck/Pennsylvania reassortant strains. 
MDCK cells were infected with the viruses indicated at a MOI of 3 for 16 h and stained as in 
figure 3.7. (A) A minimum of 100 infected cells were scored per virus to determine the 
percentage of filament-producing cells. (B) A total of 90 filaments were measured per virus 
(when visible). Data represent mean +/- SEM (n = 3). One-way ANOVA was performed to 
compare all the viruses within the group. **** p< 0.0001; ns not significant. Limits for viruses 
to be classified as possessing a filamentous budding morphology are indicated (> 15% of 













of filament-producing cells and filament length, while Ck/Penn/1370 M 169 was significantly 
different from its WT counterpart in both factors quantified.  
 
3.2.4. Assessing the importance of M1 position 234 in Ck/Italy and 
Dk/Netherlands strains 
 Pairwise alignment of M1s of Ck/Italy and Dk/Netherlands showed one sequence 
polymorphism between these at position 234, where isoleucine was present in Ck/Italy and 
leucine in Dk/Netherlands strain. These strains shared a 100% identical M2 amino acid 
sequence; therefore M2 was not assessed further. 
The first step was to reciprocally change the M1 codons at position 234 of Ck/Italy and 
Dk/Netherlands by site-directed mutagenesis, followed by rescue of the viruses using a PR8 
backbone. In addition, given that a full set of reverse genetics plasmids for the Dk/Netherlands 
strain was available, the entirely avian virus was also rescued with WT or mutant M1 alongside 
the 7:1 reassortant viruses. All viruses rescued readily twice, with an average titre of 108 
PFU/ml for the 7:1 reassortant viruses and 106 PFU/ml for the avian Dk/Netherlands (Figure 
3.9 A). Once again, the titres of the WT and mutated 7:1 reassortant or avian viruses were not 
significantly different. Plaque phenotypes were visualised in MDCK cells as described before. 
As seen in figure 2.8 B, Ck/Italy 7:1 reassortant virus produced considerably larger plaques 
than Dk/Netherlands 7:1 reassortant virus. Mutation of position 234 reduced the plaque size 
of Ck/Italy or conversely, increased the plaque size of Dk/Netherlands, suggesting subtle 
differences in replication fitness in vitro (Figure 3.9 B). 
To determine the importance of M1 position 234 on the budding morphology of Ck/Italy 
and Dk/Netherlands strains, MDCK cells were infected with the viruses and imaged as before; 
PR8 reassortant-infected cells with anti-PR8 antiserum, while cells infected with the avian 
viruses were stained with Con A lectin. Cells infected with Ck/Italy WT M1 virus showed evenly 
distributed punctate staining of the cell surface, characteristic of viruses with spherical budding 



































Figure 3.9 Replication fitness of Ck/Italy and Dk/Netherlands strains with WT and mutated M1 
genes. (A) MDCK cells were infected with 1:10 dilutions of P0 stocks and left for 48 h before 
the supernatants were collected and titred by plaque assay. Data represent mean +/- SEM (n 
= 3) from two independently rescued stocks of viruses. Blue bars correspond to spherical 
viruses and orange bars to filamentous ones. (B) Monolayers of MDCK cells were infected 





structures on the surface of the cells, similar to the ones produced by the non- reassortant 
avian WT Dk/Netherlands, albeit in smaller quantities (Figure 3.10, top half). However, when 
the amino acids at position 234 of M1 were reciprocally changed between Ck/Italy and 
Dk/Netherlands, Ck/Italy-infected cells presented long filamentous bundles on their surface, 
while the Dk/Netherlands filamentous phenotype was abrogated (Figure 3.10, bottom half). 
Like the 7:1 reassortant virus of Dk/Netherlands, the WT avian virus with an isoleucine instead 
of a leucine at position 234 of M1 also lost its filamentous phenotype. 
To quantify the budding morphology of the Ck/Italy and Dk/Netherlands strains, MDCK 
cells were infected as before with two independently generated virus stocks and two maximum 
intensity projections were collected per repeat for scoring of the budding phenotypes. Ck/Italy 
showed a predominant spherical budding phenotype, as number of filament-producing cells 
and length of the few filaments visible fell well below the previously defined thresholds (Figure 
3.11 A). By contrast, the 7:1 reassortant Dk/Netherlands induced filament formation on 
approximately 60% of infected cells. The fully avian virus Dk/Netherlands also showed a 
prominent filamentous budding morphology, with almost all the infected cells producing 
filaments. Regarding filament length, the Dk/Netherlands segment 7, both as a 7:1 reassortant 
and in its parental avian virus promoted the formation of filamentous bundles that ranged 
between 8 – 9 µm, whereas Ck/Italy showed much shorter filamentous bundles that fell well 
below the defined threshold (Figure 3.11 B). The change of an isoleucine to a leucine at 
position 234 of M1 in Ck/Italy resulted in a virus that promoted filament formation on 
approximately 60% of infected cells, while the reciprocal change of amino acids at position 234 
in M1 of Dk/Netherlands caused the virus to lose its filamentous phenotype. The percentage 
of cells producing filaments after infection with the mutant Dk/Netherlands 7:1 reassortant virus 
or the fully avian virus dropped by around ten-fold. With respect to filament length, Ck/Italy M1 
produced filaments approximately 8 µm long when position 234 of M1 was altered, while the 
reassortant Dk/Netherlands decreased from approximately the same value to around 1 µm. 
The WT Dk/Netherlands virus also showed a pronounced decrease, and although the 
remaining filaments were just above the defined threshold of 2 µm it was still regarded as a 
virus with a spherical phenotype because these were rare, appearing on less than 10% of  
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Figure 3.10 Budding phenotypes of Ck/Italy and Dk/Netherlands strains with WT or M1 I234L 
mutations. M1s of Ck/Italy and Dk/Netherlands strains were mutated at position 234 and the 
viruses were rescued as 7:1 reassortants in a PR8 backbone or as fully avian viruses 
(Dk/Netherlands strain). WT and M1-mutant viruses were used to infect MDCK cells at an MOI 
of 3 for 16 h. Cells were fixed and the surface stained with anti-PR8 antibody for the 7:1 
reassortants or Con A lectin for the full Dk/Netherlands viruses (both in green) and DAPI (blue). 
Images were collected as maximum intensity projections of Z-stacks taken on a Zeiss 710 
confocal microscope with a 63x objective and are representative of three independent 













Figure 3.11 Quantification of the budding phenotype of Ck/Italy and Dk/Netherlands strains 
and its association with plaque size. (A, B) MDCK cells were infected with the viruses indicated 
at a MOI of 3 for 16 h and imaged as in figure 3.10. (A) A minimum of 100 infected cells were 
counted per virus to determine the percentage of infected cells producing filaments. (B) A total 
of 90 filament bundles were measured per virus (when visible). Data represent mean +/- SEM 
(n = 3). One-way ANOVA was performed within the group of 7:1 reassortant viruses and a t-
test was performed within the group of fully avian viruses. *** p<0.001; **** p<0.0001. (C) A 
minimum of 72 plaques (as seen in figure 3.9 B) were measured per virus. All measurements 
were scaled to PR8 WT plaque size (set as 100%). Data represent mean +/- SEM (n = 3). One-
way ANOVA was performed to compare all viruses against PR8 WT. ** p<0.01; *** p<0.001. 
(D) Data points represent individual (circle outline) or average (circle coloured in) plaque size 
plotted against % filament-producing cells. The data was linearized and fitted against the 
model data from figure 2.11 B. Spherical viruses are represented in blued while filamentous in 























infected cells. Overall, these analyses showed that the budding phenotypes of Ck/Italy and 
Dk/Netherlands were determined by the I234L polymorphism in M1. 
To test if the phenomenon of changes to budding morphologies reciprocally affecting 
plaque phenotype was consistent for Ck/Italy and Dk/Netherlands, a minimum of 70 plaques 
(as seen in figure 3.9 B) were measured per virus and these were scaled to PR8 WT plaque 
size measured from the same experiments. Ck/Italy (spherical) exhibited plaques similar in 
size to PR8, while Dk/Netherlands (filamentous) showed plaques approximately 40% smaller 
than PR8 (Figure 3.11 C). Conversely, reciprocal alteration of position 234 in M1 of Ck/Italy 
and Dk/Netherlands resulted in a reduction of the plaque size of Ck/Italy by approximately 40% 
and an increase of approximately 60% of the plaque size of Dk/Netherlands. The plaque size 
difference between WT and M1-mutant of the full avian Dk/Netherlands virus was not assessed 
since the M1-mutant virus produced extremely small plaques that in a majority of experiments 
were too small to get accurate measurements from. To further confirm the correlation between 
budding phenotype (i.e. % filament-producing cells) and plaque size, the data was linearly 
fitted to the model data from figure 2.11 B and showed a linear inverse relationship between 
plaque size and budding phenotype. This inverse relationship confirmed the association of a 
small plaque phenotype in MDCK cells with filamentous budding (Figure 3.11 D).  
Overall, reciprocal changes of amino acids at position 234 in M1 of Ck/Italy and 
Dk/Netherlands viruses showed that a single sequence polymorphism in M1 determined the 
resultant budding morphology. More importantly, in this case, the viruses shared a 100% 
identical M2 amino acid sequence, which further supported the strength of M1 as the major 
budding morphology determinant. Furthermore, as observed previously, alteration of budding 
morphology to a filamentous phenotype also affected plaque phenotype, as demonstrated by 





3.2.5. Statistical studies of the association of M1 sequence polymorphisms 
with budding morphology, genetic background and/or host species 
Systematic characterisation of the budding morphology of the avian strains under 
study (both as 7:1 reassortant viruses and avian virus isolates), suggested that there was no 
correlation between budding morphology and segment 7 clade from which the M1 genes were 
sampled. For instance, clades 2, 3, 6 and 9 contained a mixture of viruses that showed either 
spherical or filamentous budding phenotypes. However, a closer look at the avian hosts of the 
viruses tested showed a tendency for duck IAVs to be filamentous while chicken strains of 
IAVs were predominantly spherical (Table 3.1). For instance, the two duck strains on clades 2 
and 3 showed opposite budding morphologies, while two of the three stains in clades 6 and 9 
were filamentous. A limitation of this tentative conclusion is that it was based on testing only 
22 avian M segments out of around 22,000 unique sequences. However, the work described 
above showed that avian IAV budding morphologies could (at least for the specific strains 
tested) be determined by positions M1 amino acids 59, 169 and 234; findings that could be 
used for a more detailed statistical approach to testing the hypothesis that host strain might 
affect the morphology of avian IAV budding. 
To test whether the M1 sequence polymorphisms identified above could be used to 
predict the budding morphology of a wider sample of chicken and duck IAVs, Fisher’s exact 
tests were performed to determine significant associations between M1 positions and specific 
hypotheses (Table 3.2). The Fisher’s test was performed in R by Dr Sam Lycett with further 
processing of the results in Microsoft Excel with the help of Dr Sam Lycett. These tests 
measured the probability of a “condition A” being correlated with another “condition B”, giving 
back a p-value for it. In this study, M1 codons 1 to 252 were condition A, while the hypotheses 
to be tested were condition B. All 22 M1 amino acid sequences from chicken and duck IAVs 
with known budding morphology were used for this analysis, including the ones published by 
other authors (see table 2.1). M1 sequences were aligned and individual positions were 
selected for analysis when these showed amino acid variability above 15%. This resulted in 
14 positions being chosen, across the length of the protein (Table 3.2). Following this selection, 
the M1 positions were tested for the presence of significant associations with: budding  
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Table 3.1 Summary of the budding morphology and segment 7 clade distribution of the virus 
strains used and corresponding clade distribution within the phylogenetic tree. Avian strains 
were grouped by host and clade (see figure 2.7). Host species are identified in bold and the 
avian strains of IAV that were tested as original isolated instead of as PR8-based reassortants 




Table 3.2 Associations between M1 positions and budding morphology, genetic background 
and avian host. The hypotheses tested by Fisher’s exact tests and the condition by which these 
were defined are represented. A total of 22 duck and chicken M1 sequences were aligned (see 
table 2.1) and positions tested selected based on amino acid variability (i.e. one amino acid 
had to appear in more than 4 sequences). The M1 positions identified in bold were the only 
residues that showed a significant association with at least one of the hypotheses used in the 
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15, 27, 37, 95, 
101, 107, 144, 
157, 166, 207, 
224, 230, 232, 
234 
ns ns ns 
Fully avian 
Avian virus 
rescued by RG 
versus avian 
isolate available 
in the lab 




ns ns ns 
Host Chicken or duck 0.016 0.016 0.003 
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morphology, avian backbone, PR8-based 7:1 reassortants and duck or chicken host species, 
as seen in table 3.2. Fisher’s exacts revealed three M1 positions that showed a significant 
association with at least one of the hypotheses tested. However, to prevent the occurrence of 
false positives, these data were subjected to Bonferroni correction. This consisted of 
multiplying the p-value by the number of M1 positions tested (14 positions). Following this, the 
remaining significant associations were between positions 107, 144 and 234 of M1 with host 
species (chicken or duck). Positions 107 and 144 had not been identified via multiple 
alignments, but position 234 had been previously identified as a budding morphology 
determinant by examining a pair of closely related avian strains (see section 3.2.4). 
Given that M1 is  an important factor in determining viral budding morphology, the 
amino acid variability was determined for the positions in M1 identified by site-directed 
mutagenesis (59, 169 and 234) and Fisher’s exact test (107, 144 and 234) within chicken and 
duck isolates. Firstly, all the 10,635 available sequences of segment 7 with the complete 
coding region from avian IAVs were collected from Influenza Research Database (May 2017) 
and organised into the most common avian hosts (Figure 3.12 A). From this, approximately 
two quarters of the samples were of chicken or duck-origin. Next, in order to chart the overall 
M1 sequence variation from avian viruses at the positions of interest, the prevalence of all 
amino acids seen at positions 59, 169, 107, 144 and 234 were recorded (Figure 3.12 B). This 
revealed a high prevalence of isoleucine at positions 59 and 107, whereas leucine was 
predominantly present at position 234. Phenylalanine was overrepresented at position 144, 
while threonine was predominant at position 169. Overall, this analysis (unsurprisingly) 
showed that there was a preference for specific amino acids at the indicated positions within 
avian M1s. However, since the main focus of this study was viruses isolated from chicken and 
duck host species, the same prevalence analysis was performed based on sequences derived 
from these hosts. Positions 59 and 169 that were not significant by Fisher’s exact test showed 
a very similar amino acid distribution between the two hosts. Chicken and duck viruses had 
almost equal percentages of isoleucine or methionine at position 59 and threonine at position 
169. Isoleucine at position 169 was only found in chicken IAV isolates but as this represented 




Figure 3.12 Diversity of amino acids at M1 positions 59, 107, 144, 169 and 234 within IAV 
isolates from avian host species. (A) 10,635 complete avian IAV segment 7 sequences were 
retrieved from Influenza Research Database on 16/05/2017 and organized into the main hosts 
present on the overall sample. (B) M1 sequences from A were used to determine the 
prevalence of specific amino acids at positions 59, 107, 144, 169 and 234 (Figure 3.1 and 
Table 3.2). (C) From the overall sample, chicken (2024) and duck (1899) M1 sequences were 
isolated and the prevalence of the specific amino acids determined for each of the positions 
under study. Numbers above the bars correspond to the total number of sequences. 



















hand, the positions that showed an association with chicken or duck host species by Fisher’s 
exact test (107, 144 and 234), showed a skewed pattern of amino acid distribution, particularly 
within M1s of duck IAVs. Over 90% of duck IAVs had isoleucine at position 107, phenylalanine 
at position 144 and leucine at position 234 while very few had 107M, 144L and 234I (Figure 
3.12 C). In contrast, chicken viruses were much more evenly split, with each of the I107M, 
F144L and I234L polymorphisms making up around 50% of the available sequences. These 
observations helped explain the significant association determined by Fisher’s exact test 
between positions 107, 144 and 234 and avian host species. M1 position 234 was chosen for 
further experimental work because it was identified independently by two different methods. 
Given that previous observations suggested that chicken IAVs were predominantly spherical 
and duck IAVs mainly filamentous, it was hypothesised that position 234 of M1 could be a host 
species-specific virion morphology determinant. 
 
3.2.6. Testing the importance of position 234 in another chicken virus 
The statistical and bioinformatics analyses presented above showed that most duck 
IAVs had a leucine at M1 position 234, while chicken viruses had either leucine or isoleucine 
in roughly equal proportions. Experimental data so far indicated that chicken IAVs 
predominantly showed a spherical budding phenotype whereas duck IAVs were mostly 
filamentous and that in the case of two viruses with closely related M segments, Ck/Italy and 
Dk/Netherlands, budding morphology could be swapped by I234L mutations. Therefore, in 
order to test the hypothesis that M1 position 234 could be an avian host species-specific virion 
morphology determinant, a spherical chicken virus was chosen for site-directed mutagenesis 
at position 234 of M1. A/chicken/Pakistan/UDL-01/2008 (H9N2) (Ck/Pakistan) was chosen 
because it showed a high number of sequence polymorphisms when compared with other 
avian strains under study, both those with spherical and filamentous budding phenotypes (see 
chapter 2, section 2.2.3, figure 2.13). Before the statistical and bioinformatics analyses 
reported above, this diversity had made it difficult to predict which residue would be 
responsible for the spherical budding phenotype of Ck/Pakistan. Accordingly, Ck/Pakistan 
segment 7 was mutated at M1 codon 234, where isoleucine was changed to leucine and the 
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WT and M1-mutant viruses were rescued, either as 7:1 reassortants or as full Ck/Pakistan 
viruses. The 7:1 reassortant viruses were readily rescued twice in mammalian cells as 
described previously. For reasons that defied trouble shooting and remain unknown, the 
Ck/Pakistan viruses could not be rescued in the Roslin Institute.  These were therefore rescued 
once at the Pirbright Institute by another member of the group, Anabel Clements, and sent to 
the Edinburgh laboratory. The 7:1 reassortant viruses reached titres of approximately 108 
PFU/ml, for both WT and M1-mutant virus. The avian viruses replicated to a lower titre of 
approximately 107 PFU/ml (Figure 3.13 A). Plaque phenotype was assessed in monolayers of 
MDCK cells by toluidine blue staining. Ck/Pakistan 7:1 reassortant virus showed considerably 
large plaques, which were reduced to approximately half the size when position 234 of M1 was 
altered from an isoleucine to a leucine (Figure 3.13 B). The fully avian Ck/Pakistan produced 
rather small plaques in the Edinburgh laboratory even though at the Pirbright Institute the 
plaques observed by Anabel Clements were much larger (similar to PR8 WT, see figure 2.8). 
This made it difficult to determine whether the plaque sizes of Ck/Pakistan WT or 234 were 
truly different. Therefore, the alteration of amino acid residues at position 234 seemed to have 
little effect on the plaques produced by the fully avian virus; however this did not exclude subtle 
differences in replication in vitro, which happened to be more noticeable in the PR8-based 7:1 
reassortant viruses. 
To determine the effect on the budding phenotype of swapping amino acids at position 
234 in M1 of Ck/Pakistan, MDCK cells were infected with the viruses, fixed and stained as 
before prior to imaging. Mock-infected cells showed no detectable levels of infection (data not 
shown). PR8 WT and PR8 MUd infected cells were also imaged as controls for spherical and 
filamentous budding morphologies, respectively and showed their expected patterns of cell 
surface HA staining (Figure 3.14). Ck/Pakistan showed cell surface staining indicative of a 
spherical budding phenotype, either as an M gene in a PR8 backbone or on its own avian virus 
background. In contrast, when isoleucine was changed to a leucine at position 234 in M1 of 
Ck/Pakistan, the budding phenotype of both 7:1 reassortant and avian viruses changed 





































Figure 3.13 Fitness of PR8-based and fully avian viruses with WT and mutant Ck/Pakistan 
segment 7. (A) P0 stocks of the viruses indicated were (Ck/Pakistan M viruses, at a 1:10 
dilution) used to infect MDCK cells or 10-day old embryonated chicken eggs  (full avian 
Ck/Pakistan viruses, with 100 µl of the P0 stock) for 48 h before collection of the 
supernatant/allantoic fluid, which was titred by plaque assay on MDCK cells. Blue bars 
correspond to spherical viruses and orange bars to filamentous ones. Data represent mean 
+/- SEM (n = 3) from two independent stocks for the Ck/Pakistan M reassortant viruses or a 
single rescue for the CK/Pakistan viruses. (B) Plaque assays were performed on monolayers 








Figure 3.14 Budding phenotype of Ck/Pakistan WT and M1-I234L. The Ck/Pakistan M1 gene 
was mutated from an isoleucine to a leucine at position 234 and rescued either as 7:1 
reassortants with PR8 or in the full Ck/Pakistan background were used to infect MDCK cells 
at a MOI of 3 for 16 h. Cells were fixed and the surface stained with anti-PR8 antibody (green) 
for 7:1 reassortants or Con A lectin for Ck/Pakistan (green) viruses and DAPI to indicate nuclei 
(blue). Images were collected as maximum intensity projections from Z-stacks on the Zeiss 
710 confocal microscope with a 63x objective and are representative of three independent 
experiments. Arrows indicate filamentous bundles. Scale bars (20 µm) indicated. 
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In order to extend the information given by the microscopy data, budding of the WT 
and mutant Ck/Pakistan viruses was quantified. MDCK cells were infected, once each with the 
two independently rescued 7:1 reassortant viruses and twice more with the avian viruses. Two 
maximum intensity confocal projections of the cell surfaces were collected per repeat for 
scoring of budding phenotype. As described previously, a virus was classified as filamentous 
if more than 15% of infected cells were producing filaments and these were longer than 2 µm. 
By these criteria, Ck/Pakistan WT showed a predominantly spherical budding phenotype, 
while Ck/Pakistan M1-I234L virus induced filament formation on approximately 50% of infected 
cells, both as a 7:1 reassortant or avian virus (figure 3.15 A). In both genetic backgrounds, 
Ck/Pakistan M1-I234L promoted the formation of filamentous bundles on the surface of the 
cells that ranged 7 to 8 µm (figure 3.15 B). Thus the budding phenotypes of Ck/Pakistan WT 
and M1-I234L mutant viruses proved to be drastically different. Furthermore, these 
experiments further confirmed the importance of the M1 I234L polymorphism as a determinant 
of avian IAV virion shape. 
To determine the effect of changing an isoleucine to a leucine at position 234 on the 
folding of Ck/Pakistan M1, these mutations were mapped on the structure of this protein. 
Firstly, since the crystal structure of M1 from another orthomyxovirus (infectious anaemia 
salmon virus – IASV) had been recently solved, this was considered to map the mutations of 
interest (Zhang et al., 2017). The ISAV M1 is a 196-amino acid protein with an N-terminus 
formed of eight helices and a C-terminal domain composed of four helices with both domains 
connected by a short loop linker. The authors showed that helices one to five of ISAV M1 were 
present in the same location as helices one to five of IAV, but helix 6 of IAV was absent from 
ISAV M1. ISAV M1 helices six to eight were mapped to the same location as helices seven to 
nine of IAV. Therefore, the reasoning was that the C-terminus of ISAV M1 could be used to get 
a more accurate prediction of the C-terminus of IAV M1, as the latter was also predicted to 
encode for four helices in its C-terminus (Sha & Luo, 1997). However, structural alignment of 
ISAV M1 with IAV M1 showed that the C-terminus was more distant structure-wise than the N-




Figure 3.15 Quantification of the budding phenotype of viruses with the Ck/Pakistan M gene. 
MDCK cells were infected with the viruses indicated at a MOI of 3 for 16 h and imaged as in 
figure 3.14. (A) A minimum of 100 infected cells were counted per virus to determine the 
percentage of infected cells producing filaments. (B) A total of 90 filaments were measured per 
virus (when visible). Data represent mean +/- SEM (n = 3). t-tests were performed to compare 
within the 7:1 reassortants and fully avian virus groups. **** p<0.0001. Viruses are colour-






















disordered domain, while the C-terminal domain of ISAV M1 showed a more compact and 
organised conformation with four helices that could not be mapped on the C-terminus of IAV 
M1 (data not shown) (Zhang et al., 2017). These structural differences between IAV M1 and 
ISAV M1 were considered too great to determine the effects of changing specific residues on 
the folding of IAV M1. Therefore, the online prediction tool (I-TASSER (I-TASSER, 2017)) was 
used to predict the three domain structure of M1 and also provided information on the 
conformational changes of the protein upon amino acid substitution. This program used all the 
known available protein structures and their amino acid sequences to predict the structure of 
another protein based on its amino acid sequence and likely secondary structures. Therefore, 
I-TASSER was used to obtain a predicted structure for M1 of Ck/Pakistan where the structure 
of the N and M domains were based on the PR8 M1 structure (Sha & Luo, 1997) and the 
missing C-terminal domain was organised by structure comparison. The predicted M1 
structure of Ck/Pakistan with isoleucine at position 234 showed a C-terminal domain 
comprised mainly of random coil with three α-helices arranged into a roughly triangular shape 
with the C-terminus of the protein pointing away from the plane defined by the packed array of 
-helices present in the N and M domains (Figure 3.16 A). The side chain of isoleucine 234 
was located on helix 2 pointing out into the solvent. Conversely, the predicted structure of the 
C-terminal domain of M1 with leucine at position 234 was substantially different, both in 
conformation and how it was arranged with respect to the N and M domains. As well as being 
flattened to a more horizontal direction, it also showed a more compact folding with three α-
helices (Figure 3.16 B). Furthermore, in M1 with isoleucine at position 234 the long helix of the 
M domain showed a prominent kink to the left of the helix axis, whereas the change to leucine 
at this position caused the long helix to tilt slightly to the right. Thus, even though alteration of 
isoleucine to leucine is a common occurrence in nature (Henikoff & Henikoff, 1992), the 
predicted structure of M1 with either amino acid at position 234 showed major differences in 
folding. Although only a prediction, this difference was consistent with the major phenotypic 
difference seen in budding morphologies. Collectively, these results support the hypothesis 
that position 234 could be a strong budding morphology predictor in an avian host species-
specific dependent manner.  
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Figure 3.16 Predicted structures of Ck/Pakistan strain M1 with either isoleucine or leucine at 
position 234. The structure of Ck/Pakistan M1 was predicted using the I-TASSER online tool, 
based on the crystal structure of PR8 M1 (1AA7). Ck/Pakistan M1 amino acid sequence was 
submitted to I-TASSER with an isoleucine (A) or a leucine (B) at position 234. Protein 
structures were further processed in Pymol software. The side chain of amino acid 234 is 
displayed in yellow. Established structural domains of M1 (N-terminus, linker, middle domain 








 The importance of the viral matrix protein M1 in determining the budding morphology 
of IAVs has been well characterised (Smirnov et al., 1991; Roberts et al., 1998; Gomez-
Puertas et al., 2000; Bourmakina & Garcia-Sastre, 2003; Elleman & Barclay, 2004; Chou et 
al., 2011; Campbell et al., 2014), in the process, defining the importance of amino acid identity 
at positions A41V, S85N, K95R, E204D, S207N and T218A in human and equine strains of 
IAV (Roberts et al., 1998; Bourmakina & Garcia-Sastre, 2003; Elleman & Barclay, 2004; Bialas 
et al., 2012; Elton et al., 2013). These residues have been described as the filamentous 
“signature” of mammalian IAVs (Elton et al., 2013). However, characterisation of avian strains 
of IAV revealed that these do not obey the same “rules”; therefore the aim of this part of the 
study was to identify the potential signatures that govern avian IAV budding morphology.  
 As described in chapter 2, general alignment of the avian M1 sequences tested here 
did not show a consistent pattern of mutations that would explain the different budding 
morphologies observed. However, examination of closely related avian strains, defined as 
having a very similar M1 amino acid sequence, revealed some that nevertheless showed 
opposite budding phenotypes. In this section, three pairs of strains that met these conditions 
were characterised. Dk/India and Dk/Tripura presented three sequence polymorphisms 
(residues 37, 59 and 205), while Ck/Penn/1 and Ck/Penn/1370 pair and Ck/Italy and 
Dk/Netherlands pair both showed a single amino acid polymorphism at positions 169 and 234, 
respectively (Figure 3.1). Characterisation of Dk/India (spherical) and Dk/Tripura WT 
(filamentous) and M1-mutant viruses showed that reciprocal change of amino acids at position 
59 was capable of swapping the phenotype of the two strains, suggesting that position 59 was 
the main morphology determinant (Figure 3.3). However, only the addition of the other two 
positions (37 and 205) accurately exchanged the budding phenotype of the two strains (Figure 
3.4). On the other hand, Ck/Pennsylvania strains and Ck/Italy and Dk/Netherlands only 
showed a single sequence polymorphism in M1 and characterisation of WT and M1-mutant 
viruses confirmed the importance of residues 169 and 234 as morphology determinants in 
these pairs of viruses. 
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A consistent observation throughout this section was related to the relative replication 
fitness of spherical and filamentous budding phenotypes. For all the viruses characterised, the 
spherical viruses replicated to titres similar to the filamentous viruses (Figure 3.2 A, figure 3.6 
A, figure 3.9 A and figure 3.13 A), but spherical viruses showed a clear advantage in vitro as 
these produced larger plaques (Figure 2.11 B), in agreement with previously published reports 
on the advantage of the spherical phenotype over the filamentous phenotype in vitro (Seladi-
Schulman et al., 2013; Roberts et al., 1998). 
Following identification of residues 59, 169 and 234 in M1 as modulators of budding 
morphology between closely related avian strains that showed opposite budding phenotypes, 
the next step was to access whether these residues had the potential to form a filamentous 
“signature” for avian strains of IAV. Therefore, Fisher’s exact tests were performed using all 
the M1 sequences deriving from strains of known morphology, including strains not 
characterised here but previously published (Al-Mubarak et al., 2015; Pu et al., 2017) (Table 
2.1). These tests calculated the presence of a significant association between avian virus M1 
codons (1 to 252) and specific hypotheses (Table 3.2). The positions identified by site-directed 
mutagenesis – 37, 59, 169 and 205 – did not show a significant association with any of the 
hypotheses tested. By contrast, two new positions identified in this study (residues 107 and 
144) along with an already identified residue (codon 234, see section 3.2.4) revealed a 
significant association with avian host species (Table 3.2). Therefore, this suggested that there 
was a consistent pattern of amino acid distribution at positions 107, 144 and 234 between 
chicken and duck strains of IAV. This was corroborated by bioinformatics analysis of the amino 
acid prevalence of the positions identified within a bigger sample of avian segment 7s, where 
amino acid identity at positions 107, 144 and 234 showed a clear pattern of distribution 
between chicken and duck IAVs. However, considering that position 234 was identified 
independently by two different methods, the main focus of this section of the study was on that 
position. Therefore, bioinformatics and statistical analysis coupled with the observation that 
chicken IAVs tended to be spherical with isoleucine at position 234 while duck IAVs were 
predominantly filamentous with leucine at position 234, gave rise to the hypothesis that 
position 234 could be a determinant of budding morphology in an avian host species-specific 
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dependent manner. To test the aforementioned hypothesis, a spherical chicken virus with 
isoleucine at 234 was selected (Ck/Pakistan) and mutated to encode a leucine at this position 
of M1. The M1-mutant virus of Ck/Pakistan induced the formation of the characteristic 
filamentous structures on the surface of infected cells (Figure 3.14) in both PR8-based 7:1 
reassortant viruses and in the avian virus background. Although interchange of isoleucine to 
leucine is a current occurrence in nature (Henikoff & Henikoff, 1992), the striking differences 
in the budding morphology indicate that at position 234 this naturally occurring amino acid 
alteration has a significant impact on the virus. 
In this study, mapping of residues T37A and I205V, singly or in combination, onto the 
predicted three domain structure of M1 from Dk/India or Dk/Tripura showed no striking 
differences on the folding of M1 (data not shown). Mapping of isoleucine at position 59 of 
Dk/India showed a C-terminus composed of some random coil and four helices that were 
perpendicular and dispersedly organised around the M domain (Figure 3.17 A). However, 
alteration to a methionine induced a conformational change on the C-terminus, resulting in a 
domain mainly composed of random coil that was more tightly compacted around the M 
domain with only three helices (Figure 3.17 B). Similar observations were made with 
Dk/Tripura M1, therefore these are not shown. Although methionine at position 59 of Dk/India 
M1 only slightly affected the folding of the protein therefore explaining the different 
morphologies, another hypothesis would be that this start codon is encoding for another gene 
product. The M segment has several start codons and is known to produce at least four mRNA 
transcripts (Wise et al., 2012). As explained before, mRNA 1 translates into M1 while mRNA 2 
gives M2. More recently, it was identified M42 from mRNA 4, which can functionally replace 
M2 (Wise et al., 2012). However, unlike in the case of M1, M2 or M42, the Kozak sequence 
surrounding the start codon at position 59 is relatively weak; therefore this hypothesis was 
discarded and the difference in budding morphology was solely allocated to conformational 
changes within M1. By contrast, alteration of threonine to an isoleucine at position 169 of 
Ck/Penn/1370 M1 did not reveal any striking differences that would explain the different 
budding morphologies (data not shown). However, considering that position 169 was mapped 























Figure 3.17 Predicted structures of Dk/India M1 with either isoleucine or methionine at position 
59. The three domain structure of Dk/India M1 was predicted using the I-TASSER online tool, 
based on the two domain crystal structure of PR8 M1 (1AA7). Dk/India M1 amino acid 
sequence was submitted to I-TASSER with 37T, 59I and 205I (A) or 37A, 59M and 205V (B). 
Protein structures were further processed in Pymol software. The side chain of amino acid 59 
is displayed in red, while the location of amino acids 37 (yellow) and 205 (green) is indicated. 
Established structural domains of M1 (N-terminus, linker, middle domain and C-terminus) are 










therefore not detected by the I-TASSER program. Overall, the most striking differences 
observed were with reside I234L (Figure 3.16). 
The work described so far had led to the identification of a suite of M1 sequence 
polymorphisms that affected virus budding morphology and/or potentially acted as host-
dependent “signatures”, namely residues at positions T37A, I59M, I107M, F144L, 169T, I205V 
and I234L. However, it did not inform on how the changes affected virion shape. Indeed, 
inspection of the list of key residues showed a preponderance of conservative changes to 
hydrophobic side chains; something that would perhaps not normally immediately suggest 
changes to protein function. As a first step to addressing this question, the amino acid positions 
of interest were mapped onto the crystallographic structure of the two domain M1, including 
for comparison, residues known to be important for determining particle shape in mammalian 
strains of IAV (Figure 3.18 A and B). On the other hand, the residues of interest in the C-
terminus of M1 were mapped based on the structural prediction given by I-TASSER as 
mentioned before (Figure 3.18 C and D). Residues T37A, A41V and I59M all mapped to the N 
domain of M1, with S85N in the linker region and K95R, I107M and F144L all present in the M 
domain (Figure 3.18 A). Of these, majority were clearly exposed on the surface of the two-
domain structure of M1 (T37A, A41V, S85N, K95R and I107M) (Figure 3.18 B). The residues 
I169T, E204D, S207N and T218A in the C-terminus were mapped to disordered regions of this 
domain while residue I234L was mapped to a helix (Figure 3.18 C). Similar to what was 
observed with the residues mapped in the N and M domains, majority of the residues in C-
terminus were clearly visible on the surface of M1 (I169T, E204D, T218A and I234L) (Figure 
3.18 D). 
As mentioned before, the N domain of M1 is known to be involved in association of 
the protein to the lipid membrane that composes the virion (Figure 1.6). While residue 37 was 
surface exposed, residue 59 (avian) was buried within the N domain of M1. Residue T37A did 
not cause any changes to the virion shape or folding of M1, unlike the other surface exposed 
residue - mammalian A41V – that was reported to alter virion morphology and promote 
overexpression of M42, which unpublished data from the Digard laboratory suggest that it 















Figure 3.18 Predicted structure of Ck/Pakistan M1 with previously identified mammalian 
residues and the newly identified avian residues. (A) The two domain crystal structure of 
Ck/Pakistan was predicted based on the PR8 M1 crystallographic structure of M1 (1AA7). The 
mammalian (41, 85, 95, 204, 207 and 218) and the avian (37, 59, 169, 205 and 234) with the 
corresponding amino acid substitutions were mapped onto this structure and are colour-coded 
as indicated. A rotation of 90⁰C in the y axis is shown to clearly show all positions mapped. (B) 
Surface of a M1 dimer with the residues mapped to the N and M domains showing and colour-
coded as indicated. Only the residues indicated on the picture were visible on the surface of 
the M1 dimer. (C) The C-terminus of Ck/Pakistan M1 represented was derived by structure 
comparison using I-TASSER. The residues mapped to this domain are colour-coded as 
indicated and majority were clearly visible on the surface of the C-terminus of M1 (D). A rotation 
of 90⁰C in the y axis is shown to clearly show all positions mapped. Established structural 























could be involved in intramolecular interactions important for M1 stability, since amino acid 
substitution considerably affected folding of the C-terminus of M1. Interestingly, this residue is 
also at the beginning of a recently identified NES within M1 (see figure 1.6), therefore changes 
at the amino acid level could also have an impact on export of M1 from the nucleus but this 
was not further addressed on this study. Given that the M domain of M1 was reported to be 
involved in M1 and NP association, the avian residues identified in that domain (I107M and 
F144L) could play a role in M1-NP interactions. For instance, Liu et al reported that spherical 
viruses presented a stronger association of M1-NP than filamentous viruses (Liu et al., 2002). 
Moreover, Bialas et al reported that a human M segment with a typical “filamentous signature” 
only produced filaments in a PR8 backbone, as in the human virus NP was preventing filament 
formation (Bialas et al., 2014). Furthermore, it was reported that NP also binds actin 
microfilaments to retain the newly formed vRNPs in the cytoplasm that are then incorporated 
into progeny virions (Digard et al., 1999). Therefore, it is possible that residues 107 and 144 
modulate the strength of M1-NP association which in turn can affect the interaction of NP with 
the actin cytoskeleton that was reported to be a detrimental factor in filament formation 
(Roberts & Compans, 1998).  
Residues I169T and I234L were exposed in the C-terminus of M1 while I205V was 
buried within M1. The C-terminal domain is a relatively flexible and disordered domain, which 
limits its ability to crystalize. This domain is known to be involved in M1-M1 oligomerisation 
and it was recently reported to promote M1 polymerisation at physiological pH, but as the pH 
drops (below 6) the C-terminus prevents M1-M1 association, explaining the release of vRNPs 
into the cytoplasm in late endosomes during viral entry (Calder et al., 2010; Shtykova et al., 
2017). Furthermore, while the N and M domains of M1 seem to share a considerably conserved 
structure, the conformation of the C-terminal domain changes between M1s, even though M1 
is the most conserved protein in IAV (compare C-terminus of figures 3.16 and 3.17). Residue 
I169T mapped to the edge between the M and C-terminal domains, but within the avian strains 
where it was identified caused no striking difference on the folding of M1, which was also the 
case of I205V even though an alteration in the nearby region (E204D) was identified in 
mammalian IAVs as a morphology modulator (Bourmakina & Garcia-Sastre, 2003). By 
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contrast, the amino acid alteration I234L was shown to more tightly pack the C-terminus 
around the M domain, similar to what was observed with I59M alteration. Although it is not 
documented how the C-terminus is packed in the matrix layer of a filamentous virus, it was 
reported by Calder et al that filamentous strains typically display an ordered helical matrix 
which forms a relatively rigid structure that supports the virion (Calder et al., 2010). Therefore, 
the more compact conformation of the C-terminus could lead to a more tightly packed M1 with 
closer M1-M1 interactions, leading to the formation of a more rigid structure that provides 
support to filamentous virions. 
Even though the genetic determinants within M1 identified in this section of the study 
were shown to be the main determinants of budding morphology, there are other viral and 
cellular determinants of virion morphology. As previously discussed (sections 1.6.1 and 1.6.2), 
HA and NA were also shown to affect budding morphology, more specifically a filamentous NA 
was reported to promote the formation of a few filamentous virions by the spherical strain PR8 
(Campbell et al., 2014). Therefore, it is possible that a cumulative effect exists between M1 
and NA that promotes filament formation. Cellular components such as Rab11 or Rab11-FIP3 
were shown to considerably affect virus budding, with Rab11-FIP3 causing abrogation of the 
filamentous phenotype of PR8 MUd (Bruce et al., 2010). Furthermore, components of the 
ESCRT pathway were also identified interacting with IAV M1, namely VPS28; however it is 
known that IAV buds out of the cell in an ESCRT-independent manner (Bruce et al., 2009; 
Rossman et al., 2010). Yet, like in the case of FIP3, the role of VPS28 in budding morphology 
remains unknown. Nonetheless, considering that the endosomal recycling and ESCRT 
pathways are both associated with membrane scission during cell division, it is possible that 
their components play a role in promoting membrane fission or stabilising the site of budding 
alongside the viral protein M2 (Roberts et al., 2013; Rossman et al., 2010). 
Overall, this section of the study showed that avian strains of IAV have their own 
filamentous “signature”, involving positions I59M, I169T and I234L which were identified by 
comparison of closely related avian strains that showed opposite budding phenotypes. This 
section also showed that budding morphology was not clade-dependent, but potentially host-
dependent as spherical budding phenotypes were common in chicken but rare in duck IAVs. 
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Therefore, to test whether positions 59, 169 and 234 could make a filamentous “signature” for 
a wider sample of chicken and duck IAVs, Fisher’s exact test was performed leading to the 
identification of positions 107, 144 and 234. Positions 107 and 144 were not further studied, 
but this study does not exclude their potential to be morphology determinants, but perhaps a 
bigger sample of chicken and duck IAVs with known morphology would be needed. By 
contrast, the strength of position 234 was so great that even in a small sample (22 sequences) 
it was possible to identify it. Thus, it was hypothesised that this position could be a morphology 
determinant in an avian host dependent manner. This hypothesis was corroborated by 
alteration of the amino acid identity at position 234 of M1 from a spherical chicken virus 
(Ck/Pakistan). Not only position 234 altered the budding phenotype of Ck/Pakistan, it also 
potentially altered the folding of the M1 protein, which could explain the differences observed. 
Therefore, this section strongly supports the importance of position 234 of M1 in determining 
budding morphology in an avian host dependent manner and adds this position towards the 












Chapter 4: Functional characterisation of spherical and filamentous 
budding phenotypes in vitro and in ovo 
4.1. Introduction and aims 
As discussed in chapter 3, pairwise alignment of closely related avian strains that 
showed opposite budding phenotypes revealed sequence polymorphisms in M1 correlating 
with the different budding morphologies. Site-directed mutagenesis confirmed the importance 
of M1 amino-acids 59, 169 and 234 in determining budding morphology. Characterisation of 
these WT and M1-mutant viruses gave a clear idea of how different the budding morphology 
of these viruses can be, but it did not address the question of how the viruses would behave 
in an avian host. Recently, Al-Mubarak et al showed that a duck strain of IAV replicated to 
higher titre in CEF when compared with DEF cells (Al-Mubarak et al., 2015). The authors 
showed that this duck isolate of IAV had a spherical budding phenotype in CEF cells but a 
prominent filamentous budding phenotype in DEF cells. Therefore, the authors suggested that 
the different growth kinetics observed could be due to the different budding morphologies 
present in these cells. Furthermore, several studies have also reported that spherical viruses 
showed a growth advantage in ovo and filamentous viruses were selected against (Kilbourne 
& Murphy, 1960; Seladi-Schulman et al., 2013). 
Hence, the aim of this part of the study was to (1) assess the growth kinetics of the 
viruses in different avian cell types and (2) investigate in ovo fitness and pathogenesis of the 
M1-mutant viruses versus their WT counterparts. 
 
4.2. Results 
4.2.1. In vitro and in ovo characterisation of Dk/India and Dk/Tripura WT and 
M1-mutant viruses 
 Identification of sequence polymorphisms in M1 of closely related avian strains with 
opposite budding phenotypes allowed the construction of mutant viruses where spherical and 
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filamentous budding morphologies were promoted or abrogated. Given that these M1-mutant 
viruses were built in the same genetic backgrounds as their WT counterparts, they provided 
tools to functionally characterise spherical and filamentous budding phenotypes in vitro and in 
ovo. First, the PR8 background Dk/India and Dk/Tripura reassortants were tested. WT versions 
of these viruses showed either spherical or filamentous budding phenotypes, where amino 
acid identity at position 59 of M1 was the main determinant of their different budding 
morphologies. However, the other sequence polymorphisms identified at positions 37 and 205 
were also important to achieve a complete exchange of budding morphologies between the 
two avian strains. Therefore, in vitro and in ovo characterisation was performed with Dk/India 
and Dk/Tripura 7:1 reassortants containing WT segment 7, segment 7 with M1 reciprocally 
changed at position 59 or with M1 reciprocally changed at positions 37, 59 and 205. 
 The first step to better characterise the WT and M1-mutant viruses was to evaluate 
their growth kinetics in mammalian and avian cells and embryonated chicken eggs. The 
viruses were used to infect MDCK, CEF or DEF cells at a MOI of 0.01 for a period of 48 h. 
Time points were collected over the 48 h, clarified by centrifugation and titred by plaque assay. 
The PR8-based 7:1 reassortants with WT and mutated M1 from Dk/India and Dk/Tripura 
replicated well with no significant differences throughout the 48 h in MDCK cells, reaching 
maximum titres of approximately 108 PFU/ml by 24 h (Figure 4.1 A). In both CEF and DEF 
cells, similar outcomes were observed, where WT and M1-mutant viruses reached maximum 
titres by 24h of approximately 106 PFU/ml in CEF (Figure 4.1 B) and 107 PFU/ml in DEF (Figure 
4.1 C) cells. In all cell types, Dk/India and Dk/Tripura WT or M1-mutant viruses replicated 
similarly over the 48 h period, thus suggesting that viral fitness was not affected by budding 
morphology in these settings. 
 The reassortant Dk/India and Dk/Tripura viruses were also used to infect 10-day old 
embryonated chicken eggs with 100 PFU via the allantoic cavity (Burnet, 1941) for 48 h. 
Following infection, the allantoic fluid was harvested, clarified by centrifugation and titred by 
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Figure 4.1 Growth characteristics of Dk/India and Dk/Tripura WT and M1-mutant viruses in 
vitro and in ovo. (A-C) MDCK, CEF and DEF cells were infected at an MOI of 0.01 for 48 h with 
the indicated viruses. Supernatants were collected at the indicated time points, cleared by 
centrifugation and the viral titre assessed by plaque assay. Data represent mean +/- SEM (n 
= 3). (D, E) Embryonated 10-day old chicken eggs were infected with 100 PFU of the indicated 
viruses for 48 h. Allantoic fluid and embryos were harvested for viral titre determination by 
plaque assay. Viral titre determination of the embryos was preceded by maceration of the 
embryo and centrifugation. A total of 18 embryos were used, where 9 were macerated and the 
other 9 were used for histology studies. One-way ANOVA was performed to compare the 
viruses within Dk/India and Dk/Tripura groups. * p < 0.05 Data points represent individual 
samples and bars mean +/- SEM (D: n = 18 E: n = 9). Spherical viruses are represented by 























The PR8-based Dk/India 7:1 reassortant viruses with WT M1, M1 59 and M1 37, 59 205 
mutations replicated to titres ranging between 108 and 109 PFU/ml (Figure 4.1 D). Even though 
Dk/India M 59 and Dk/India M 37 59 205 both possessed a filamentous budding morphology, 
the latter replicated to a significantly lower average titre at 48 h p.i (approx. 108 PFU/ml), 
suggesting that mutating positions 37 and 205 caused subtle changes which in turn affected 
viral replication in the allantoic fluid. The Dk/Tripura reassortants with WT or mutated M1 all 
replicated to indistinguishable average titres of approximately 109 PFU/ml. To determine viral 
replication in the embryo, 9 embryos were sampled from a total of 18. These were harvested, 
washed twice in PBS, macerated, debris pelleted by centrifugation and the supernatants 
collected for titre by plaque assay. Mock-infected embryos showed no detectable levels of 
infection by plaque assay (data not shown). Dk/India reassortants with WT M1 or M1 37 59 205 
gave virus titres of approximately 107 PFU/ml (Figure 4.1 E). By contrast, Dk/India 59 
replicated to a greater titre than its WT counterpart. Conversely, Dk/Tripura 59 showed a (non-
statistically significant) tendency to replicate to a lower titre than Dk/Tripura WT and Dk/Tripura 
37 59 205, for which the average titres were approximately 107 PFU/m.  Dk/India M1 59 
showed an advantage in viral replication in the allantoic fluid compared with the triple mutant, 
reaching a similar titre to the WT virus. In the embryo, Dk/India M1 59 replicated to a higher 
titre when compared with the WT and Dk/India M1 37 59 207 viruses.  However, the reciprocal 
effect was not definitively observed with any of the Dk/Tripura M1-mutant viruses, thus 
suggesting this result could be strain-specific. 
 Following assessment of the growth kinetics of Dk/India and Dk/Tripura reassortants 
in embryonated chicken eggs, the next step was to examine the gross and tissue pathology of 
chicken embryos infected with these viruses. For gross pathology, pictures of the embryos 
were taken on the day of harvest and representative pictures of the embryos were chosen. 
Mock-infected embryos showed no obvious signs of haemorrhage, as characterised by the 
pale colour these displayed (Figure 4.2). Embryos inoculated with Dk/India M WT (a spherical 
virus) showed considerable haemorrhage in both head and body. In contrast, Dk/Tripura M 
WT (a filamentous virus) infected embryos showed only subtle signs of bleeding when 
compared to Dk/India M WT. The filament-inducing amino acid change at position 59 in M1 of  
 130 
 
Figure 4.2 Gross pathology of chicken embryos infected with Dk/India or Dk/Tripura WT and 
M1-mutant viruses at 48 h p.i.. Chicken embryos from eggs inoculated (or mock infected) with 
100 PFU of the viruses indicated were harvested at 48h and washed twice in PBS. Embryos 
were placed on a light coloured background before photographing. These are representative 





Dk/India caused more severe pathogenesis which affected embryo integrity, something which 
was not observed with its WT counterpart. However, the converse change in Dk/Tripura did 
not obviously change the overall pathology compared to the matching WT virus. Furthermore, 
embryos infected with the triple mutants of Dk/India or Dk/Tripura showed similarly mild gross 
pathology with only subtle haemorrhages observed in the neck area, even though these M1-
mutant viruses showed opposite budding morphologies. In fact, if anything, the reciprocal 
change of amino acids 37, 59 and 205 of Dk/India decreased viral pathogenicity compared to 
the WT counterpart. However, the Dk/Tripura triple mutant did not increase the pathogenesis 
when compared with the WT counterpart, which would be expected since this virus became 
Dk/India WT-like in vitro (see chapter 3, section 3.2.2). Thus, embryos infected with Dk/India 
M1 37 59 205 showed pathology similar to Dk/Tripura WT-infected embryos, but the reciprocal 
outcome was not observed for Dk/Tripura viruses. 
To better assess the pathogenesis caused by these viruses, six representative 
embryos were chosen from the nine collected over the three independent repeats to be 
sectioned for histopathology. The embryos were fixed in 10% formalin, sectioned and stained 
with haematoxylin and eosin (H&E). Histopathology of mock-infected embryos showed no 
pathogenesis, characterised by no noticeable presence of red blood cells in tissues other than 
the heart. In agreement with the information provided by gross pathology, Dk/India M WT 
infected embryos showed severe haemorrhages throughout the embryo, with emphasis in the 
liver and kidney tissues (Figure 4.3). By contrast, embryos inoculated with Dk/Tripura M WT 
virus showed only subtle haemorrhages, mainly localised to the kidney. Dk/India M1 59 
infected embryos showed haemorrhages spread throughout the body, particularly in the liver 
and kidney tissues, similar to the WT counterpart. In contrast, the alteration of position 59 in 
M1 of Dk/Tripura showed clearly decreased pathogenicity when compared with its WT 
counterpart; a difference which was less obvious in the gross pathology data. Embryos infected 
with the triple mutants of Dk/India or Dk/Tripura showed an overall reduced pathogenesis when 
compared with their WT counterparts. Gross pathology of embryos upon infection with Dk/India 
triple mutant only showed subtle pathology, but the histopathology sections revealed 


































Figure 4.3 Histopathology of chicken embryos infected with Dk/India or Dk/Tripura WT and 
M1-mutant viruses. Embryonated 10-day old chicken eggs were infected (or mock-infected) 
with 100 PFU of the indicated viruses and the embryos were harvested 48 h p.i., fixed in 10% 
formalin before sectioning and staining with haematoxylin and eosin stain (H&E). Sectioning 
and staining was performed by the Pathology Unit at the Royal (Dick) Veterinary School. 
Embryos were randomly selected from the 3 independent experiments performed. The organs 
indicated are heart (H), liver (L), ventriculus (V) and kidney (K).  
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throughout the body. Conversely, embryos infected with Dk/Tripura triple mutant showed very 
little pathogenesis and were generally similar to mock-infected embryos.  
 To quantify the information given by the gross and tissue pathology data, the embryos 
were scored blindly according to the observed pathology. For the purpose of assessing whole 
embryos, a score of 0 was defined as no noticeable levels of pathology in the embryo while 
score of 1 corresponded to the observation of subtle bleeding. Scores 2 and 3 were 
characterised by the presence of considerable bleeding and obvious haemorrhages with loss 
of embryo integrity, respectively. Tissue pathology was performed blindly by Prof Lonneke 
Vervelde. The scoring was as follows: a score of 0 was characterised by the lack of bleeding 
(except in the heart) and infiltration of immune cells to the identified organs, while a score of 3 
was characterised by the presence of severe haemorrhages, infiltration of immune cells and 
disruption of the organ’s structure due to inflammation, Another metric assessed was embryo 
length, to test whether there would be any association with pathogenesis. For this, embryo 
length was measured using ImageJ software from pictures as in figure 4.2 relative to a scale 
bar. As previously observed, mock-infected embryos showed no noticeable haemorrhaging in 
any tissue with the exception of the heart, which translated in scores of 0 for both gross and 
tissue pathology. Embryos inoculated with Dk/India M WT and Dk/India M 59 showed the most 
severe gross pathology, which resulted in average scores > 2 (Figure 4.4 A). However, 
alteration of Dk/India M1 at positions 37, 59 and 205 significantly reduced the severity of 
disease, resulting in a gross pathology score of approximately 1. On the other hand, Dk/Tripura 
infected embryos showed a similar low score (approximately 1) regardless of the mutations 
inserted in the M1 amino acid sequence. Furthermore, scoring of the embryos made it obvious 
that while Dk/India triple mutant adopted a gross pathology similar to Dk/Tripura WT, the 
reciprocal change was not observed following mutation of the Dk/Tripura M1. Regarding the 
histopathology data, Dk/India M WT again displayed the most severe pathological signs, which 
translated into an average score of 2 (Figure 4.4 B). However, neither the single or triple mutant 
gave significantly different scores from the WT virus. Conversely, Dk/Tripura M WT and 




Figure 4.4 Characterisation of chicken embryo pathology following infection with Dk/India or 
Dk/Tripura WT and M1-mutant viruses. (A) Embryo gross pathology scoring of pictures taken 
on the day of harvesting (Figure 4.2) was performed blindly by two independent observers 
using a scale defined as follows: 0 – no bleeding seen on the embryo; 1 – subtle bleeding in the 
embryo; 2 – considerable bleeding in the embryo; 3 – very obvious bleeding in the embryo 
and/or loss of embryo integrity. (B) Tissue pathology scores were taken from the H&E staining 
(Figure 4.3) using a similar scoring system focussing on the degree of haemorrhage seen in 
the tissues. Scoring was performed by Professor Lonneke Vervelde on blinded images. One-
way ANOVA was performed to compare all the viruses against each other. Data represent 
individual embryos and bars the mean +/- SEM (A: n = 12; B: n = 6). * p < 0.05 ** p < 0.01 *** 
p < 0.001 ns not significant (C) Embryo length was measured from a single experiment from 
photographs using ImageJ. Data represent individual embryos and bars the mean +/- SEM (n 
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triple mutant gave an average just below 1, which was significantly different from Dk/India M 
WT even though the viruses had identical M1 sequences and indistinguishable budding 
phenotypes. Regarding embryo size, no differences were observed between the mock-
infected, Dk/India or Dk/Tripura infected embryos, which measured between 4.5 and 5 cm in 
length (Figure 4.4 C), thus excluding any association between viral pathogenesis and embryo 
development. 
Overall, in MDCK, CEF or DEF cells no significant differences were observed in viral 
replication kinetics for either Dk/India or Dk/Tripura WT or M1-mutant viruses. However, in 
ovo, differences in virus replication were observed for Dk/India viruses in both the allantoic 
fluid and the embryo. Additionally, the most severe pathogenesis was observed for Dk/India 
reassortant viruses, as Dk/India M WT (spherical) and M 59 (filamentous) viruses caused 
obvious haemorrhaging in the embryos, whereas the Dk/India triple mutant (Dk/Tripura-like) 
showed a noticeable reduction in damage. A similar pattern of the lowest pathology occurring 
with the triple mutants was observed with Dk/Tripura reassortant viruses, but overall these 
presented more subtle signs of pathogenesis and none of the pathology scores were 
significantly different. In summary, these results showed that alteration of Dk/India budding 
morphology to Dk/Tripura-like caused Dk/India to be less pathogenic. On the other hand, 
alteration of Dk/Tripura budding morphology to Dk/India-like did not significantly change the 
pathogenic nature of Dk/Tripura, thus suggesting that the differences observed could be 
mainly strain-specific instead of budding morphology-specific. 
 
4.2.2. In vitro and in ovo characterisation of Ck/Italy and Dk/Netherlands 
WT and M1-mutant viruses 
To further explore the correlation between budding phenotype and IAV biology, the 
Ck/Italy and Dk/Netherlands sets of PR8-based reassortant viruses were studied. The M1 
genes of these viruses were previously shown to possess single sequence polymorphisms at 
position 234 in M1, which accounted for the different budding morphologies observed (see 
chapter 3, section 3.2.4). Ck/Italy was predominantly spherical while Dk/Netherlands showed 
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a prominent filamentous budding phenotype. Reciprocal change of amino acids at position 234 
in M1 of both strains swapped their budding phenotype. 
To better characterise effect of altered budding phenotypes on the replication of these 
viruses, mammalian and avian cells and embryonated chicken eggs were infected as before 
(section 4.2.1). Firstly, the growth kinetics of these viruses was assessed in MDCK, CEF and 
DEF cells. Cells were infected at a MOI of 0.01 over a period of 48 h and the supernatant was 
collected at various time points for quantification of viral load by plaque assay. In all three cell 
types, Ck/Italy and Dk/Netherlands with WT or M1-mutant viruses replicated similarly (with no 
statistically significant differences) throughout the time courses. In MDCK (Figure 4.5 A), CEF 
(Figure 4.5 B) and DEF (Figure 4.5 C) cells, viral replication peaked at 24 h p.i reaching titres 
of approximately 108 PFU/ml for MDCK and either side of ~ 106 PFU/ml for the avian cells. 
Replication of Ck/Italy and Dk/Netherlands M WT and M1-mutant viruses was also assessed 
in 10-day old embryonated chicken eggs. Allantoic fluid was harvested for titration by plaque 
assay 48h after infection with 100 PFU. Ck/Italy M WT replicated to near 109 PFU/ml whereas 
its M1-mutant counterpart replicated significantly less in the allantoic fluid (Figure 4.5 D). 
Conversely, Dk/Netherlands M WT replicated to an end point titre of approximately 108 
PFU/ml, but its M1-mutant counterpart replicated to significantly higher titres of approx. 109 
PFU/ml. In fact, viral replication in the allantoic fluid was similar between spherical viruses 
(Ck/Italy M WT and Dk/Netherlands M 234), and higher than replication observed with the 
filamentous viruses (Ck/Italy M 234 and Dk/Netherlands M WT). To determine viral replication 
within the embryo, these were collected, macerated and cleared by centrifugation before titre 
determination by plaque assay. In the chicken embryo, there was also a trend for spherical 
viruses (Ck/Italy M WT and Dk/Netherlands M 234) to replicate better than the filamentous 
viruses (Ck/Italy M 234 and Dk/Netherlands M WT) albeit to lower titres (approx. 107 PFU/ml), 
with only the Dk/Netherlands pair reaching statistical significance (Figure 4.5 E). 
Given that the viruses with spherical or filamentous budding phenotypes showed 
differential growth properties in embryonated chicken eggs, the next step was to examine the 













Figure 4.5 Replication of Ck/Italy and Dk/Netherlands strains with WT or mutated M1 genes in 
vitro and in ovo. (A-C) MDCK, CEF and DEF cells were infected with the viruses indicated at 
a MOI of 0.01 for 48 h. Viral load in the supernatant was quantified at the indicated time points 
by plaque assay. Data represent mean +/- SEM (n = 3). (D, E) Embryonated 10-day old chicken 
eggs were infected with 100 PFU of the virus indicated for 48 h. Allantoic fluid and embryos 
were harvested for viral titre determination by plaque assay. Embryo titres were determined 
after maceration and centrifugal clarification. A total of 18 embryos were used, where 9 were 
macerated and the other 9 were used for histology studies. One way ANOVA was performed 
to compare Ck/Italy and Dk/Netherlands WT and M1-mutant viruses. Data represent mean +/- 
























of the embryos taken on the day of harvesting as described before (section 4.2.1). Mock-
infected embryos showed no obvious signs of haemorrhage. Ck/Italy M WT infected embryos 
showed considerable amounts of haemorrhaging throughout the body, unlike embryos 
inoculated with Dk/Netherlands M WT which displayed more subtle haemorrhagic signs 
(Figure 4.6). Ck/Italy WT-infected embryos showed considerably more bleeding than embryos 
infected with the filamentous mutant, which was more similar to Dk/Netherlands WT-infected 
embryos. In contrast, the majority of the embryos infected with the spherical budding M1 234 
mutant of Dk/Netherlands presented considerable amounts of haemorrhage, more similar to 
the normally non-filamentous Ck/Italy M1 WT virus. Looking back at figure 4.5 D, the spherical 
viruses which caused obvious pathology in the embryos also replicated to higher titres in the 
allantoic fluid, suggesting a correlation. 
To better determine the extent of the pathogenesis caused by the pairs of Ck/Italy and 
Dk/Netherlands M1 viruses, tissue histopathology was performed on the chicken embryos 
infected with these viruses as described before (section 4.2.1). As expected, mock-infected 
embryos showed no noticeable signs of bleeding in any of the tissues indicated. 
Histopathology of embryos infected with Ck/Italy and Dk/Netherlands WT or M1-mutant viruses 
revealed no obvious differences within the embryos (Figure 4.7), in contrast to what was 
observed by gross pathology. Thus, in order to get a more quantitative measure of pathology 
signs, the embryos were scored on three metrics: pathology (gross and tissue) and embryo 
length, using the system defined above (see section 4.2.1). Mock-infected embryos showed 
no noticeable signs of pathology, which translated in scores of 0 for both gross and tissue 
categories (Figure 4.8). Embryos inoculated with Ck/Italy M WT and Dk/Netherlands M 234, 
both spherical viruses, showed higher average signs of damage, whereas the filamentous 
Ck/Italy M 234 and Dk/Netherlands M WT viruses presented slightly lower average scores. 
However, the overall differences were subtle, translating into gross pathology scores between 
1 and 2 with no significant differences between groups (Figure 4.8 A). Regarding 
histopathology, the average score for all the viruses was between 0.5 and 1 (Figure 4.8 B), 
regardless of budding morphology or viral strain. Lastly, measuring embryo length also did not 
reveal any association with pathogenesis, with the average body size lying between 4.5 and 5 
cm (Figure 4.8 C).  
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Figure 4.6. Gross pathology of chicken embryos infected with Ck/Italy or Dk/Netherlands 
viruses. Embryos were inoculated with 100 PFU of the viruses indicated, harvested 48 h p.i., 







Figure 4.7 Histopathology of chicken embryos infected with Ck/Italy or Dk/Netherlands viruses. 
Embryonated 10-day old eggs were infected with 100 PFU of the indicated viruses and the 
embryos were harvested 48 h p.i. Embryos were fixed in 10% formalin for a minimum of 24 h 
followed by sectioning and staining with haematoxylin and eosin stain (H&E), performed by 
the Royal (Dick) Veterinary School pathology service. Embryos were randomly selected from 
the 3 independent experiments performed. The organs indicated correspond to heart (H), liver 




































Figure 4.8 Embryo pathology and size following infection with Ck/Italy or Dk/Netherlands WT 
and M1-mutant viruses. (A, B) Gross pathology score was based on photographs taken on the 
day of harvesting (Figure 4.6), while tissue pathology score used H&E stained sections. The 
score was defined as follows: 0 – no bleeding detected; 1 – subtle bleeding in the embryo and 
tissues; 2 – considerable bleeding seen in the embryo and the tissues; 3 – very obvious bleeding 
in the embryo and tissues (loss of embryo integrity). Data represent mean +/- SEM (A: n = 12; 
B: n = 6). (C) Embryo length was measured from photographs taken for (A) using ImageJ. 
Embryos from one repeat were used (as seen in figure 4.6). Data represent mean +/- SEM (n 







A B Histopathology 
Embryo size C 
Gross pathology 
 143 
Overall, in vitro the WT and M1-mutant viruses had similar growth kinetics, regardless 
of budding morphology. However, in the allantoic fluid, spherical viruses (Ck/Italy M WT and 
Dk/Netherlands M 234) showed a replication advantage when compared with filamentous 
viruses (Ck/Italy M 234 and Dk/Netherlands M WT). Furthermore, embryos infected with 
spherical viruses showed subtle pathological signs not present in embryos infected with 
filamentous viruses, however on quantification, these differences were not significant. 
Nonetheless, these results showed that alteration of Ck/Italy budding morphology to 
Dk/Netherlands-like caused Ck/Italy to replicate less in embryonated chicken eggs. 
Conversely, alteration of Dk/Netherlands budding morphology to Ck/Italy-like improved 
Dk/Netherlands replication kinetics in ovo. Therefore, the differences observed suggested an 
association with budding morphology, where spherical viruses clearly showed an advantage 
in embryonated chicken eggs, even though the pathology was similar in embryos infected with 
either spherical or filamentous viruses. 
 
4.2.3. Investigating the spherical and filamentous budding phenotypes 
of Ck/Pakistan strain in vitro and in ovo 
 From statistical and bioinformatic analyses of the M1 sequences of the strains tested 
in this study, it was hypothesised that position 234 was a strong predictor of the budding 
morphologies of chicken and duck strains of IAV. This was corroborated when the amino acid 
identity at position 234 in M1 of Ck/Pakistan was altered. Ck/Pakistan WT virus showed a 
spherical budding phenotype, while its M1-mutant produced prominent filamentous virions. 
This was confirmed in both PR8-based 7:1 reassortant viruses and in the full avian virus 
backbone. These two virus pairs were therefore used as tools to further assess budding 
morphology-dependent differences on virus growth and pathogenicity. 
 The first step was to characterise the effects of the different budding morphologies of 
Ck/Pakistan on virus replication in vitro and in ovo. MDCK and CEF cells were infected with 
Ck/Pakistan WT or M1-mutant viruses at a MOI of 0.01 for 48 h, after which multiple time points 
were collected for viral load quantification by plaque assay. The PR8-based 7:1  
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reassortant viruses with WT or mutated M1 from Ck/Pakistan both reached an average titre of 
108 PFU/ml in MDCK (Figure 4.9 A) and 105 PFU/ml in CEF (Figure 4.9 B) cells. The authentic 
avian Ck/Pakistan WT and M1-mutant viruses replicated to a lesser extent in both MDCK 
(approximately 106 PFU/ml) and CEF (approximately 104 PFU/ml) cells. However, for neither 
cell type nor virus background, did the M1 I234L mutation significantly affect virus replication. 
To determine the effect of the M1 mutation on viral replication in ovo, 10-day old embryonated 
chicken eggs were infected with 100 PFU of the fully avian WT or M1-mutant virus of 
Ck/Pakistan. Allantoic fluid and embryos were collected at 48 h p.i. and processed as 
described before (section 4.2.1) prior to titre determination by plaque assay. Mock-infected 
eggs showed no detectable levels of infectious particles. Both viruses replicated to similar titres 
in the allantoic fluid (approx. 107 PFU/ml) (Figure 4.9 C) and in the embryo, albeit to a lower 
titre in the latter (approx. 106 PFU/ml) (Figure 4.9 D), indicating that in this in vivo system, 
budding morphology did not affect end point titres. 
 The next step was to determine the embryo pathology caused by the Ck/Pakistan 
strains to test whether position 234 altered the in ovo pathogenesis of this avian virus. Pictures 
for gross pathology purposes were obtained as previously described (section 4.2.1). Mock-
infected embryos showed no signs of haemorrhages as characterised by their pale colour, 
while both Ck/Pakistan WT and M1-mutant-infected embryos showed considerable levels of 
bleeding throughout the embryo, with no obvious differences between the two viruses (Figure 
4.10 A). However, given that gross pathology can differ from histopathology as previously 
noted, the embryos collected were sectioned and stained for H&E. Mock-infected embryos 
showed no obvious bleeding in any of the tissues indicated, while Ck/Pakistan WT-infected 
embryos showed noticeable bleeding throughout the body but mainly localised to the liver and 
kidney tissues (Figure 4.10 B). Ck/Pakistan 234-infected embryos also showed obvious 
bleeding in a pattern similar to Ck/Pakistan.  
 To better quantify the pathology caused by the Ck/Pakistan viruses, the infected 
embryos were scored as previously described (section 4.2.1). In agreement with the results in 
figure 4.10, the pathology scores of embryos infected with Ck/Pakistan or its filamentous 
























Figure 4.9 Viral fitness of Ck/Pakistan with WT or mutated M1 in vitro and in ovo. (A, B) MDCK 
and CEF cells were infected with the viruses indicated at an MOI of 0.01 for 48 h. Supernatants 
taken at the time points indicated were titrated by plaque assay. Data represent mean +/- SEM 
(n = 3). (C, D) Embryonated 10-day old chicken eggs were infected with 100 PFU of the viruses 
indicated for 48 h. Allantoic fluid and embryos were harvested for viral titre determination by 
plaque assay. A total of 18 embryos were used, where 9 were macerated and the other 9 were 
used for histology studies. t-tests were performed to compare Ck/Pakistan WT and M1-mutant 
viruses. Data represent mean +/- SEM (C: n = 18; D: n = 9). Spherical viruses are represented 
by circles and filamentous viruses by crosses. The 7:1 reassortant viruses are represented in 



















Figure 4.10 Chicken embryo pathology following infection with Ck/Pakistan WT or M1-mutant 
viruses. 10-old embryonated chicken eggs were inoculated with 100 PFU of the avian strain 
Ck/Pakistan or its M1-mutant for 48 h. (A) Embryos were collected, placed in a petri dish and 
washed twice in PBS. Gross pathology pictures were taken on the day of harvesting. (B) Half 
of the embryos were fixed in 10% formalin and sectioned for H&E staining, performed at the 
Royal (Dick) Veterinary School Pathology Unit. The organs indicated are: heart (H), liver (L), 

































pathology (score of approx. 1.5) (Figure 4.11 A, B). Furthermore, embryo length was also 
unaffected, with no significant differences detected (Figure 4.11 C). Thus, as seen previously 
with the other IAV strains, budding morphology did not significantly affect gross or tissue 
pathology or embryo development. 
As a further test of the relative pathogenicity of the Ck/Pakistan virus pair, chicken 
embryo viability was determined upon infection with titrated doses of the spherical or 
filamentous strains. Embryonated 10-day old chicken eggs were infected with 10-fold dilutions 
from 10 PFU down to 0.001 PFU of the viruses for a period of up to 96 h. To determine embryo 
viability, eggs were candled every 12 h for a period of at least 60 seconds to detect embryo 
movement, which was recorded as 0 if present or 1 if absent. In addition, following embryo 
death or at the end of the experiment, allantoic fluid samples were taken and tested for virus 
by HA assay. By this measure, all eggs within the infected groups were productively infected 
with the exception of a single egg inoculated with 10 PFU of Ck/Pakistan M1 I234L (data not 
shown). This latter egg was discarded from the survival analysis. Of the successfully infected 
eggs, those infected with 10 PFU of Ck/Pakistan WT were no longer viable after 72 h, while 
after infection with 1 PFU or 0.1 PFU, there were embryos viable until 84 h p.i. but no later. 
(Figure 4.12 A). At 0.01 PFU, the majority of infected embryos remained viable and no 
casualties were recorded with 0.001 PFU or mock-infected embryos. From these data, the 
virus dose responsible for killing 50% of embryos (LD50) of Ck/Pakistan WT was calculated as 
0.16 PFU. With Ck/Pakistan M1 I234L, none of the embryos were viable 72 h after infection 
with 10 PFU, but 20-40% lasted until 96 h after inoculation with either 1 PFU or 0.1 PFU (Figure 
4.12 B), similar to the WT counterpart. At 0.01 PFU, the majority of the infected embryos 
remained viable and no deaths were recorded with 0.001 PFU or mock-infected embryos. 
Overall, Ck/Pakistan 234 had a LD50 of 0.18 PFU.  
Overall, these data showed that two almost identical avian strains of IAV, differing only 
at position 234 of M1 with either spherical or filamentous budding phenotypes did not behave 
differently in vitro or in ovo; i.e., viral replication and pathogenesis was indistinguishable for 
the spherical Ck/Pakistan and its M1 filamentous mutant regardless of host system tested.  
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Figure 4.11 Embryo pathology following infection with Ck/Pakistan viruses. (A, B) Gross 
pathology score was based on photographs taken on the day of harvesting (figure 4.10), while 
tissue pathology scores focused on the H&E staining shown in figure 4.10. Scores were 
defined as follows: 0 – no bleeding detected; 1 – subtle bleeding in the embryo and tissues; 2 – 
considerable bleeding seen in the embryo and the tissues; 3 – very obvious bleeding in the 
embryo and tissues and/or loss of embryo integrity. Data represent mean +/- SEM (A: n = 18; 
B: n = 12). (C) Embryo length was measured from photographs (as seen in figure 4.10) using 
ImageJ. Data represent mean +/- SEM (n = 18). Circles represent spherical and crosses 
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Figure 4.12 Embryo viability upon infection with Ck/Pakistan viruses. Embryonated 10-day old 
chicken eggs were infected with the indicated doses of Ck/Pakistan WT (A) or M1-mutant virus 
(B) and incubated for up to 96 h. Eggs were candled every 12 h and embryo viability 











 The main focus of this section of the study was to characterise in vitro and in ovo the 
WT and M1-mutant viruses built in chapter 3 that showed opposite budding morphologies. 
Overall, these data showed that spherical and filamentous viruses behaved similarly in vitro, 
regardless of the host system (MDCK, CEF or DEF cells). On the other hand, significant 
differences were detected in ovo between spherical and filamentous viruses but not for all the 
viruses tested. Regarding chicken embryo pathology, it was noted that alteration of budding 
morphology did not significantly affect pathogenesis of most strains, with the exception of the 
Dk/India reassortant virus. However, embryo viability decreased sooner for a spherical chicken 
virus than for the same strain with a filamentous budding morphology. 
 Dk/India and Dk/Tripura strains differed in M1 at position 37, 59 and 205 and while 
position 59 was the sole determinant of budding morphology between the two strains, the 
closest exchange of budding phenotype only happened when all the three positions were 
reciprocally replaced. Dk/India and Dk/Tripura viruses with WT M1s, M1 59 or M1 37, 59 and 
205 mutations replicated similarly regardless of cell origin (Figure 4.1), despite their 
differences in budding morphology. Similar replication in vitro was also observed with Ck/Italy 
and Dk/Netherlands WT or M1-mutants (Figure 4.5) and the Ck/Pakistan WT or M1-mutant 
viruses in either the avian or PR8 backbones (Figure 4.9). These observations were in contrast 
with recent studies, which showed that filamentous avian strains adopt a mainly spherical 
budding phenotype in CEF cells, resulting in a fitness advantage in these cells when compared 
with DEF cells. However, this was not the case here for the PR8-based 7:1 reassortant viruses 
with the M genes of Dk/India, Dk/Tripura, Ck/Italy, Dk/Netherlands or Ck/Pakistan, as in both 
CEF and DEF cells these strains maintained their corresponding budding morphologies 
(Figures 2.12 A, B). One difference that could account for the different observations between 
the published studies and this study was the virus background, as the published studies used 
an avian virus genetic background while here many of the viruses were built as 7:1 
reassortants in a PR8 backbone with only segment 7 of the avian strain. However, as 
previously shown in chapter 2, section 2.2.2 and in chapter 3, section 3.3, segment 7 was the 
major morphology determinant in a PR8 backbone. Furthermore, several studies on 
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mammalian strains have also shown that segment 7 is the predominant regulator of budding 
morphology (Bialas et al., 2012; Bourmakina & Garcia-Sastre, 2003; Elleman & Barclay, 2004; 
Elton et al., 2013 Gomez-Puertas et al., 2000; Roberts et al., 1998), therefore suggesting that 
the differences observed with the published studies could be more strain-specific than budding 
morphology- or virus backbone-specific.  
 Regarding in ovo viral replication, it was observed that the 7:1 reassortant virus of 
Dk/India with M1 59 replicated to a higher titre than the triple mutant (M1 37 59 205) in the 
allantoic cavity (Figure 4.1 D), which was unexpected as both viruses shared a filamentous 
budding morphology. However, in the case of Ck/Italy and Dk/Netherlands, the spherical 
viruses (Ck/Italy M1 WT and Dk/Netherlands M1 234) showed a clear replication advantage in 
the allantoic cavity when compared with the filamentous viruses (Ck/Italy M1 234 and 
Dk/Netherlands M1 WT) (Figure 4.5 C). The latter example is consistent with previous studies 
which showed that serial passage of filamentous viruses in embryonated chicken eggs 
resulted in the loss of the filamentous phenotype and predominance of the spherical virion 
morphology instead (Kilbourne & Murphy, 1960; Seladi-Schulman et al., 2013), which may 
explain the presence of filaments almost exclusively in clinical isolates or low-passage isolates 
of mammalian strains of IAV (Choppin & Tamm, 1960; Chu et al., 1949; Nakajima et al., 2010). 
 Following assessment of viral replication kinetics of spherical and filamentous viruses, 
the next step was to determine if these morphologies affected pathogenesis in the chicken 
embryo model. Dk/India M1 WT and M1 59 infected embryos showed severe gross pathology 
as the embryos were poorly developed with dilated blood-vessels throughout the body, more 
remarkably so for Dk/India M1 59 which drastically affected embryo integrity (Figure 4.2). 
Histopathology of these embryos revealed that the liver and kidney tissues were the most 
affected with an obvious accumulation of blood cells not seen with mock-infected embryos 
(Figure 4.3). This pattern was in agreement with previous reports on the pathology of chicken 
embryos infected with a LPAI avian IAV strain (H1N1), which showed that the most severely 
affected tissues were lung, liver and kidney characterised by the accumulation of blood and 
disruption of the organ’s structure (Westwood, 1952). Furthermore, development of renal 
disease in chickens infected with avian influenza has also been reported in infected chickens 
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under laboratory conditions (Swayne & Alexander, 1994; Swayne et al., 1994) and in the field 
(Halvorson et al., 1979; Johnson & Maxfield, 1976). In this study, the above mentioned 
pathological signs of IAV infection were only observed with Dk/India WT or M1-mutant viruses 
and it was independent of budding morphology as Dk/India M1 WT and M1 59 viruses showed 
opposite budding phenotypes but similar gross and tissue pathology (Figure 4.4 A and figure 
4.4 B). For Dk/Tripura, Ck/Italy, Dk/Netherlands and Ck/Pakistan chicken embryo pathology 
was similar regardless of budding phenotype (Figure 4.4, figure 4.8 and figure 4.11). 
Therefore, it is possible that Dk/India is just a naturally more virulent strain in chicken embryos 
when compared with the other strains. In fact, it is known that Dk/India strain is more 
pathogenic to ducks than Dk/Tripura strain (Kumar et al., 2017). Therefore, these data suggest 
that spherical or filamentous budding morphology does not alter the pathogenicity of the 
original parental strain, and tentatively proposes that filaments might not play a role in 
pathogenesis, at least in ovo. 
 So far all the viruses characterised have been in a PR8 backbone where the M1 
mutations responsible for alteration of budding morphology were identified by pairwise 
alignment of closely related avian strains. On the other hand, the Ck/Pakistan strain was 
selected to test the hypothesis whether position 234 of M1 could be a morphology determinant 
within chicken and duck strains of IAV (see chapter 3, sections 3.2.5 and 3.2.6). Ck/Pakistan 
WT and M1-mutant virus were built in the avian genetic background of Ck/Pakistan, thus 
providing the perfect tool to test the significance of spherical and filamentous budding 
morphologies in vitro and in ovo without the interference of a mismatched genetic background. 
As previously discussed, Ck/Pakistan WT and M1-mutant virus showed no significant 
differences in replication kinetics in either MDCK or CEF cells or embryonated chicken eggs 
(Figure 4.9), thus suggesting that filamentous morphology does not deleteriously affect viral 
fitness of Ck/Pakistan in vitro (beyond an effect on plaque size) nor in ovo, which is not in 
agreement with published studies even with other H9N2 avian strains (Pu et al., 2017). 
Moreover, embryos infected with Ck/Pakistan WT (spherical) or its M1 filamentous mutant 
showed similar gross and tissue pathology (Figure 4.11), displaying the characteristic 
haemorrhages throughout the body and accumulation of blood cells in the liver and kidney 
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tissues, as seen with other avian chicken viruses (Westwood, 1952). These observations 
further support the idea that pathogenesis in ovo is not dependent on budding morphology. 
Furthermore, embryo viability was also tested with the WT and M1-mutant virus of Ck/Pakistan 
strain. Ck/Pakistan WT decreased embryo viability 12 h earlier than Ck/Pakistan 234, but at 
48 h p.i both viruses reached similar embryo mortality levels (Figure 4.12). This was 
unexpected as all the characterisation previously done showed that both viruses behaved 
similarly in vitro and in ovo regardless of budding morphology. Therefore, these data perhaps 
suggest that spherical viruses deposited in the allantoic fluid could cross the amniotic 
membrane and reach the embryo faster than the filamentous counterpart, which is in 
agreement with spherical viruses having a fitness advantage in embryonated chicken eggs 
(Seladi-Schulman et al., 2013). Another explanation could be that the filaments never reach 
the embryo and the population of spherical particles still produced by Ck/Pakistan 234 (over 
40% of infected cells do not produce filaments, figure 3.15 A) just take longer to accumulate 
and cause embryo mortality. However, it remains unknown whether filaments are able or not 
of crossing the amniotic membrane. 
Overall, this section of the study mainly showed that alteration of the budding 
phenotype did not drastically alter the viral fitness of the parental strain in vitro or in ovo, 
suggesting that filaments may not play a role in pathogenesis. On the other, in an avian 
background, embryo viability decreased faster for a spherical chicken strain than for its 
filamentous derivative, hinting that there could be impairment in the transmission of the 
filaments within the chicken egg. However, looking back at figure 2.3 (chapter 2), some avian 
isolates produced filaments and characterisation of avian segment 7s showed that the majority 
promoted the formation of filaments; therefore there must be a positive selection for the 
filamentous budding phenotype in vivo, as seen with mammalian strains (Seladi-Schulman et 
al., 2013). Yet, the biological function of filaments remained unclear, which will be addressed 
in chapter 5 by using the avian strain Ck/Pakistan and its M1 filamentous mutant in a chicken 
challenge and transmission model. 
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Chapter 5: In vivo studies with spherical and filamentous 
forms of an avian strain of IAV 
5.1. Introduction and aims 
As shown in chapter 2, avian strains of IAV are as pleomorphic as mammalian strains 
and some can produce filamentous bundles up to 10 µm in length. Next, it was shown that the 
M1 “filamentous signatures” previously identified in mammalian strains of IAV do not apply to 
avian strains, where instead, amino acid identity at position 234 was demonstrated to be a 
major budding morphology determinant. However, for both mammalian and avian strains of 
IAV it remains unclear what is the biological function of these filamentous structures.  
As previously discussed in chapter 1, spherical virions are commonly found in 
laboratory-adapted mammalian strains of IAV that have been serially passaged in eggs and/or 
cells. On the other hand, filamentous structures are often present in low-passage viruses, as 
seen by observation of clinical isolates of human and veterinary origin. Furthermore, Seladi-
Schulman et al. showed that the filamentous phenotype was selected in vivo following passage 
of a spherical virus in guinea pigs, but it was mainly lost when passaged in chicken eggs or 
MDCK cells (Seladi-Schulman et al., 2013). Several studies have suggested that the 
advantage of the filamentous phenotype in vivo is associated with an increased 
transmissibility. For instance, Campbell et al. reported that a H1N1 2009 pandemic strain 
transmitted efficiently in guinea pigs and introduction of the M segment of this strain into PR8 
resulted in a virus with a filamentous budding morphology and also increased transmissibility 
in guinea pigs, unlike PR8 WT which did not transmit (Campbell et al., 2014). Similarly, Ma et 
al. showed that insertion of the NA and M segments of pandemic 2009 strains in the backbone 
of a poorly transmissible swine influenza virus (SIV) significantly increased virus replication 
and transmission in pigs (Ma et al., 2012). Lakdawala et al. also showed that the M segment 
of the pandemic 2009 strains conferred a filamentous budding phenotype and increased the 
transmissibility of non-pandemic strains in the ferret model (Lakdawala et al., 2011). Therefore, 
these studies showed that filamentous mammalian strains of IAV have an increased 
 156 
transmissibility in animal models, yet it remains unknown whether this is also the case for avian 
strains of IAV. However, it is known that both morphologies are present in natural influenza 
infections; therefore these budding morphologies could play different roles in vivo in order to 
ensure viral fitness. 
As described in chapter 3, the avian strain Ck/Pakistan was built with or without a 
single sequence alteration at position 234 of M1, which resulted in a virus pair where it was 
possible to control its budding morphology. Therefore, the aim of this part of the study was to 
use this pair of viruses in vivo to interrogate the biological significance of filaments produced 
by an avian strain of IAV. 
 
5.2. Results 
5.2.1. Shedding profiles of chickens infected with spherical or 
filamentous Ck/Pakistan viruses 
In vivo studies were designed to assess transmission and pathogenicity differences 
between the spherical WT Ck/Pakistan avian strain and its filamentous mutant (M1 I234L). A 
group of 10 Rhode Island Red chickens were infected nasally with 105 PFU of the spherical 
WT or the filamentous mutant of Ck/Pakistan, while a group of 9 chickens were mock-infected 
with PBS at day 0. To study the transmissibility of the viruses, two further groups of birds were 
added at days 1 and 5 p.i., designated contact group 1 and contact group 2, respectively 
(Figure 5.1). All birds were swabbed daily (excepting days 0 and 12) from day -1 for buccal 
and cloacal shedding, as it is known that IAV can be shed in both the faeces and respiratory 
secretions of infected birds in the field (Spickler et al., 2008). On day 12 p.i., birds were not 
swabbed as contact group 2 mutant-infected birds had to be culled because these displayed 
severe clinical symptoms. To evaluate the ability of spherical and filamentous viruses to spread 
within the host, several tissues representing the respiratory and gastrointestinal tracts were 




Figure 5.1 Schematic representation of the in vivo studies with spherical and filamentous forms of Ck/Pakistan avian strain. 3-week old Rhode Island 
Red chickens were mock-infected (PBS) (9 birds) or infected with the indicated amount of either virus (100 µl) via the nasal cavity (10 birds per virus 
group). At day 1 p.i., 8 birds were added to each group (contact group 1). At days 3 and 4 p.i. tissues were collected from directly infected birds and 
contact group 1 birds. At day 5 p.i. the second contact groups (6 birds) were added. All birds of contact group 2 infected with the filamentous mutant 
were humanely culled at day 12 p.i.. At day 13 p.i, all remaining birds were humanely culled and sera and tissues collected. Birds were swabbed daily 
for buccal and cloacal shedding of virus (except at days 0 and 12 p.i.). 
 
birds, day 4 p.i. for contact group 1 and day 13 (study end) for the remaining animals. The 
swabs collected daily were titrated by plaque assay in monolayers of MDCK cells under 
agarose overlay. Mock-infected birds showed no detectable levels of infectious virus (< 4 
PFU/ml). The directly infected birds (added at day 0) with either the spherical WT or the 
filamentous mutant of Ck/Pakistan showed no significant differences in the buccal shedding 
profile, reaching maximum titres of approximately 104 PFU/ml at day 3 p.i. and dropping below 
detectable levels at day 5 p.i. for the WT virus and day 6 p.i. for the filamentous mutant (Figure 
5.2 A). By contrast, infectious virus in the cloaca was detected more irregularly and only up 
until day 3 p.i. for both WT and mutant Ck/Pakistan. The birds introduced at days 1 or 5 p.i. 
became infected with either WT or mutant virus. Contact group 1 birds infected with the 
spherical WT virus shed peak titres of approximately 104 PFU/ml from the buccal cavity from 
day 2 until day 4 p.i., then titres dropped sharply on day 5 and levels of virus were undetectable 
by day 6 p.i. (Figure 5.2 B). Contact-infected birds with the filamentous mutant (Ck/Pakistan M 
234) reached similar peak titres in the buccal cavity to WT-infected birds over days 2-4 p.i., but 
the mutant-infected birds at day 5 p.i shed significantly more (> 10-fold) virus than birds 
infected with the WT virus. Contact-infected birds still showed sporadic cloacal shedding, 
although one WT-infected bird shed virus on two consecutive days. Nonetheless, for both 
groups of birds, cloacal shedding was detected from day 3 to day 4 p.i, corresponding with the 
peak viremic period detected in the buccal cavity. Lastly, contact group 2 birds (added at day 
5 p.i.) infected with the spherical WT virus shed relatively high amounts of virus (103 – 104 
PFU/ml) from the buccal cavity from day 6 to 9 p.i., with the peak amounts detected at day 8 
p.i. (Figure 5.2 C). However, the group 2 contact birds infected with the filamentous mutant 
virus shed approximately 103 - 104 PFU/ml of virus from day 6 to 10, reaching a peak at day 9 
p.i.. Significantly, birds infected with the filamentous mutant virus were shedding almost 100-
fold more virus at day 10 p.i. than birds infected with the spherical WT virus. In addition, cloacal 
shedding was only detected from contact group 2 birds infected with the filamentous mutant, 
between days 7 to 10 p.i. with some birds shedding over 2 or 3 consecutive days. Overall, 
these data showed that there were no detectable differences in buccal shedding between WT- 
and mutant-infected birds within the direclty-infected groups. In contrast, contact-infected birds 






A                                           Directly infected birds 
B                                             Contact group 1 
C                                               Contact group 2 
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Figure 5.2 Shedding profiles of Ck/Pakistan WT and M1-mutant viruses. Chickens either 
directly infected with WT or mutant virus of Ck/Pakistan (A), or from contact groups 1 (A) added 
at day 1 p.i. and contact groups 2 (C) added at day 5 p.i. were swabbed daily from buccal and 
cloacal cavities. Contact group 2 birds infected with mutant virus (orange) were culled at day 
10 p.i.. Swabs were placed in virus transport media and titrated by plaque assay in MDCK 
cells. Data from birds infected with the spherical WT is represented with blue circles while that 
of the filamentous mutant virus is depicted with orange crosses. Data points in the buccal 
shedding graphs represent mean ± SEM of all the birds swabbed (n = 48) while only positive 
samples from cloacal swabs are shown. Data points connected in cloacal shedding graphs 
indicate consecutive positive samples from the same bird. One-way ANOVA and non-
parametric Mann-Whitney tests were performed to compare WT- and mutant-infected birds 
throughout the course of the experiment (see chapter 7, section 7.2.8); ** p < 0.01, * p < 0.05. 



















Ck/Pakistan generally showed higher buccal shedding of virus than WT-infected contact birds. 
Therefore, these data suggest that the spherical WT and filamentous mutant virus were able 
to transmit to naïve birds introduced at days 1 and 5 p.i., however mutant-infected birds shed 
generally more virus than WT-infected birds and for longer periods of time. 
 Ck/Pakistan WT is a LPAI H9N2 virus endemic across Asia, Middle East and North 
Africa that usually affects growth rate and egg production (Spickler et al., 2008). However, it 
has been reported that some field strains of Ck/Pakistan-like viruses seemingly display an 
HPAI phenotype and can cause up to 50% mortality; something which has also been observed 
in the laboratory (Zhang et al., 2014). Therefore, to determine whether the spherical WT or 
filamentous mutant of Ck/Pakistan showed differences in lethality, the clinical signs of infected 
chickens during the study period were considered. Observational data throughout the 
experiment revealed that birds infected with the spherical WT virus presented ruffling of 
feathers, snicking and the birds tended to group together, but no mortality was seen, thus 
corresponding to 100% survival from day 0 to 13 p.i, within directly-infected, contact 1 and 
contact 2 groups (Table 5.1). Birds directly infected with the filamentous mutant showed similar 
symptoms to WT-infected birds with 100% survival, however, contact group 1 showed a slightly 
exacerbation of the symptoms previously described with more anti-social behaviours observed 
up until day 9 p.i., but still 100% survival. By contrast, contact group 2 birds infected with the 
filamentous mutant were severely affected by respiratory distress, diarrhoea, depression, 
reduced activity and loss of appetite, and 2/6 birds were humanely culled at day 10 p.i. and the 
other 4 birds had to be culled at day 11 p.i.. As mentioned, up to 50% mortality was observed 
previously with WT Ck/Pakistan avian strain, however that was not the case presented here. 
The WT-infected birds survived throughout the experiment displaying only minor symptoms, 
while the mutant-infected birds showed exacerbated symptoms with the highest mortality in 
the contact group 2, corresponding to the group where the shedding profile was more 





Table 5.1 Symptoms and survival rate of birds infected with the spherical WT or the 








Virus Group Symptoms observed Fatalities 
Live birds at the 









Ruffled feathers, snicking 
and huddle together 
0 3 100 
Contact 
group 1 
Ruffling of feathers, 
snicking and huddle 
together 
0 4 100 
Contact 
group 2 
Ruffling of feathers, 
snicking and huddle 
together 





Ruffling of feathers, 
snicking and huddle 
together 
0 6 100 
Contact 
group 1 
Ruffling of feathers and 
snicking and huddle 
together 
0 4 100 
Contact 
group 2 
Ruffling of feathers, 
snicking, diarrhoea, 
respiratory distress, 
depression and isolation 
behaviour. 
2 (day 10 







5.2.2. Environmental sampling 
 In order to examine the environmental contamination with virus from the infected birds, 
water and food samples were collected daily over the course of the experiment and titrated by 
plaque assay. Water and food samples collected from the housing of mock-infected birds were 
negative for infectious virus, to a detection limit of 4 PFU (data not shown). Food samples 
collected from the isolators housing spherical WT- or filamentous mutant-infected birds also 
showed no detectable levels of infectious particles throughout the course of the experiment 
(Figure 5.3 A). However, the isolator with WT-infected birds showed water contamination with 
virus from days 1 to 3 p.i. and at days 7 and 8 p.i., with a peak titre of 103 PFU/ml detected at 
day 1 p.i. which decreased to 10 PFU/ml at later times p.i. (Figure 5.3 B), correlating with the 
days where buccal shedding was the highest. By contrast, AIV was detected in the water of 
the isolator containing the mutant-infected birds at days 2 to 5 p.i. and days 7 to 9 p.i., in both 
instances with an average peak titre of 102 PFU/ml. Therefore, the filamentous mutant virus 
was present in the environment for longer period of time than the spherical WT virus, which 
could be a direct result of the prolonged buccal shedding observed with the mutant-infected 
birds. 
 
5.2.3. Spherical and filamentous virus spread within the host and 
histopathology of respiratory tissues 
Since birds infected with the filamentous-mutant virus showed significantly increased 
viral shedding over a longer period of time, the next step was to examine whether spread within 
the host differed between the two viruses. For this, tissues representative of the respiratory 
and gastrointestinal tracts were collected at day 3 p.i. from directly infected and contact group 
1-infected birds, homogenised and titrated by plaque assay for the detection of infectious virus. 
As expected, mock-infected birds showed no detectable levels of infectious virus (< 4 PFU/ml 
in 50 mg of tissue) nor viral genome (< 10 copies/30 mg tissue) (data not shown). In the nasal 






















Figure 5.3 Environmental sampling of isolator units containing the infected chickens. Following 
daily collection (except at day 12) of 1 g of food (A) and 1 ml of water (B), these samples were 
processed and titrated by plaque assay (see chapter 7, section 7.2.6.6). The detection limit of 











reached similar titres of between 104 and 105 PFU/ml. By contrast, in the tracheal tissue, the 
filamentous mutant replicated significantly more than the spherical WT virus, by almost 100-
fold (Figure 5.4 A). Infectious virus was detected sporadically in all other respiratory and 
gastrointestinal tissues, but at generally low titres (mostly < 100 PFU/ml in a single animal) 
with no significant differences between the spherical WT and the filamentous mutant. 
However, the WT virus was detected in the brain at approximately 103 PFU/ml in four birds 
while the filamentous mutant was only detected in the brain of one bird, at 10 PFU/ml. RNA 
samples extracted from the same tissues were examined by qRT-PCR to quantify the 
presence of viral genome (measured by the amount of M segment) present in each of the 
organs tested. Within the respiratory and gastrointestinal tissues, no significant differences 
were detected in the amounts of viral genome from WT or mutant virus in any of the tissues 
analysed. Nonetheless, higher amounts of M segment were detected in the nasal and tracheal 
tissues, correlating with the higher amounts of infectious virus present in these samples 
(Figure 5.4 B). Overall, these data showed that both morphologies of the virus were detected 
within the host in the same respiratory and gastrointestinal organs, mostly in similar quantities, 
thus suggesting that Ck/Pakistan virus spread within the host was morphology-independent. 
However, in the tracheal tissues the filamentous mutant virus produced a higher number of 
infectious virions when compared with the spherical WT, suggesting a fitness advantage of the 
filamentous mutant in this tissue. 
Given that both morphologies of Ck/Pakistan virus spread within the host to similar 
extents, the next step was to determine whether pathology signs associated with infection were 
strain-dependent. The tissues which were the main focus of this section were from the upper 
and lower respiratory tract, as it is well established that IAV in domestic poultry mainly 
replicates in these locations (discussed in chapter 1). Thus, tracheal and lung tissues of 
directly infected and contact group 1 birds harvested at day 3 p.i. were sectioned and H&E 
stained. Mock-infected trachea showed no signs of lesions, characterised by the presence of 
an organised structure of ciliated epithelial cells and goblet cells with an intact lamina propria 
underneath and normal size capillaries (see chapter 1, figure 1.7). Trachea from WT-infected 








Figure 5.4 Detection of infectious virus and viral genome in tissues of chickens infected with 
WT or M1-mutant Ck/Pakistan viruses. The indicated tissues were extracted at day 3 p.i. of 
directly infected birds or contact-infected birds and titrated by plaque assay for the detection 
of infectious virus (A) or RNA extracted and quantified by RT-qPCR for the presence of viral M 
segment (B). Directly infected birds are represented in a darker colour while contact birds are 
represented in a lighter shade. Blue circles represented birds infected with the spherical WT 
virus while orange crosses represent filamentous mutant-infected birds. (A) 50 mg of each 
tissue was used for the detection of infectious virus. (B) Total RNA was extracted from 30 mg 
of tissue and used for the detection of M segment in the indicated tissue. Non-parametric 
Mann-Whitney tests were performed to compare WT and mutant for each tissue. Data 





















goblet cells and considerate loss of cilia in some occasions. Furthermore, leakage of blood 
cells and/or infiltration of immune cells into the lamina propria was also observed, disrupting 
its structure (Figure 5.5). Comparison of the tracheal tissues between WT and mutant-infected 
birds did not reveal obvious differences in pathology, suggesting that the damage observed 
was a result of IAV infection rather than virus budding morphology-dependent. Looking at the 
lung tissue, mock-infected birds showed no signs of disease, characterised by the lack of 
haemorrhages or infiltration of immune cells into the area within or surrounding the 
bronchioles. By contrast, WT- or mutant virus-infected birds displayed moderate 
haemorrhages in the lung with severe congestion around and, in some instances, within the 
bronchioles with red blood cells and/or immune cells. Yet once again, there were no obvious 
differences between the two virus strains. Therefore, these data suggested that the pathology 
signs presented in the tracheal and lung tissues were the result of IAV infection, regardless of 
virion morphology.  
 
 
5.3. Discussion  
The aim of this part of the study was to determine the biological function of filamentous 
forms of IAV in vivo using the Ck/Pakistan avian strain. The filamentous mutant of Ck/Pakistan 
was designed and built in chapter 3 based on bioinformatics and statistical analyses. Since 
this virus presented a virion morphology able to be controlled via one single amino acid 
mutation (I234L) in M1, it provided an appropriate tool to test the biological function of filaments 
in vivo. Therefore, Ck/Pakistan viruses with spherical or filamentous budding morphologies 
were used to infect chickens and contact groups were added to test for differences in 
transmission between the two forms. Directly infected birds with the spherical or filamentous 
virus showed no significant differences, however contact-infected birds shed the filamentous 
mutant virus at higher titres and for longer periods of time than WT contact-infected birds 
(Figure 5.2). Remarkably, contact birds added at day 5 p.i. showed more pronounced buccal 











































































Figure 5.5 Representative histopathology of tracheal and lung tissues infected with the 
spherical WT or filamentous mutant of Ck/Pakistan. Tracheal (A) and lung (B) tissues were 
harvested at day 3 p.i. from 3 or 4 directly infected birds and 4 contact group 1 birds infected 
with WT or mutant virus. Tissues were fixed in 10% formalin and prepared for H&E staining by 
the histopathology team at the Pathology unit of the Royal (Dick) Veterinary School (University 
of Edinburgh). Slides were scanned using the Nanozoomer at 20X magnification and 
visualised with the NDP software. Represented are the H&E sections from 2 directly infected 




suggesting that the filamentous mutant of Ck/Pakistan was transmitted more efficiently than 
the spherical WT virus. This agrees with previous reports for filamentous mammalian strains. 
Lakdawala et al. reported that ferrets infected with a filamentous human strain released 
respiratory droplets more consistently than WT-infected ferrets, therefore resulting in an 
enhanced transmissibility of the filamentous virus between ferrets (Lakdawala et al., 2011). 
More recently, Campbell et al also showed that insertion of the viral glycoproteins and the M 
segment of a filamentous human strain into the poorly transmissible PR8 strain increased its 
transmissibility in guinea pigs (Campbell et al., 2014).  
Regarding pathogenicity, filamentous virus-infected chickens dropped to 
approximately 40% survival rate by the end of the experiment (Table 5.1). It has been reported 
that infections with WT Ck/Pakistan can reach a mortality rate of 50%, however in this 
experiment, the mortality rate of WT was 0% while the filamentous mutant was 60%. This 
raises the question whether this increased mortality rate was a result of virion morphology. 
However, as shown in chapter 4, the death rate of the filamentous form of Ck/Pakistan in ovo 
was 12 h delayed in comparison with WT-infected eggs. Therefore, the high mortality rate 
observed with the filamentous mutant in hatched birds was unexpected; to further address this 
problem whole virus deep sequencing and analysis of the cytokine response would be needed 
to compare WT and mutant-infected chickens but there was not enough time to perform this.  
Environmental sampling of the isolator units with WT or mutant-infected chickens 
showed that the filamentous virus persisted for longer periods of time in the water and to higher 
titres than the WT virus (Figure 5.4). This could either correlate with the fact that filamentous 
mutant-infected chickens were also shedding more virus via the buccal cavity than WT-
infected birds, or that the filamentous form of Ck/Pakistan is more stable in water than the 
spherical WT counterpart. It was shown by Lowen et al. that a human strain of IAV transmitted 
better in guinea pigs exposed to lower temperatures and relative humidity levels lower than 
50% (Lowen et al., 2007). Outside these parameters, virus particles tended to be less stable; 
therefore it is possible that the filamentous mutant virus is more stable at temperatures 
between 22 – 25°C with high relative humidity (50% - 80%) (the conditions of the isolator units). 
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Stability assays would be the next step to address this question but there was insufficient time 
to finalise these. 
Infectious spherical or filamentous forms of Ck/Pakistan were detected in all the 
tissues of directly-infected or contact group 1 birds, with the exception of the kidney, for which 
only viral genome was detected. Thus these data showed that both viruses spread similarly 
within the host (Figure 5.5). Of importance, the main difference was observed in the respiratory 
tissues. Although spherical and filamentous forms of Ck/Pakistan replicated similarly in the 
nasal tissue, in the tracheal tissue the filamentous form replicated to a higher titre than the 
spherical WT virus. The trachea is composed of a mucous layer that overlays the respiratory 
epithelium, which is coated by a less viscous layer of about 7 µm in depth with the epithelial 
cells underneath (see chapter 1, section 1.7.1 and figure 1.7). Therefore, Roberts and 
Compans hypothesised that a filamentous virus that can be up to 30 µm in length would have 
an advantage when crossing this barrier in comparison to spherical particles of ~ 100 nm in 
diameter (Roberts & Compans, 1998). The data described here corroborates the hypothesis 
that filamentous viruses show a fitness advantage when crossing the mucus barrier of the 
trachea. For instance, a filamentous virus could more readily cross the mucous barrier and 
reach the epithelial cells where it replicates and its elongated form might also enhance release 
from the surrounding mucous barrier, allowing virus release into the upper mucous layer and 
into the lumen of the trachea. Furthermore, Sakai et al. recently showed that filamentous ICV 
particles showed movement in one direction on a sugar-coated surface in contrast with the 
random movement of spherical IAV particles (Sakai et al., 2018). Therefore, this property of 
filamentous particles could facilitate virus travel within the respiratory mucosa to more readily 
reach the epithelial cells. 
Lastly, we also wanted to test whether viral pathogenesis was virion morphology-
dependent, thus tissues were collected at day 3 p.i. and the respiratory tissues were analysed. 
Similarly to what was observed in chapter 4, the mild clinical manifestations detected in these 
tissues were virion morphology-independent and were simply typical of those associated with 
a LPAI infection (Spickler et al., 2008). Therefore, these data demonstrated that viral 
pathogenesis could be independent of virion morphology; however immunohistochemistry 
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against viral proteins would be needed to ensure the clinical manifestations in the tissues were 
associated with sites of viral infection. 
Overall, these data demonstrated that contact-infected birds with the filamentous 
mutant of Ck/Pakistan shed the virus via the buccal cavity to a similar titre but for longer periods 
of time than the WT virus. The filamentous mutant of Ck/Pakistan was also detected in water 
samples for longer periods of time than the spherical WT. Within the chicken host, even though 
both forms spread similarly and reached the same organs, the filamentous mutant replicated 
to a higher titre than the spherical WT in tracheal tissues. Lastly, as observed in chapter 4, 
spherical or filamentous forms of Ck/Pakistan showed similar levels of pathogenesis in H&E 
section, which could suggest that pathology is budding morphology-independent. By contrast, 
the in vivo data described in this chapter support the hypothesis that filamentous morphology 















Chapter 6: Concluding remarks and future directions 
6.1. Concluding remarks 
The aim of this study was to determine the predominant budding morphology 
presented by avian strains of IAV and, if filaments were shown to be a common occurrence, 
then determine their biological significance. In chapter 2, it was shown that avian isolates can 
be as pleomorphic as mammalian strains. Furthermore, segment 7 was also identified as the 
major morphology determinant for avian strains of IAV, thus PR8-based 7:1 reassortant virus 
with segments of avian strains were built and their budding phenotype characterised. 
Characterisation of these viruses revealed that filamentous ‘avian’ strains induced filament 
formation in over 40% of infected cells and the filamentous bundles were as long as 10 µm, 
comparable with previous results seen with mammalian strains of IAV. Next, it was asked 
whether avian strains also followed the “filamentous signature rules” previously identified 
within M1 of mammalian strains. The data described in chapter 3 suggested that was not the 
case; in fact, the budding morphology of specific avian strains was shown to depend on the 
amino acid identities at positions 59, 169 and 234 of M1. From this, it was hypothesised that 
positions 59, 169 and 234 of M1 could be budding morphology determinants for a wider range 
of avian strains. Bioinformatics coupled with statistical analysis revealed that the amino acid 
identity at position 234 of M1 was a strong predictor of budding morphology, as chicken viruses 
with isoleucine at this position tended to show a spherical budding morphology whereas duck 
viruses with leucine were filamentous. This hypothesis was experimentally corroborated as 
changing position 234 of M1 in a spherical chicken virus Ck/Pakistan induced the formation of 
filaments. In chapter 4 the growth of WT and M1-mutant viruses with opposing budding 
phenotypes was characterised, which showed that in an in vitro system the avian viruses 
replicated similarly, regardless of budding morphology. Yet, in ovo, a replication advantage 
was observed with spherical viruses in contrast with their filamentous counterparts, as 
previously reported (Seladi-Schulman et al., 2013). This chapter also addressed the pathology 
caused in chicken embryos upon infection with spherical or filamentous counterpart viruses, 
which indicated that budding morphology did not have a strong phenotypic effect in this 
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respect. Finally, in chapter 5 the aim was to determine the biological significance of filaments, 
thus the Ck/Pakistan chicken viruses built in chapter 3 were used. This virus pair had either a 
spherical (M1 234 Ile) or filamentous (M1 234 Leu) budding morphology and therefore 
provided a tool to test the role of filaments in vivo in the natural virus host (chicken). The data 
described in this chapter suggested that filamentous structures could play a role in shedding 
as the filamentous virus persisted in the respiratory tract of birds for longer periods of time and 
to higher titres than the spherical WT counterpart, and was shed in greater amounts  
A further outcome of the work presented here is the observation that chicken viruses 
were more likely to be non-filamentous while duck viruses were predominantly filamentous. 
This suggests that avian IAVs present in wild aquatic birds could be predominantly filamentous 
and, following adaptation to domestic poultry, lose this trait. This adaptation could be a result 
of the way domestic poultry is raised, as in a poultry shed filled with hundreds of chickens the 
virus is under lower selective pressure to transmit efficient as the chances of infecting a new 
host are very high, while in the wild aquatic birds, not kept in close contact, this pressure is 
maintained. 
 
6.2. Future directions 
6.2.1.  In vitro analysis 
Like with every PhD project, time is always a limiting step and many things are left 
undone and questions left unanswered, yet it is still a bulk of work that improves the current 
knowledge on the topic. In chapter 5, it was addressed the biological function of filamentous 
particles, which suggested a role in enhancing transmission of IAV particles. In addition, it 
would have been interesting to measure NA activity of the filamentous mutant of Ck/Pakistan, 
since several studies have reported that filamentous viruses transmitted better and had higher 
NA activities in comparison to their spherical counterparts, suggesting that M1 and NA 
activities could have a cumulative effect in enhancing transmission of filamentous viruses 
(Campbell et al., 2014; Seladi-Schulman et al., 2014). Furthermore, even though the 
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Ck/Pakistan filamentous virus showed a replication advantage in the tracheal tissue of 
chickens, it would be good to repeat this observation in vitro or ex vivo. For instance, Yang et 
al. developed an in-capsule-mucous penetration system to determine the role of NA during 
movement of swine IAV through a mucous layer (Yang et al., 2014). The system comprises of 
inserting a portion of mucous from the host of interest in a plastic capsule, overlaid with a 
certain amount of virus and allow for vertical dissemination of the virus through the mucus. To 
measure the distance travelled by the virus from the top of the mucus layer, the authors used 
cryo-sectioning and immunofluorescence assays. In fact, using a labelled virus and staining 
for mucins (to delineate the start of the mucus barrier), the authors showed that the virus 
reached a depth of 30 µm in just 2 min. Therefore, this could be an important system to 
determine how fast the two budding morphologies of IAV can penetrate the mucous barrier. 
Although this would provide information about speed, it does not provide information about 
replication fitness of filamentous and spherical viruses. Thus, another option would be to use 
cultures of tracheal organ rings (TOCs). Initial efforts at establishing this system in the 
laboratory showed that PR8 or PR8-based 7:1 avian reassortant viruses replicated well in 
TOCs and preliminary results showed a tendency for filamentous virus to replicate better in 
TOCs where the mucous barrier had not been cleared before infection (data not shown).  
 
6.2.2. In ovo and in vivo studies 
Even though it is well established that M1 is the major IAV morphology determinant, it 
is undeniable that the host also plays some role in determining particle shape as described 
before. Therefore, in ovo studies with duck eggs would be the next step to determine if a virus 
with a spherical morphology has the advantage in any embryonated egg or if morphology 
fitness is host-dependent, i.e., would a filamentous virus show an advantage in embryonated 
duck eggs in comparison with its spherical counterpart. Lastly, it would be interesting to 
perform the same animal experiment described in chapter 5 but with ducks instead of chickens. 
For instance, use a filamentous duck virus and its spherical counterpart and assess differences 
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in transmission, mortality rates and pathogenesis to determine if virion morphology is truly a 

















Chapter 7: Materials and methods 
7.1. Materials 
7.1.1. Antibodies and dyes 
Table 7.1 Primary antibodies and antisera raised against IAV and cellular proteins. 
Antibody Application Source 
Rabbit polyclonal anti-PR8 IF (1:500) (Amorim et al., 2007) 
Mouse monoclonal anti-NP (AA5H) IF (1:1000) Abcam (ab20343) 
Rabbit polyclonal anti-PR8 M1 
(A2917) 
WB (1:500) (Amorim et al., 2007) 
Rabbit polyclonal anti-MBP-NP 
(A2915) 
WB (1:500), plaque 
immunostaining (1:1000) 
(Noton et al., 2007) 
Rat monoclonal anti-alpha-tubulin WB (1:1000) Serotec (MCA77G) 
 
Table 7.2 Plant lectins. 
Lectin Application Source 
Concanavalin A Alexa Fluor® 488 conjugate IF (1:50) Life Technologies 
Wheat germ agglutinin biotinylated IF (1:50) Sigma 
Lycopersicon esculentum agglutinin biotinylated IF (1:50) Sigma 
 
Table 7.3 Secondary antibodies. 
Antibody Application Source 
Donkey anti-rabbit IgG (H+L) secondary 
antibody, Alexa Fluor® 488 conjugate 
IF (1:1000) Thermo Fisher (A-21206) 
Donkey anti-mouse IgG (H+L) secondary 
antibody, Alexa Fluor® 488 conjugate 
IF (1:1000) Thermo Fisher (A-21202) 
Streptavidin Alexa Fluor® 488 conjugate 1:200 Thermo Fisher (S11223) 
IRDye®800LT Donkey anti-rabbit IgG (H+L) WB (1:10000) Li-Cor 926-32213 
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IRDye®680LT Goat anti-rat IgG (H+L) WB (1:10000) Li-Cor 925-68076 





Table 7.4 Fluorescent dyes. 
Dye Application Source 
ProLong Gold Antifade Mountant with DAPI IF (neat) Invitrogen 
DAPI IF (1:10000) Invitrogen 
 
7.1.2. Oligonucleotides 
DNA oligonucleotides were synthesised by and purchased from Sigma. 
Table 7.5 Sequencing primers. 
Primer name Sequence (5’ to 3’) 
Uni12 AGCAAAAGCAGG 
pDUAL FWD ATGTCGTAACAACTCCGCCC 
pDUAL REV TTTTTGGGGACAGGTGTCCG 
PR8 HA internal FWD ACGGAGAAGGAGGGCTCATA 
PR8 HA internal REV TCCAGAGTCCTTTCATTTTCCAGT 
PR8 NA internal FWD TCTTTGTCCCATCCGTGGGT 
PR8 NA internal REV AAGCACGGCCTCATACAGTC 
PR8 NP internal FWD TGCGGGGAAGGATCCTAAGA 
PR8 NP internal REV CATCCTGGGATCCATTCCGG 
Dk/Netherlands HA internal FWD TGCTTTGGGGAGTGCATCAT 
Dk/Netherlands HA internal REV GTTGAACTCCTTGCTCACTGC 
Dk/Netherlands NA internal FWD GGTTTCAGTGACATTAGCGGG 
Dk/Netherlands NA internal REV GTCAGTTCTGGATGCTGGACA 
Dk/Netherlands NP internal FWD GGAGAGGCGAAAATGGACGA 
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Dk/Netherlands NP internal REV AGTCCGTACACACAAGCAGG 
M segment FWD (MF1) AGCAAAAGCAGGTAGATATTGAAAGA 
M segment REV (MR1027) AGTAGAAACAAGGTAGTTTTTTACTC 
 
Table 7.6 Site-directed mutagenesis primers. 
Primer name Sequence (5’ to 3’) 
Dk/India M1-A225G (aa 37) FWD CTTTGCAGGAAAGAACGCCGATCTCGAGGCTCT 
Dk/India M1-A225G (aa 37) REV AGAGCCTCGAGATCGGCGTTCTTTCCTGCAAAG 
Dk/India M1-T293G (aa 59) FWD 
CTGTCACCTCTGACTAAAGGGATGTTGGGATTTG
TATTCA 
Dk/India M1-T293G (aa 59) REV 
TGAATACAAATCCCAACATCCCTTTAGTCAGAGGT
GACAG 
Dk/India M1-A729G (aa 205) FWD CTAGCCTGATTAGCAACCTCCATGGCTTCCGCT 
Dk/India M1- A729G (aa 205) REV AGCGGAAGCCATGGAGGTTGCTAATCAGGCTAG 
Dk/Tripura M1-G230A (aa 37) FWD 
TCTTTGCAGGAAAGAACACCGATCTTGAGGCTCT
C 
Dk/Tripura M1-G230A (aa 37) REV 
GTGAATACAAATCCCAAAATCCCTTTAGTCAAAGG
TGACAGG 
Dk/Tripura M1-G298T (aa 59) FWD 
CCTGTCACCTTTGACTAAAGGGATTTTGGGATTT
GTATTCAC 
Dk/Tripura M1-G298T (aa 59) REV 
GTGAATACAAATCCCAAAATCCCTTTAGTCAAAGG
TGACAGG 
Dk/Tripura M1-G734A (aa 205) FWD TAGCCTGATTAGCGATCTCCATGGCTTCCGC 
Dk/Tripura M1-G734A (aa 205) REV GCGGAAGCCATGGAGATCGCTAATCAGGCTA 
Ck/Penn/1 M1-T550C (aa 169) FWD 
GCCTGATTAGTGGGTTGGTTGTTGTCACCATCTG
T 
Ck/Penn/1 M1-T550C (aa 169) REV 
ACAGATGGTGACAACAACCAACCCACTAATCAGG
C 










Ck/Italy M1-A725C (aa 234) FWD 
GTGCCGGTCTGAAAGATGATCTTCTTGAAAATTT
GCAGG 
Ck/Italy M1-A725C (aa 234) REV 
CCTGCAAATTTTCAAGAAGATCATCTTTCAGACCG
GCAC 








Ck/Pakistan M1-A700C (aa 234) FWD 
CTCAAGTGCAGGTCTAAAAGATGATCTTCTTGAAA
ATTTGCAGGC 




Table 7.7 Primer and probe for RT-qPCR. 
Target gene Sequence (5’ to 3’) Probe 




Table 7.8 Primers for cloning avian segment 7s into pDUAL. 
Strain Primer Sequence (5’ to 3’) 
Ck/Italy 
pDUAL + BsmBI site FWD 
GTATCGTCTCTGGGGAGCAAAAGCAGGTAG
A 




pDUAL + BsmBI site FWD 
GTATCGTCTCTGGGGAGCAAAAGCAGGTAG
A 






pDUAL + BsmBI site FWD 
GTATCGTCTCTGGGGAGCGAAAGCAGGTAG
A 




In blue is represented the BsmBI recognition site with a few nucleotides (underlined) 
as a spacer since the enzyme cuts upstream of the recognition site. In purple is represented 
the 5’ and 3’ UTR of the segment 7s. The nucleotides before the indicated in blue correspond 
to pDUAL sequences. 
7.1.3. Plasmids 
Table 7.9 Plasmids used throughout the study. 
Name Description Source 
pDUAL 
Reverse genetics plasmid system. RNA pol 
I and pol II promoters on either side of the 
insert for mRNA and vRNA-like synthesis. 
Prof Ron Fouchier (Erasmus 
University Medical centre, 
Rotterdam, Netherlands) 
pHH21 
Reverse genetics plasmid with a pol I 
promoter for the synthesis of vRNA-like. 
Prof Robert Lamb 
(Department of Molecular 
Biosciences, North-Western) 
pcDNA 3.1 
CMV pol II promoter upstream of the insert 
for constitutive protein expression. 
Invitrogen 
pCAGGS 
AG promoter (chicken β-actin linked to rabbit 
β globin) with a CMV enhancer, rabbit globin 
polyadenylation site and terminator for 
constitutive protein expression.  
Prof Munir Iqbal (The 
Pirbright Institute, Surrey, 
UK) 
pPol I Luc 
Reporter for minigenome reconstitution 
assays. Contains firefly luciferase reporter 
gene under the control of pPol I promotor. It 
is in the reverse orientation flanked by UTRs 
of PR8 segment 8. 
Dr Laurence Tiley (University 








7.1.4. Viruses and reverse genetics system 
7.1.4.1. A/Puerto Rico/8/1934 (H1N1) 
Table 7.10 Reverse genetics system for PR8. 
Plasmid backbone Segment Accession number Reference/Source 
pDUAL 
PB2 EF467818 
(de Wit et al., 2004) 
Kindly provided by Prof Ron 
Fouchier (Erasmus University 











Table 7.11 Avian strains from which segment 7s were used in this study.  
Strain 




A/duck/Korea/GJ54/2004 Synthesised from NCBI sequence GU351861 
A/duck/India/02CA10/2011 
Provided by Drs Ashwin Raut and Anika 
Mishra, ICAR, India (Kumar et al., 2017) 
CY089416 
A/duck/Tripura/103597/2008 
Provided by Drs Ashwin Raut and Anika 
Mishra, ICAR, India (Kumar et al., 2017) 
GU252825 
A/duck/Shandong/Q1/2013 Synthesised from NCBI sequence KM504104 
A/duck/Dongguan/2685/2013 Synthesised from NCBI sequence KP285008 
A/Duck/Shantou/1588/2000 Synthesised from NCBI sequence AF523499 
A/chicken/Pakistan/UDL-01/2008 
Provided by Prof Munir Iqbal, The 
Pirbright Institute (Iqbal et al., 2013) 
CY038461 
A/Zhejiang/DTID-ZJU01/2013  
Provided by Prof Chen Honglin, The 





Provided by Prof Lonneke Vervelde, The 
Roslin Institute, University of Edinburgh 
(Molesti et al., 2013) 
AJ416630 
A/duck/Mongolia/200/2015 
Provided by Prof Pablo Murcia, Centre for 
Virus Research, Glasgow 
- 
A/mallard/Netherlands/10-Cam/1999 
Provided by Prof Laurence Tiley, 
University of Cambridge (Bourret et al., 
2013) 
KC209518 
A/mallard/Wisconsin/1719/1983 Synthesised from NCBI sequence CY179300 
A/mallard/New York/170/1982 Synthesised from NCBI sequence CY014902 
A/chicken/Pennsylvania/1/1983 Provided by Dr Darrell kapczynski (USDA) CY015074 
A/chicken/Pennsylvania/1370/1983 Provided by Dr Darrell kapczynski (USDA) CY015109 
A/gull/Maryland/1824/1978 Synthesised from NCBI sequence JX982948 
A/turkey/South Dakota/7034/1986 Synthesised from NCBI sequence EU743168 
 
Table 7.12 Avian isolates used in this study. 
Strain Source 
A/duck/England/1962 
Prof Wendy Barclay, University College London, 
UK 
A/duck/Singapore/5/1997 
Prof Lonneke Vervelde, The Roslin Institute, 
University of Edinburgh 
A/chicken/Israel/215/2007  
Prof Lonneke Vervelde, The Roslin Institute, 
University of Edinburgh (Wang et al., 2016) 
A/chicken/Saudi Arabia/SP02525/3AAV/2000 
Prof Lonneke Vervelde, The Roslin Institute, 
University of Edinburgh (de Geus et al., 2011) 
A/chicken/Italy/1067/1999  
Prof Lonneke Vervelde, The Roslin Institute, 
University of Edinburgh (Molesti et al., 2013) 
A/turkey/Canada/1965 






7.1.4.2. A/Udorn/1972 (H3N2) 
Table 7.13 Reverse genetics system for Udorn. 
Plasmid backbone Segment Accession number Reference/Source 
pcDNA 3.1 
PB2 CY009643 
(Chen et al., 2007) 
Kindly provided by Prof Robert 
















7.1.4.3. A/mallard/Netherlands/10-Cam/1999 (H1N1) 
Table 7.14 Reverse genetics system for Dk/Netherlands. 
Plasmid backbone Segment Accession number Reference/Source 
pDUAL 
PB2 KC209512 
(Bourret et al., 2013) 
Kindly provided by Prof. 













7.1.4.4. A/chicken/Pakistan/UDL-01/2008 (H9N2) 
Table 7.15 Reverse genetics system for Ck/Pakistan. 
Plasmid backbone Segment Accession number Reference/Source 
pCAGGs PB1 CY038456 
(Iqbal et al., 2013) 
Kindly provided by Prof Munir 











7.1.5. Eukaryotic cells 
Table 7.16 Eukaryotic cell lines. 
Cell Description Source 
MDCK Madin-Darby Canine kidney cells Prof Bernadette Dutia, The Roslin Institute 
293T Human embryonic kidney cells ATCC 
QT-35 Japanese quail fibrosarcoma cells Dr Laurence Tiley, University of Cambridge 
DF-1 Chicken fibroblast cells Dr Lita Murphy, The Roslin Institute 
CEF Chicken embryo fibroblasts Prepared as detailed in 7.2.1.1 
CKC Chicken kidney cells Dr Inga Dry, The Roslin Institute 






7.1.6. Bacterial culture 
Table 7.17 Bacterial culture media. 
Medium name Composition Source 
Luria Broth (LB) 
10 g/L tryptone, 5 g/L yeast extract, 5 
g/L NaCl (pH 7.0) 
Central Service Unit (CSU) at 
the Roslin Institute 
LB agar 
15 g/L agar, 10 g/L tryptone, 5 g/L 
yeast extract, 10 g/L NaCl (pH 7.0) 
CSU 
CCMB 
10 mM potassium acetate (pH 7.0), 
10% Glycerol (w/v), 80 mM 
CaCl2.2H2O, 20 mM MnCl2.4H2O, 10 
mM MgCl2.6H2O 
Made as necessary with 
communal laboratory 




5 g/L yeast extract, 20 g/L tryptone, 0.5 
g/L NaCl, 2.5 mM KCl, 10 mM MgCl2, 




7.2.1. Cell culture 
MDCK, 293T, QT-35 and DF-1 cells (Table 7.16) were passaged and maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM, GIBCO), supplemented with 10% (v/v) Foetal 
Bovine Serum (FBS), 200 mM L-Glutamine (Life technologies), penicillin and streptomycin 
both at 100 U/ml (Life technologies), also referred to as complete DMEM, in tissue culture 
flasks (Corning, USA). Before passaging, cells were detached from the flask using 0.25% 
trypsin-EDTA solution (Life Technologies) for 5 to 15 min, resuspended 1:10 to 1:20 in 





7.2.1.1. Isolation of CEF cells 
CEF cells were prepared from 10-day old embryonated hens’ eggs (Henry Stewart 
and Co Ltd, UK). Embryos were killed by membrane disruption, removed from the egg and 
placed in a petri dish with sterile PBS for confirmation of death by decapitation. The head and 
viscera were removed and the bodies washed at least twice in PBS (138 mM NaCl, 2.7 mM 
KCl, 8 mM Na2HPO4, pH 6.7). The bodies were then chopped up using a sterile scalpel and 
scissors, passed through a 20 ml syringe (Fisher scientific) and loaded onto a 50 ml centrifuge 
tube (VWR). This was followed by at least three washes in PBS or until bodies were well 
homogenised using serially smaller syringes (ending with 10 ml ones). Between each wash, 
the cells were spun at 1500 rpm for 5 min and the supernatant discarded. Following this, 0.25% 
trypsin-EDTA solution was added to the homogenate (5 ml per embryo) and left to incubate for 
30 min at 37°C, 5% CO2. This solution was filtered with a small metal mesh filter and pelleted 
at 1500 rpm for 10 min. To the solid parts, it was added more 0.25% trypsin-EDTA solution 
and left to incubate as before. The supernatants recovered after these steps were passed 
through a 100 µm nylon filter and pelleted at 1500 rpm for 10 min. This step was repeated until 
no cells were recovered. The resulting cells were resuspended in 1 ml of M199 (Sigma) 
supplemented with 4% FBS and penicillin and streptomycin (Pen/Strep) both at 100 U/ml. The 
cells were then counted and seeded at a density of 1x106 cells/ml and incubated until 
confluency. Once this point was reached, cells were washed twice in PBS and dissociated 
using 0.25% trypsin-EDTA:HBSS (1:4). Medium as described above was added to neutralise 
the trypsin and cells were spun at 1500 rpm for 5 min. Following this, cells were resuspended 
in 6 ml (for a confluent T175 flask) of freezing medium (containing 10% DMSO and M199 
supplemented as before) and stored at -120ᵒC. When needed, cells were revived in M199 
supplemented with 10% FBS and penicillin and streptomycin (Pen/Strep) both at 100 U/ml, 
followed by passage in M199 supplemented with 7% FBS also with Pen/Strep and kept in 
M199 supplemented with 4% FBS containing Pen/Strep. Between each passage, cells were 




7.2.1.2. Culture of other primary cell types 
CKC cells were maintained in Eagle’s Minimum Essential Media (EMEM) (Sigma), 
supplemented with 10% (v/v) FBS, 10% (v/v) tryptose phosphate broth and penicillin and 
streptomycin both at 100 U/ml. CEF cells were maintained in M199, supplemented with 4% 
(v/v) FBS, 200mM L-Glutamine, penicillin and streptomycin both at 100 U/ml. DEF cells were 
maintained in DMEM, supplemented with 10% (v/v) FBS, 200 mM L-Glutamine, penicillin and 
streptomycin both at 100 U/ml. DEF cells were kept at 37ᵒC and CKC cells at 38ᵒC, both with 
5% CO2. When the cells were confluent, the media was removed, the cell monolayer washed 
with PBS and trypsin-EDTA solution was added to the flasks and incubated at 37ᵒC. When the 
monolayer started to detach, the cells were resuspended in complete medium and counted 
when necessary to seed in fresh flasks, multi-well plates or coverslips at the appropriate 
density. 
 
7.2.2. Molecular techniques 
7.2.2.1. Preparation of competent DH5α bacterial cells 
Stocks of Escherichia coli bacteria (strain DH5α) were used to produce competent 
cells. Briefly, at least 10 µl of a starter culture was propagated overnight in 5 ml of SOB medium 
at 37ºC on an orbital shaker. The next day, the culture was diluted 1:100 in 60 ml of SOB and 
incubated at 37ºC for 3 h on an orbital shaker until the optical density at 550 nm (OD550) was 
approximately 0.3. Spectrophotometry was performed using 1 ml of the bacterial culture using 
blank SOB medium only as a reference. For the first two hours, the OD550 was measured once 
every hour, however in the last hour measurements were taken every 15-30 min. Once the 
desired OD550 was reached, the bacteria were incubated on ice for 10 min followed by 
centrifugation at 3000 rpm at 4ºC for 10 min. The supernatant was removed and the pellet 
resuspended in 0.25X of the starting volume (15 ml) of cold CCMB media and left on ice for 4 
h. Bacteria were pelleted as before, resuspended in 1/12th of the starting volume (5 ml) of cold 
CCMB medium, and100 µl aliquots snap frozen on dry ice and stored at -80ºC. 
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7.2.2.4. Preparation of agar plates 
Briefly, 250 ml of LB agar (Table 7.17) was heated in a microwave or boiling water 
bath until all agar had dissolved. The LB agar was left for a minimum of 30 min at room 
temperature to cool before the appropriate selection antibiotic was added and the solution 
mixed. The liquid LB agar was poured into 100 mm x 20 mm petri dishes on a clean bench 
under the flame of a Bunsen burner. The agar plates were then left at room temperature for a 
minimum of 1 h to set and stored at 4ºC until further use. 
7.2.2.3. Transformation of competent DH5α bacterial cells 
The competent DH5α E. coli cells prepared before were used to amplify plasmid DNA. 
The bacterial cells (10-20 µl) were transformed with 20 to 50 ng of the plasmid DNA or mock-
transformed with Milli-Q water. This bacteria-DNA mixture was gently mixed and left on ice for 
a maximum of 30 min. Transformation was then performed by a 45 sec to 1 min heat shock at 
42ºC immediately followed by 5 min incubation on ice. After incubation, 750 µl of LB was added 
and the cells were placed in a shaker (180-200 rpm) for 1 h at 37ºC to recover. 100 µl of 
bacterial cells were spread onto agar plates containing the appropriate antibiotic using a sterile 
spreader whilst working under a flame. Agar plates were incubated in an inverted position 
overnight at 37ºC. The remaining volume of the transformation reaction was stored at 4ºC until 
confirmation of successfully transformed colonies along with the absence of colonies in the 
water-transformed bacteria under antibiotic selection. To amplify plasmid DNA from the 
transformed bacteria, single colonies were picked with a P200 tip and incubated in 5 ml of LB 
(mini-prep) or 50-100 ml of LB (midi-prep) with antibiotic selection at 37ºC in a shaker. 
Following overnight incubation, the bacterial cells were pelleted at 4300 rpm at 4ºC for 15 min 
and the supernatant discarded. Cells were then used to prepare the plasmid DNA or stored at 
-20ºC. 
7.2.2.4. Preparation of plasmid DNA 
Small preparations of plasmid DNA were isolated from overnight E. coli cultures using 
a QIAprep miniprep kit (Qiagen), while larger preparations used a QIAprep midiprep kit, as per 
191 
 
the manufacturer’s instructions. DNA was dissolved in Milli-Q water and the final concentration 
was determined by measuring the absorbance at 260 nm using a NanoDrop 
spectrophotometer. Plasmid integrity was also checked by agarose gel electrophoresis. 
7.2.2.5. Isolation of total RNA from allantoic fluid, cells, tissues and swabs 
RNA was extracted from virus-containing allantoic fluid of chicken eggs with average 
titres between 1x105 and 1x109 PFU/ml and cell culture supernatants with a minimum titre of 
1x104 PFU/ml. Extractions were performed using a QIAmp viral RNA mini kit (Qiagen), 
following the manufacturer’s instructions. Isolated RNA was dissolved in 30µl of Milli-Q water 
and quantified using a NanoDrop spectrophotometer. 
The chicken tissues collected (described in 7.7.5) were dissected using a sterile 
scalpel and scissors into appropriate size sections and added to safe-lock microcentrifuge 
tubes (Fisher scientific) with 700 µl of TRizol reagent (Life technologies) and one 5 mm 
stainless steel bead (Qiagen). The tissue was then homogenised in a TissueLyser II (Qiagen) 
for 4 to 12 min at 25 Hz. Following this, 300 µl of chloroform (Sigma) was mixed with the 
homogenate followed by centrifugation at 13,000 for 30 min at 4ºC. The upper aqueous phase 
was carefully collected, mixed with one volume of 70 % ethanol (typically 200 µl) and the RNA 
extracted using an RNeasy mini kit (Qiagen) according to the manufacturer’s instructions. Total 
RNA was extracted from buccal swab samples collected at days 8 and 10 p.i... Briefly, 100 µl 
of sample was mixed with 100 µl of acidic phenol:chloroform (Thermo Scientific) and vortexed 
vigorously for 5 sec. The mix was separated by centrifugation at 14,000 rpm for 5 min at 4ᵒC 
and the upper aqueous phase was transferred to a new tube. Another 100 µl of acidic 
phenol:chloroform was added and processed as before. Following this, the aqueous phase 
was collected and mixed with 1 µl of 3M sodium acetate (Invitrogen) and 250 µl of ice-cold 
100% ethanol (EtOH) (Sigma). This mix was incubated at -20ᵒC for 20 min and spun at 14,000 
rpm for 20 min at 4ᵒC. The supernatant was removed and the pellet washed with 500 µl of ice-
cold 70% EtOH before re-pelleted by centrifugation at 14,000 rpm for 10 min at 4ᵒC. The 




7.2.2.6 Reverse transcription (RT) 
Single-stranded cDNA was generated from IAV vRNA using a Verso cDNA synthesis 
kit (Thermo Scientific) and the Uni12 primer (Table 7.5), which anneals to the 12 conserved 
nucleotides present on the 3’ end of all IAV negative sense segments. Each RT reaction 
contained 1 µg of vRNA, 0.5 µM of Uni12 primer, 20% (v/v) cDNA synthesis buffer, 0.5 mM of 
each dNTP and 1 µl of reverse transcriptase up to a final volume of 20 µl. This was incubated 
at 65ᵒC for 10 min followed by 1 h at 42ᵒC and for RT enzyme inactivation, a step at 95ᵒC for 
2 min was performed. No template controls (Milli-Q water) were included separately. 
7.2.2.7. Polymerase chain reaction (PCR) 
Amplification of IAV segment cDNAs was carried out by Taq DNA polymerase 
(Invitrogen). Forward and reverse oligonucleotides were designed to complement conserved 
regions of segment 7 of the viruses in study (Table 7.5). To validate the sequence of 
reassortant or fully avian viruses, forward and reverse primers were designed for segments 4 
and 6 of A/PR/8/34 (H1N1) and A/mallard/Netherlands/10-Cam/1999 (H1N1). Each reaction 
contained: 5 mM of each dNTP, 1.5 mM MgCl2, 10 µM each primer and 20% (v/v) of the 
manufacturer’s 5X reaction buffer (Taq DNA polymerase, Invitrogen), up to a final volume of 
25 µl. The cycle used was as follows: 94ᵒC for 2 min, followed by 30 cycles at 94ᵒC for 1.5 min, 
55ᵒC for 1 min and 72ᵒC for 3 min, with a final step at 72ᵒC for 10 min. 
Selected avian segment 7s (Table 2.1) were synthesised, flanked by the BsmBI (New 
England Biolabs) site and a few more nucleotides to stabilise the restriction enzyme near the 
recognition site (Table 7.8). Thereafter, the segment 7s were amplified from their original 
plasmid using forward and reverse primers containing the BsmBI site as seen in table 7.8. The 
PCR reaction was prepared as before. 
7.2.2.8. Quantitative reverse transcription PCR (RT-qPCR) 
Tissues collected from the in vivo experiment were placed in RNA later and used for 
RT-qPCR reactions that were performed in MicroAmp optical 96-well reaction plates (Applied 
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Bioscience) using a 7500 Fast & Real-Time PCR system (Applied Biosystems). Samples were 
loaded in technical duplicate and no reverse transcriptase and no template (nuclease free 
water) controls were included. The output CT values and dissociation curves were analysed 
using 7500 software v2.3 (Applied Biosystems), Microsoft Excel and GraphPad Prism v7.00. 
Quantification of vRNA was done using a SuperScript III one-step reverse transcription PCR 
(RT-PCR) system with platinum Taq DNA Polymerase kit (Invitrogen) following the 
manufacturer’s instructions. Primers and a Taqman probe specific for a conserved region of 
IAV M1 protein were used as described previously (Spackman et al., 2002) (see table 7.7). 
The PCR program ran as follows: 50ºC for 5 min, 95ºC for 2 min and 40 cycles of 95ºC for 3 
seconds and 60ºC for 30 seconds. For the standard curve, a T7 transcribed RNA standard of 
the M gene from PR8 strain was used (provided by Dr Anabel Clements). The CT values were 
then extrapolated against this curve and the results expressed as M gene copy numbers. 
7.2.2.9. Agarose gel electrophoresis 
Agarose gel electrophoresis was carried out using 0.8-2% (w/v) agarose (Sigma-
Aldrich) gels depending on the size of DNA fragments to be separated, stained with SYBRSafe 
DNA gel stain (1:10,000) (Invitrogen). 1X DNA loading buffer (stock at 6X, New England 
Biolabs) was added to each sample prior to loading the gel and separation was performed at 
80-100 V for 45-60 min in 1X TAE running buffer, made with 0.04 M Tris-acetate and 1 mM 
EDTA and supplied by the central service unit (CSU) at the Roslin Institute. All agarose gel 
electrophoresis was carried out in a horizontal electrophoresis tank (Bio-Rad). 
7.2.2.10. Isolation of DNA fragments from agarose gels 
The vector used for cloning throughout this study (pDUAL) was enzymatically cut and 
linearized and agarose gel electrophoresis was performed in 2% (w/v) agarose gels to ensure 
efficient separation of cut and uncut vector. The DNA fragments were visualized on a UV 
transilluminator and the fragments of interest (linearized plasmid) excised from the gel using a 
sterile scalpel. The agarose slices containing DNA were transferred to a 1.5 ml centrifuge tube 




7.2.2.11. Purification of DNA segments 
DNA inserts containing the restriction site of BsmBI derived from PCR were purified to 
remove salts, nucleotides, primers and enzymes using a QIAquick PCR purification kit 
(Qiagen) as per the manufacturer’s instructions. DNA inserts were diluted in 30 µl of Milli-Q 
water. The vector to be used was isolated from agarose gels (see above) and purified using a 
QIAquick gel extraction kit (Qiagen) as per the manufacturer’s instructions. Vector DNA was 
diluted in 50 µl of Milli-Q water. 
7.2.2.12. Restriction enzyme digestion 
To clone DNA segments from one plasmid to another, inserts and vector (normally 
pDUAL unless otherwise indicated) were digested with BsmBI (New England Biolabs) for 2 h 
at 55ᵒC. Each reaction contained 10% (v/v) of the manufacturer’s 10X reaction buffer, 1-2 µg 
of DNA and 5-10 units of enzyme to a final volume of 50 µl in Milli-Q water. A water control 
was added to ensure that there was no other DNA contaminants present.  
7.2.2.13. Ligation of DNA fragments 
Prior to ligation, the vector DNA 5’ and 3’ ends were dephosphorylated to prevent self-
ligation of the plasmid, using rSAP phosphatase (New England Biolabs) according to the 
manufacturer’s instructions. Reactions with rSAP were prepared as follows: 1 µg of vector 
DNA, 2 µl of the 10X CutSmart buffer, 1 unit of rSAP and Milli-Q water up to a final volume of 
20 µl. This reaction was incubated at room temperature for a maximum of 30 min as indicated 
in the protocol for ligations involving sticky ends within the vector. rSAP was then inactivated 
at 65ºC for 5 min. 
For ligation of DNA inserts and plasmid vector, reactions were prepared with the 
following: 10% (v/v) of the ligation buffer (New England Biolabs), 40-50 ng of vector DNA, 
insert DNA (1:5 or 1:7 ratio (w/w)) and 1 µl of T4 DNA ligase in Milli-Q water to a final volume 
of 20 µl. The reaction was left at room temperature for between 30 min and 1 h. As a negative 
control, a ligation reaction was prepared containing only vector DNA. 5 µl of each ligation mix 
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were used to transform 25 µl of competent E.coli. Plasmid DNA was extracted from the 
resulting individual colonies as described before (section 7.3.4) and to check for the presence 
of DNA insert, DNA plasmids were digested for 1 h with Apa I (New England Biolabs) at 37ᵒC. 
Each reaction contained 10% (v/v) of the manufacturer’s 10X reaction buffer, 1 µg of DNA and 
5 U of enzyme to a final volume of 50 µl in Milli-Q water.  
7.2.2.14. Sanger sequencing 
Sequencing of purified DNA segments (plasmids or PCR amplicons) was performed 
by GATC biotech. A reaction mix was prepared as follows: 2.5 µM of the appropriate primer 
and 500 ng of plasmid DNA or 80 ng of PCR amplicon to a final volume of 10 µl in Milli-Q water. 
Sequencing results were analysed using BioEdit Sequence Alignment Editor V7.1.3.0, BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) to confirm the identity of the IAV segment and ExPASy 
(https://web.expasy.org/translate/) to determine amino acid sequence. 
RNA extracted from the buccal swab samples (as described in 7.3.5) was converted 
to cDNA and the M segment amplified by PCR. Prior to sequencing 10 µl of the PCR product 
was mixed with 4 µl of ExoSap-It enzyme to digest the primers and dephosphorylate 
nucleotides (Life technologies), as per the manufacturer’s instructions. Then, 9.5 µl of this mix 
with 0.5 µl of primer (at 10 µM/µl) were sent for sequencing. 
7.2.2.15. SDS-PAGE and Western blotting  
SDS-PAGE was performed using a resolving gel of 12% (v/v) stacked with a 4% (v/v) 
gel, which were prepared using reagents supplied by Protogel according to the manufacturer’s 
instructions. All electrophoresis was performed in a Bio-Rad tank (Mini-protean tetra system) 
at 80 V for 30 min to cross the stacking gel, followed by 140 V for 60 min. 
For western blotting analysis, SDS-PAGE gels were transferred to a 0.45 µm 
nitrocellulose membrane (GE healthcare) with the Trans-blot Turbo blotting system (Bio-Rad), 
according to the manufacturer’s instructions (7 min at 25V). Following semi-dry transfer, 
membranes were incubated in PBS with 0.1% Tween-20 (Sigma-Aldrich) (PBST) and 5% (w/v) 
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dried milk (from local supermarkets) for 60 min at room temperature on a rocking platform. 
Primary antibody was diluted at the desired ratio (see table 7.1) in PBST with 5% (w/v) dried 
milk and left for 1 h at room temperature or overnight at 4ºC, with rocking. The membrane was 
then washed 3 times for 5 min in PBST and incubated with secondary antibody diluted (Table 
7.3) in PBST with 5% (w/v) dried milk for 45-60 min at room temperature on a rocking platform. 
The membrane was again washed 3 times for 5 min in PBST and placed in PBS prior to 
imaging on an infrared scanner (LiCor). 
 
7.2.3. Virus work 
7.2.3.1. Generation of P0 stocks 
Recombinant viruses were rescued using eight- or twelve-plasmid transfection 
systems based on the pDUAL RNA Polymerase I/II promoter vector (Tables 7.10 and 7.11). 
293T cells at 70-80% confluency were transfected with 250 ng of each plasmid for each 
segment with 4 µl of Lipofectamine 2000 and Optimem to a final volume of 300 µl. The 
Lipofectamine/DNA/Optimem mix was left to incubate at room temperature for 30 min. In the 
meantime, complete medium was removed from the cells and 750 µl of DMEM supplemented 
with 10% (v/v) FBS and 200 mM L-Glutamine was added. The Lipofectamine/DNA/Optimem 
mix was then dripped over the cells and left overnight at 37ᵒC, 5% CO2. The following day, 
transfection medium was replaced by 1 ml of DMEM containing 200 mM L-Glutamine, penicillin 
and streptomycin both at 100 U/ml, 0.14% (v/v) Bovine Serum Albumin (BSA) (Sigma) and 1 
µg/ml of TPCK treated trypsin (Sigma) (Viral Growth Medium – VGM). The cells with VGM were 
left for 48 h at 37ᵒC, 5% CO2. After that, the supernatant containing the virus was harvested 
and cleared by low-speed centrifugation (5 min at 1500 rpm), giving a “passage zero” (P0) viral 
stock. The 7:1 reassortant virus with WT segment 7 of Ck/Penn/83 was rescued once as 
previously described. However, the counterpart reassortant virus with a mutated M1 gene was 
not possible to rescue this way. Instead, co-cultures of 293T and DF-1 or QT-35 cells were 




The avian 8-plasmid transfection system for A/mallard/Netherlands/10-Cam/1999 
(Table 7.14) used with Lipofectamine 2000 reagent only rescued virus with low efficiency (1 in 
5 attempts would be positive for viral rescue). Therefore, the transfection reagent XFect 
(Takara) and higher amounts of the reverse genetics plasmids were used. Briefly, 625 ng of 
each plasmid of the 8 plasmids was added to 80 µl of XFect reaction buffer and 1.5 µl of XFect 
polymer solution to a total of 100 µl. Following a 10 sec vortex, this mix was left to incubate at 
room temperature for 30 min before being dripped over 70-80% confluent 293T cells and left 
overnight at 37ᵒC, 5% CO2. The following day, the medium was replaced by 1 ml of VGM and 
the cells were left for 48 h at 37ᵒC, 5% CO2. The supernatant was harvested as described 
before. Xfect provided a 1:1 ratio of positive viral rescues for A/mallard/Netherlands/10-
Cam/1999. However, this methodology did not work for other hard-to-rescue viruses such as 
the PR8-based 7:1 reassortant virus with segment 7 of Ck/Penn/1. 
7.2.3.2. Generation of P1 stocks 
To generate P1 stocks, MDCK cells were seeded at 4x106 cells/ml in T25 flasks to 
reach confluency the next day. Cells were washed twice with PBS, inoculated with 100 µl of 
the P0 stock diluted in 1 ml of serum free DMEM (see above) and incubated for 1 h at 37ᵒC 
with gentle mixing every 30 min. After this, 5 ml of VGM (see above) was added and the cells 
were once again incubated at 37ᵒC for 48 h or until CPE was observed by comparison with 
cells inoculated with supernatants from mock transfected cells (Lipofectamine only control) or 
cells transfected with 7 instead of 8 RG plasmids (e.g. lacking PB1 segment). Following this, 
the supernatant of the cells was harvested and spun at 4500 rpm for 5 min at 4ᵒC, aliquoted in 
200-500 µl aliquots and stored at -80ᵒC until further use. For attempted rescues of the PR8-
based Ck/Penn/1 WT or M1-mutant viruses, 1 ml of the P0 stock (neat) was used to inoculate 
MDCK cells but with no success. Another method tried was to scrape off the 293T cells along 
with the supernatant (P0 stock) from the 6-well plate using a P1000 pipette and inoculate this 




7.2.3.3. Minigenome reconstitution assays 
To determine if the failed rescues of Ck/Penn/1 were due to incompatibility of the avian 
segment 7 with the PR8 polymerase, minigenome reconstitution assays were performed with 
the polymerase, NP and NS segments of PR8 and the WT or mutated segment 7 of Ck/Penn/1. 
NS segment was added because it was reported to aid in the nuclear export of M segment 
mRNA (Pereira et al., 2017). In this instance, NS1 was tagged with GFP for easier distinction 
between this protein and M1 by western blotting (Pereira et al., 2017). To reach approximately 
80-90% confluency on the day of use, 293T cells were seeded at 2x105 cells per well of a 24-
well plate. The following day, 50 ng of the plasmids mentioned above and 20 ng of the firefly 
reporter plasmid (pPol I luciferase) were diluted in 50 µl of Opti-MEM (GIBCO). Per reaction, 
1 µl of Lipofectamine 2000 was added to 50 µl of Opti-MEM and left at room temperature for 
5-10 min. This last mixture was added to the plasmid-Opti-MEM solution and incubated at 
room temperature for a minimum of 30 min. At this point, the complete DMEM of 293T cells 
was removed and 500 µl of Opti-MEM was added per well. Following the incubation period, 
the transfection mix was dripped over the 293T cells and these were incubated for 48 h at 
37ºC, 5% CO2. Next, the medium was removed and the cells lysed with 120 µl of 1X reporter 
lysis buffer (Promega). Following scraping and mixing of the cells, the lysates were pelleted at 
13,000 rpm for 2 min at 4ºC and the supernatants collected into new tubes and placed on ice. 
60 µl of the cell lysate was added to a white-bottom 96-well plate (Corning) and kept on ice. 
To add the luciferase substrate, the promega GloMax multi detection reader was used to infect 
25 µl of 0.6 mM beetle luciferin (Promega) per well and to measure luciferase activity (200 
µl/sec injection speed, 0.5 sec gap and 5 sec integration time). The reconstitution assay 
showed that the PR8 RNPs were actively transcribing the luciferase reporter gene (figure 7.1 
A.) 
7.2.3.4. Protein electrophoresis and western blotting analyses for the detection of M1 
from Ck/Penn/1 
While the luciferase expression data from the minigenome reconstitution assays 
proved that the system was generating active PR8 RNPs, it remained unknown at this point 
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whether M1 was being expressed. Therefore, aliquots of cell lysate from the reconstitution 
assays were analysed by western blotting (see section 7.2.2.15). Cells transfected in 24-well 
plates were washed once in PBS and lysed in 2X laemmli’s buffer (final volume of 200 µl). The 
lysates were boiled at 100ºC for 10 min and 15 µl were loaded onto a polyacrylamide gel and 
the proteins separated as described before followed by western blotting (see section 7.2.2.15). 
In addition to the detection of M1 and NP viral proteins, the host protein tubulin was used as a 
loading control. Virus-infected cells with PR8 and mock transfected cells were used as positive 
and negative controls, respectively. As expected, mock-transfected cells or cells incubated 
only with lipofectamine and Opti-mem showed no detectable levels of the viral proteins. All 
cells were transfected with NP and two (2PNP) or three (3PNP) components of the RdRp. Only 
in the presence of 3PNP (i.e., active RNP) it was possible to detect the expression of M1 with 
Ck/Penn/1370 but not Ck/Penn/1 (Figure 7.1 B). NS1 expression was detected in all 3PNP 
transfected cells, thus the lack of M1 expression was not due to the lack of NS1 (data not 
shown). Therefore, these results suggest that the segment 7 of Ck/Penn/1 might be 
incompatible with the PR8 RdRp, but Ck/Penn/1 was not available to use. This may explain 
the difficulty in rescuing Ck/Penn/1 7:1 in a PR8 backbone and the unsuccessful tries at 
rescuing Ck/Penn/1 M1 mutant virus. 
7.2.3.5. Generation of mutant viruses by site-directed mutagenesis of RG plasmids 
Specific segment 7s were mutated with the primers indicated in table 7.6. Mutagenesis 
was performed using the QuickChange lightning site-directed mutagenesis kit as per the 
manufacturer’s instructions (Agilent technologies). The PCR to introduce point mutations on 
the specific segment 7s contained: 2.5 µl of the kit’s Ta10X reaction buffer, 30 ng of plasmid 
DNA (with segment 7 inserted), 62.5 ng of each forward and reverse primer, 0.5 µl of dNTP 
mix, 0.5 µl of Pfu Turbo DNA polymerase and the appropriate volume of Milli-Q water to make 
up to 25 µl of reaction. After the PCR reaction, DpnI enzyme was added (10 U/reaction) to 
digest methylated parental DNA that did not possess the desired mutation. Next, 5 µl of the 
PCR reactions were used to transform XL-10 gold competent E. coli bacterial cells with a heat 
shock at 42ºC for 30 sec. Bacterial cells were left to recover for 1 h in 500 µl of SOB medium 




Figure 7.1 Minigenome reconstitution assay with Ck/Penn/1 and Ck/Penn/1370 M segment 
and PR8 RNP. (A) Minigenome reconstitution assays were performed in 293T cells transfected 
with 50 ng of the indicated plasmids and 20 ng of luciferase plasmid reporter. Cells were lysed 
at 48 h post transfection. Luciferin was added and relative light units (RLU) were measured. 
One way ANOVA analysis was performed to compare all samples to mock-transfected cells. 
Data represent mean +/- SD (n = 2 biological replicates with 2 technical replicates each). ** p 
< 0.01; *** p < 0.001; **** p < 0.0001. Spherical viruses are represented in blue and filamentous 
in orange. (B) WB analysis was performed to detect the expression of M1 from 
Ck/Pennsylvania segment 7s. NP expression levels were used as a positive control for the 
detection of viral proteins and tubulin was used as a loading control. A sample of PR8-infected 
lysed cells was also included as a positive control for the detection of M1. All cells were 
transfected with PB2, PA and NP (2PNP) and PB1 (3PNP). WT indicates WT segment 7 of 





Following recovery, the bacterial cells were spun for 1 min at 8,000 rpm and resuspended in 
100 µl of the medium, which were used to plate the bacteria into LB agar plates with ampicillin 
selection overnight at 37ºC in an inverted position. A minimum of 5 colonies were picked, 
amplified in LB overnight and DNA plasmid extraction was performed as described before 
(section 7.3.1). The plasmid DNA was then used to generate P0 and P1 viral stocks with the 
mutated segment 7s in the PR8 or avian background as described previously. 
7.2.3.6 Growth of virus in embryonated chicken eggs 
P0 viral stocks were obtained as described in section 7.4.1.1 and 100 µl used to infect 
10-day old embryonated chicken eggs via the allantoic fluid cavity. Eggs were incubated for 
48 h at 37.5ᵒC with 40-50% humidity. Mock-infected eggs were inoculated with 100 µl of DMEM 
containing 200 mM of L-Glutamine and penicillin and streptomycin both at 100 U/ml. Infection 
was performed by puncturing the shell at the top of the egg and just below the line of the air 
sac, where inoculation was carried out.  These small holes were then sealed with Scotch Magic 
tape and the eggs incubated as above. After infection, eggs were chilled at 4ᵒC overnight and 
the allantoic fluid harvested after disruption of the top of the shell and air sac membrane with 
forceps. Allantoic fluid was clarified by centrifugation at 4500 rpm for 10 minutes at 4ᵒC and 
this P1 stock was stored at -80ᵒC until further use.  
7.2.3.7. Haemagglutination assays (HA spot) 
To confirm the presence of virus in allantoic fluid from infected eggs, HA spot tests 
were performed. Briefly, 50 µl of allantoic fluid was mixed with 50 µl of 1% (v/v) of chicken red 
blood cells (TCS Biosciences) in a V-bottom 96-well plate (Fisher Scientific) and left for 30 min 
at room temperature. A sample with PBS and blood mixed at a 1:1 ratio was added to check 
blood cell integrity. 
7.2.3.8. Haemagglutination inhibition (HAI) assays 
HAI assays were performed to assess the presence of reactive antibodies against 
influenza virus in pre-infected chicken sera. Chicken serum (50 µl) was serially diluted in a 2-
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fold dilution in a 96-well v-bottom plate and mixed with 25 µl of Ck/Pakistan and the plate 
incubated at 37ºC for 1 h to allow the neutralisation of the virus by the neutralising antibodies. 
Following this incubation, 50 µl of 1% (v/v) chicken red blood cells was added to each well and 
the plates incubated at room temperature for 30 to 45 min. 
7.2.3.9. Quantification of viral load by plaque assay 
Viral titre determination was performed on monolayers of MDCK cells, which were 
seeded in a 6-well plate at a density of 4x106 cells per well on the day prior to infection to reach 
a 100% confluency the next day. On the day of infection, cells were washed once with PBS, 
infected with 450 µl of 10-fold dilutions (in serum free DMEM) of viral stocks (10-2 to 10-7) and 
incubated for 1 h at 37ᵒC, 5% CO2. Following incubation, cells were overlaid with 1:1 of VGM 
and 2.4% (w/v) Avicel (FMC Biopolymer) in H2O and left for 48 h at 37ᵒC, 5% CO2. Cells were 
then fixed with 2 ml of 10% neutralised buffered formalin (NBF) for at least 20 min and either 
stained with toluidine blue or immunostained for viral NP. For NP staining, cells were 
permeabilised with 0.2% Triton X-100 in PBS for 10 min at room temperature on a rocking 
platform and washed twice with PBS. Following permeabilisation, cells were incubated with 
rabbit anti-NP diluted 1:1000 in 2% BSA in PBS for 1 h at room temperature on a rocking 
platform. Cells were then washed twice with PBS and incubated with anti-rabbit-Horse Radish 
Peroxidase (HRP) antibody (diluted as above) for 1 h at room temperature on a rocking 
platform. Cells were washed three times with PBS and NP viral protein was detected with a 
TrueBlue kit (Kirkegaard & Perry Labs), as per the manufacturer’s instructions. 
Viral load quantification of the tissues collected from in vivo studies (section 7.2.6.4) 
was performed with 50 mg of tissue processed as described in 7.3.5. For this, MDCK cells 
were washed, infected as before but overlaid with agarose overlay medium and left for 72 h. 
This medium contained: 0.6% (w/v) low-melting point agarose (Oxoid), 10% (v/v) of EMEM, 
0.21% (w/v) of BSA, 1 mM of L-Glutamine, 0.15% (v/v) of sodium bicarbonate (Sigma), 10 mM 
of HEPES (Sigma), 1X Penicillin-Streptomycin, 0.01% (v/v) Dextran DEAE (Sigma) and 2 
µg/ml TPCK treated trypsin. Following 72 h, solid overlay media was removed and the cells 
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fixed and stained with a solution of 1:1 methanol:acetone containing crystal violet stain 
(Sigma). 
7.2.3.10. Embryonic lethality assays 
To measure embryo viability following infection, 10-day old embryonated chicken eggs 
were mock-infected (serum free DMEM) or infected (as described before) with increasing 
quantities of virus ranging from 0.001 to 1 PFU in 10-fold increments. The viruses were diluted 
in serum free DMEM to reach the desired PFU dose. The eggs were then incubated at 37.5ºC 
with 40-50% humidity and embryo viability was checked every 12 hrs by candling the eggs for 
at least 60 sec followed by record of embryo movement. This was performed over a period of 
96 hrs and when a loss of embryo viability was detected, eggs were chilled overnight at 4ºC 
followed by confirmation of death by membrane disruption. Following the infection period, 1 ml 
of allantoic fluid from each egg was harvested and used to test for the presence of infectious 
virus by HA spot tests (described above). 
7.2.3.11. Viral infections 
The cells used for these studies were typically seeded the day prior to infection to 
reach approximately 70-80% confluency on the day of infection. Cells were washed once with 
PBS and incubated with virus stock (diluted in serum free DMEM to achieve the desired MOI) 
for 1 h at 37ᵒC, 5% CO2. 
7.2.3.12. Multicycle infections  
Multicycle infections were typically performed in monolayers of cells in 12-well plates 
infected with 300 µl of virus stock diluted in serum free DMEM to a MOI of 0.01 and kept for 1 
h at 37ᵒC with 5% CO2. Following virus adsorption, the cells were overlaid with VGM and the 
supernatants harvested at 48 h p.i., cleared by centrifugation at 4,500 rpm for 5 min and stored 




7.2.3.13. Single cycle infections 
Single cycle infections were typically performed in monolayers of cells in 24-well plates 
incubated for 1 h with 200 µl of virus stock diluted in serum free medium. To test the best 
conditions to study the filamentous budding morphology of IAV, cells were infected at MOI of 
3 for 8, 12, 16, 20 or 24 hrs at 37ºC. Representative images from each time point at different 
MOI are shown in figure 7.2. Based on this, infections were performed in complete DMEM at 
a MOI of 3 for a period of 16 h and kept at 37ᵒC with 5% CO2. 
 
7.2.4. Fluorescent imaging 
7.2.4.1. Antibody staining 
Virus-infected cells seeded on glass coverslips following single cycle infections were 
washed once in PBS and fixed in 4% formaldehyde for a maximum of 20 min at room 
temperature. Following fixation, cells were washed three times for 5 min each time with 
PBS/1% FBS on a rocking platform. For staining of cytoplasmic or nuclear proteins, cells were 
permeabilised for 5 min with 0.2% TX-100 in PBS, followed by PBS/1% FBS washes as 
described before. At this point, the primary antibody was added to the cells at the appropriate 
dilution (see table 7.1) for 1 h at room temperature or overnight at 4ºC on a rocking platform. 
Following primary antibody incubation, cells were washed three times with PBS/1% FBS as 
described before. The secondary antibody was then added at the appropriate dilution (see 
table 7.3) and the cells were kept in the dark for 45 min at room temperature on a rocking 
platform. The secondary antibody incubation also included DAPI (Table 7.4) to delineate 
nuclei. Coverslips were mounted on microscope slides using ~10 µl drops of ProLong Gold 
antifade reagent (Life technologies) and stored in the dark at 4ºC before imaging. 
7.2.4.2. Lectin staining 
Cells infected with avian IAV isolates had to be surface-stained with plant lectins, as 
































Figure 7.2 IF assays at different time points. MDCK cells were infected with PR8 WT or PR8 
MUd at MOI of 3 and fixed at the times indicated. Cells were stained with antibody against 
whole PR8 virus that on unpermeabilised cells mainly detects HA (green) and DAPI for nuclei 
(blue). At 8 h and 12 h p.i., filamentous bundles were just starting to appear on the surface of 
the cells, whereas at 16 h p.i. it seemed that the bundles had reached a maximum length. At 
20h and 24h p.i. it was possible to see bundles of filaments detaching from the cells. It was 
also noted that at 20 and 24 h p.i. the cells started to round up and detach, especially with PR8 
WT-infected cells. Therefore, MOI of 3 at 16 h p.i. was selected for use throughout the study. 
Scale bar (20 µm) indicated. Z-stack images were collected using a LSM710 confocal 
microscope and maximum intensity projections are represented. 
206 
 
cycle infection, cells were washed once with PBS and fixed with 4% formaldehyde for a 
maximum of 20 min at room temperature. Cells were then washed three times with PBS, 5 min 
each, on a rocking platform at room temperature. Lectin was added (see table 7.2) for 1 h at 
room temperature on a rocking platform. Three 5 min washes with PBS were then performed 
and the avidin-FITC complex was added to biotin-conjugated lectins (Table 7.3) along with 
DAPI (Table 7.4) and left at room temperature for 45 min on a rocking platform. Following this 
incubation, cells were washed in PBS as before and mounted on microscope slides as 
previously. 
7.2.4.3. Imaging 
Once the cells in glass coverslips were mounted and dried on microscope slides, these 
were imaged on a LEICA DMLB epifluorescence microscope (using 20X or 40X lenses) or a 
Zeiss LSM710 confocal microscope (40X or 63X lenses). These images were collected as 
stacking files and tif files. The stacking files were further processed in ImageJ. For the confocal 
microscope, all the images presented in this study are maximum intensity projections of Z-
stacks taken across the depth of the plasma membrane at approximately 0.30-0.45 µm 
increments. The excitation wavelengths typically used were410-467 m for cells stained with 
488-Alexa fluorophore and 493-586 m for the detection of DAPI staining. The  
pinhole size was of 51 µm for the detection of 493-586 m wavelengths and of 41 µm for 
wavelengths within 410-467 m. The scanning was done in frame mode with an average of 0.03 
ms per line, 0.64 µs per pixel and 1.56 sec per frame with a kalman averaging of two to improve 
signal to noise ratio and prevent bleaching of the sample. The image size was of 1024x1024 
pixels with an 8-bit depth. The scanner zoom was generally kept at 1 in the x and y axis. Images 






7.2.5. Study of in ovo pathology 
To study the gross and tissue pathology of virus- or mock-infected chicken embryos, 
these were killed by membrane disruption followed by decapitation. For photographic record, 
the embryos were pulled from the egg and placed in a petri dish with PBS. Embryos were 
photographed along with a ruler for scale purposes, on the day of harvesting. Following this, 
embryos were decapitated with a scalpel and placed in 10% neutralised buffered formalin 
(NBF) for a minimum of 24 h. Embryos to be stained for H&E were sent to the pathology 
department at the Royal (Dick) School of Veterinary Studies at the Easter Bush Campus in 
Edinburgh, where they were paraffin-embedded, sectioned and stained for H&E.  
Embryos to be used for titre determination were killed as described above and washed 
in PBS twice. Embryos were macerated through a 50 ml syringe and then through a 20 ml 
syringe inside a 50 ml falcon tube which contained 2 ml of serum free DMEM. This homogenate 
was vortexed for 30 sec to 1 min and centrifuged at 4500 rpm for 10 min at 4ºC to remove the 
solid debris. 1 ml aliquots were harvested and stored at -80ºC until further use. 
 
7.2.6. In vivo experiments 
7.2.6.1. Ethics statement 
All animal procedures were performed as instructed by the United Kingdom Home 
Office Guidelines under the Animals (Scientific procedures) Act 1986, and the protocols 
approved by the Home Office of the United Kingdom. All chicken experimentation was carried 
out under an approved project license (Numbers: P68D44CF4X and PPL3002952) and by 
licensed personnel. Individual studies were performed after a study request protocol had been 






All chicken animal work with IAV was performed in self-contained BioFlex B50 Rigid 
Body Poultry isolators (Bell Isolation systems) at the Pirbright Institute Containment level 2 + 
facility. 
7.2.6.3. In vivo viral infections 
Mixed sex 3-week old specific pathogen free Rhode Island Red chickens bred at the 
Pirbright Institute poultry production unit were used. Pre-infection sera were obtained from all 
chickens and were all negative for antibodies reactive against A/chicken/Pakistan/UDL-
01/2008 through HAI assays performed by Dr Jean-Remy Sadeyen (data not shown). 
Chickens were separated into groups: Mock, WT and mutant. The WT and mutant groups were 
housed in self-contained poultry isolators, while the mock group was kept in the Pen floor. 
Chickens were infected with 50 µl per nostril of 105 PFU/ml of virus or mock-infected with the 
same volume of PBS using a P200 Gilson pipette, performed by Dr Jean-Remy Sadeyen at 
the Pirbright Institute. At day 1 or 5 p.i., naïve sentinel birds were introduced into the isolators 
with the infected birds in order to determine if transmission occurred. At 13 days p.i., birds were 
humanely culled using 1 ml of pentobarbital and sera samples collected for analysis of virus 
specific antibodies. 
All birds were tested for the presence of virus daily by swabbing both buccal and 
cloacal cavities with sterile polyester tipped swabs (Fisher Scientific), which were submerged 
in 1 ml of viral transport media (WHO, 2006), vortexed for 10 sec, clarified by centrifugation at 
1500 rpm for 10 min at 4ºC, aliquoted in 400 µl aliquots and stored at -80ºC until further use. 
7.2.6.4. Tissue collection 
At days 3 and 13 p.i. four birds from each group (only 3 birds for WT at day 3) were 
humanely culled as described above and organs (nasal tissue, trachea, lungs, liver, 
duodenum, spleen, kidney, bursa, cecal tonsils, colon and brain) were snap frozen for 
infectious titre determination, for viral genome quantification by RT-qPCR of M segment in 
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RNA later, or were placed in 10% NBF for histopathology analysis. Where possible, the tissues 
were harvested from the same region (e.g. upper trachea) 
7.2.6.5. Infectious virus isolation from infected tissues 
At days 3 p.i., the snap frozen tissues were thawed on ice and 50 mg of each tissue 
was cut up using sterile scalpels and forceps. The tissue was placed in a 1.5 ml centrifuge 
tube with 250 µl of PBS with 1% (v/v) Pen/Strep and nystatin (Sigma) and a 5 mm stainless 
steel bead. The tissues were then homogenised in a tissue lyser II for 4 min at 28 Hz. The 
homogenate was centrifuged at 13,000 rpm for 10 min at 4ºC and the supernatant harvested 
and kept on ice to proceed with plaque assays for the detection of infectious virus.  
7.2.6.6. Environmental sampling of food and water 
Food and water samples were collected daily from the isolators with infected chickens 
(WT or mutant) and from the pen floor where mock-infected chickens were kept. 1.5 ml 
centrifuges were used to collect approximately 1 g of food and 1 ml of water. The food samples 
were dissolved in 1 ml of serum free DMEM and vortexed until homogeneous. The samples 
were centrifuged at 13,000 rpm for 20 min at 4ºC and the supernatant stored at -80ºC until 
further use. To the water samples, 250 µl of Pen/Strep and nystatin (100U/ml) were added and 
these were stored as above. 
 
7.2.7. Bioinformatics analysis 
To select the segment 7 nucleotide sequences, just over 8000 complete sequences 
were collected from the Influenza Research Database (www.fludb.org) on May 2016. A 
random subsample of 2000+ sequences was selected, aligned in MEGA6 and grouped into a 
phylogenetic tree with the help of Dr Sam Lycett. This tree was divided into clades based on 
the oldest identified branches within the tree, as it would guarantee more distinction between 
clades. The sequences that composed the clades were copied into an Excel spreadsheet and 
a random number generator was used to decide which segment 7s to synthesise. 
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The sequences used in figure 3.12 were collected in June 2017 from the Influenza 
Research Database, grouped into avian hosts using Excel and aligned with MEGA6. A script 
from Dr Sam Lycett was adapted to identify the amino acids present at the desired positions. 
Then, the amino acid prevalence overall was calculated as: 
(
# sequences with specific amino at specific position
# total sequences
) × 100. For the amino acid prevalence within 
chicken and duck sequences, the denominator was replaced for the number of chicken or duck 
sequences.  
7.2.7.1. Structural modelling  
Predicted tertiary structures of M1 were obtained using the online programme I-
TASSER (https://zhanglab.ccmb.med.umich.edu/I-TASSER/) (Yang et al., 2015) using the 
programme’s default settings. All protein models were further processed using PyMOL 
molecular graphics system (https://pymol.org/2/). 
7.2.7.2. Filamentous phenotype quantification 
To quantify the filamentous budding phenotype two measurements were collected: % 
of infected cells producing filamentous bundles and the average length of these bundles. Virus-
infected cells were imaged and a total of 6 pictures portraying different fields of view were 
collected per virus over a total of three independent experiments. The % of infected cells was 
calculated as indicated: 
# cells producing filaments
# infected cells
 × 100. To determine the length of the 
filamentous bundles produced, 15 filamentous bundles were randomly selected per field of 
view (or picture), as illustrated in figure 7.3. These bundles were measured in ImageJ 
(Schneider et al., 2012) in pixels and converted to µm as indicated: 
bundle length (pixels) × scale bar (µm)







7.2.8. Statistical analysis 
Most statistical analyses were performed in GraphPad prism v7.00 or Microsoft Excel. 
In chapter 3, the statistical analysis with the Fisher’s exact test was performed in R, for which 
Dr Sam Lycett designed a script to fit the research questions of the project (see table 3.2). In 
chapter 5, the data from the in vivo studies was tested for normality in GraphPad using 






















Figure 7.3 Example length measurements for filamentous bundles. MDCK cells were infected 
with PR8-based 7:1 reassortant virus with segment 7 from Dk/Netherlands at an MOI of 3 and 
fixed 16 h p.i.. Cells were stained with antibody against whole PR8 virus that mainly detects 
HA (green) and DAPI to delineate the nuclei (blue) before imaging by confocal microscopy. 
Filamentous bundles present on the surface of the cells were measured as indicated by the 
white scale bars. Scale bars were fitted to the image that were measured in ImageJ in pixel 
units, which were then used to convert the pixel size of the bundles into µm. The filamentous 
bundles were selected as randomly as possible to represent the overall population. Per 
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